{
  "metadata": {
    "mode": "rag",
    "provider": "openai",
    "model": "gpt-4o-mini",
    "temperature": 0.0,
    "question_type": "domain-relevant",
    "rag_file_name": "voyage_voyage-3-large_chunk512_k80_global_rerank_k20-baseline.json",
    "prompt_template": "You are a financial expert. Answer the question based on the provided evidence from financial documents.\n\nEvidence:\n{evidence}\n\nQuestion: {question}\n\nProvide:\n1. Your reasoning: Analyze the relevant information from the evidence\n2. Final answer: A clear, concise answer based strictly on the evidence",
    "template_alias": "domain_rag_basic",
    "structured_output": true,
    "output_schema": {
      "reasoning": "Step-by-step reasoning and analysis",
      "final_answer": "The final answer only (concise and precise)"
    },
    "structured_output_method": "with_structured_output",
    "dataset": "PatronusAI/financebench",
    "dataset_split": "train",
    "total_questions": 50,
    "total_dataset_questions": 150,
    "generated_at": "2025-11-09T20:50:32.005691Z",
    "call_delay": 1,
    "max_retries": 3
  },
  "queries": [
    {
      "financebench_id": "financebench_id_00499",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning)",
      "question": "Is 3M a capital-intensive business based on FY2022 data?",
      "doc_name": "3M_2022_10K",
      "company": "3M",
      "answer": "No, the company is managing its CAPEX and Fixed Assets pretty efficiently, which is evident from below key metrics:\nCAPEX/Revenue Ratio: 5.1%\nFixed assets/Total Assets: 20%\nReturn on Assets= 12.4%",
      "reasoning": "To determine if 3M is a capital-intensive business based on FY2022 data, we can analyze the capital spending and property, plant, and equipment (PP&E) figures provided in the evidence. In FY2022, 3M's capital spending was $1,749 million, which is a significant investment in PP&E. Additionally, the net PP&E as of December 31, 2022, was $9,178 million. This indicates that 3M allocates a substantial portion of its resources to maintain and expand its physical assets, which is characteristic of capital-intensive businesses. Furthermore, the company is increasing its investment in manufacturing and sourcing capabilities to align with product demand, further emphasizing its capital-intensive nature. The evidence also highlights that capital expenditures are essential for growth and efficiency, which aligns with the definition of a capital-intensive business. Therefore, based on the significant capital spending and the focus on maintaining and expanding physical assets, it can be concluded that 3M is indeed a capital-intensive business.",
      "generated_answer": "Yes, 3M is a capital-intensive business based on FY2022 data.",
      "evidence": [
        {
          "evidence_text": "3M Company and Subsidiaries\nConsolidated Statement of Income\nYears ended December 31\n(Millions, except per share amounts)\n2022\n2021\n2020\nNet sales\n$\n34,229 $\n35,355 $\n32,184",
          "doc_name": "3M_2022_10K",
          "evidence_page_num": 47,
          "evidence_text_full_page": "Table of Contents\n3M Company and Subsidiaries\nConsolidated Statement of Income\nYears ended December 31\n(Millions, except per share amounts)\n2022\n2021\n2020\nNet sales\n$\n34,229 $\n35,355 $\n32,184 \nOperating expenses\nCost of sales\n19,232 \n18,795 \n16,605 \nSelling, general and administrative expenses\n9,049 \n7,197 \n6,929 \nResearch, development and related expenses\n1,862 \n1,994 \n1,878 \nGain on business divestitures\n(2,724)\n \n(389)\nGoodwill impairment expense\n271 \n \n \nTotal operating expenses\n27,690 \n27,986 \n25,023 \nOperating income\n6,539 \n7,369 \n7,161 \nOther expense (income), net\n147 \n165 \n366 \nIncome before income taxes\n6,392 \n7,204 \n6,795 \nProvision for income taxes\n612 \n1,285 \n1,337 \nIncome of consolidated group\n5,780 \n5,919 \n5,458 \nIncome (loss) from unconsolidated subsidiaries, net of taxes\n11 \n10 \n(5)\nNet income including noncontrolling interest\n5,791 \n5,929 \n5,453 \nLess: Net income (loss) attributable to noncontrolling interest\n14 \n8 \n4 \nNet income attributable to 3M\n$\n5,777 $\n5,921 $\n5,449 \nWeighted average 3M common shares outstanding basic\n566.0 \n579.0 \n577.6 \nEarnings per share attributable to 3M common shareholders basic\n$\n10.21 $\n10.23 $\n9.43 \nWeighted average 3M common shares outstanding diluted\n567.6 \n585.3 \n582.2 \nEarnings per share attributable to 3M common shareholders diluted\n$\n10.18 $\n10.12 $\n9.36 \nThe accompanying Notes to Consolidated Financial Statements are an integral part of this statement.\n48\n"
        },
        {
          "evidence_text": "3M Company and Subsidiaries\nConsolidated Balance Sheet\nAt December 31\n(Dollars in millions, except per share amount)\n2022\n2021\nAssets\nCurrent assets\nCash and cash equivalents\n$\n3,655 $\n4,564 \nMarketable securities current\n238 \n201 \nAccounts receivable net of allowances of $174 and $189\n4,532 \n4,660 \nInventories\nFinished goods\n2,497 \n2,196 \nWork in process\n1,606 \n1,577 \nRaw materials and supplies\n1,269 \n1,212 \nTotal inventories\n5,372 \n4,985 \nPrepaids\n435 \n654 \nOther current assets\n456 \n339 \nTotal current assets\n14,688 \n15,403 \nProperty, plant and equipment\n25,998 \n27,213 \nLess: Accumulated depreciation\n(16,820)\n(17,784)\nProperty, plant and equipment net\n9,178 \n9,429 \nOperating lease right of use assets\n829 \n858 \nGoodwill\n12,790 \n13,486 \nIntangible assets net\n4,699 \n5,288 \nOther assets\n4,271 \n2,608 \nTotal assets\n$\n46,455 $\n47,072",
          "doc_name": "3M_2022_10K",
          "evidence_page_num": 49,
          "evidence_text_full_page": "Table of Contents\n3M Company and Subsidiaries\nConsolidated Balance Sheet\nAt December 31\n(Dollars in millions, except per share amount)\n2022\n2021\nAssets\nCurrent assets\nCash and cash equivalents\n$\n3,655 $\n4,564 \nMarketable securities current\n238 \n201 \nAccounts receivable net of allowances of $174 and $189\n4,532 \n4,660 \nInventories\nFinished goods\n2,497 \n2,196 \nWork in process\n1,606 \n1,577 \nRaw materials and supplies\n1,269 \n1,212 \nTotal inventories\n5,372 \n4,985 \nPrepaids\n435 \n654 \nOther current assets\n456 \n339 \nTotal current assets\n14,688 \n15,403 \nProperty, plant and equipment\n25,998 \n27,213 \nLess: Accumulated depreciation\n(16,820)\n(17,784)\nProperty, plant and equipment net\n9,178 \n9,429 \nOperating lease right of use assets\n829 \n858 \nGoodwill\n12,790 \n13,486 \nIntangible assets net\n4,699 \n5,288 \nOther assets\n4,271 \n2,608 \nTotal assets\n$\n46,455 $\n47,072 \nLiabilities\nCurrent liabilities\nShort-term borrowings and current portion of long-term debt\n$\n1,938 $\n1,307 \nAccounts payable\n3,183 \n2,994 \nAccrued payroll\n692 \n1,020 \nAccrued income taxes\n259 \n260 \nOperating lease liabilities current\n261 \n263 \nOther current liabilities\n3,190 \n3,191 \nTotal current liabilities\n9,523 \n9,035 \nLong-term debt\n14,001 \n16,056 \nPension and postretirement benefits\n1,966 \n2,870 \nOperating lease liabilities\n580 \n591 \nOther liabilities\n5,615 \n3,403 \nTotal liabilities\n31,685 \n31,955 \nCommitments and contingencies (Note 16)\nEquity\n3M Company shareholders equity:\nCommon stock par value, $.01 par value; 944,033,056 shares issued\n9 \n9 \nShares outstanding - December 31, 2022: 549,245,105\nShares outstanding - December 31, 2021: 571,845,478\nAdditional paid-in capital\n6,691 \n6,429 \nRetained earnings\n47,950 \n45,821 \nTreasury stock, at cost:\n(33,255)\n(30,463)\nAccumulated other comprehensive income (loss)\n(6,673)\n(6,750)\nTotal 3M Company shareholders equity\n14,722 \n15,046 \nNoncontrolling interest\n48 \n71 \nTotal equity\n14,770 \n15,117 \nTotal liabilities and equity\n$\n46,455 $\n47,072 \nThe accompanying Notes to Consolidated Financial Statements are an integral part of this statement.\n50\n"
        },
        {
          "evidence_text": "3M Company and Subsidiaries\nConsolidated Statement of Cash Flows\nYears ended December 31\n(Millions)\n2022\n2021\n2020\nCash Flows from Operating Activities\nNet income including noncontrolling interest\n$\n5,791 $\n5,929 $\n5,453 \nAdjustments to reconcile net income including noncontrolling interest to net cash provided by operating\nactivities\nDepreciation and amortization\n1,831 \n1,915 \n1,911 \nLong-lived and indefinite-lived asset impairment expense\n618 \n \n6 \nGoodwill impairment expense\n271 \n \n \nCompany pension and postretirement contributions\n(158)\n(180)\n(156)\nCompany pension and postretirement expense\n178 \n206 \n322 \nStock-based compensation expense\n263 \n274 \n262 \nGain on business divestitures\n(2,724)\n \n(389)\nDeferred income taxes\n(663)\n(166)\n(165)\nChanges in assets and liabilities\nAccounts receivable\n(105)\n(122)\n165 \nInventories\n(629)\n(903)\n(91)\nAccounts payable\n111 \n518 \n252 \nAccrued income taxes (current and long-term)\n(47)\n(244)\n132 \nOther net\n854 \n227 \n411 \nNet cash provided by (used in) operating activities\n5,591 \n7,454 \n8,113 \nCash Flows from Investing Activities\nPurchases of property, plant and equipment (PP&E)\n(1,749)\n(1,603)\n(1,501)",
          "doc_name": "3M_2022_10K",
          "evidence_page_num": 51,
          "evidence_text_full_page": "Table of Contents\n3M Company and Subsidiaries\nConsolidated Statement of Cash Flows\nYears ended December 31\n(Millions)\n2022\n2021\n2020\nCash Flows from Operating Activities\nNet income including noncontrolling interest\n$\n5,791 $\n5,929 $\n5,453 \nAdjustments to reconcile net income including noncontrolling interest to net cash provided by operating\nactivities\nDepreciation and amortization\n1,831 \n1,915 \n1,911 \nLong-lived and indefinite-lived asset impairment expense\n618 \n \n6 \nGoodwill impairment expense\n271 \n \n \nCompany pension and postretirement contributions\n(158)\n(180)\n(156)\nCompany pension and postretirement expense\n178 \n206 \n322 \nStock-based compensation expense\n263 \n274 \n262 \nGain on business divestitures\n(2,724)\n \n(389)\nDeferred income taxes\n(663)\n(166)\n(165)\nChanges in assets and liabilities\nAccounts receivable\n(105)\n(122)\n165 \nInventories\n(629)\n(903)\n(91)\nAccounts payable\n111 \n518 \n252 \nAccrued income taxes (current and long-term)\n(47)\n(244)\n132 \nOther net\n854 \n227 \n411 \nNet cash provided by (used in) operating activities\n5,591 \n7,454 \n8,113 \nCash Flows from Investing Activities\nPurchases of property, plant and equipment (PP&E)\n(1,749)\n(1,603)\n(1,501)\nProceeds from sale of PP&E and other assets\n200 \n51 \n128 \nAcquisitions, net of cash acquired\n \n \n(25)\nPurchases of marketable securities and investments\n(1,250)\n(2,202)\n(1,579)\nProceeds from maturities and sale of marketable securities and investments\n1,261 \n2,406 \n1,811 \nProceeds from sale of businesses, net of cash sold\n13 \n \n576 \nCash payment from Food Safety business split-off, net of divested cash\n478 \n \n \nOther net\n1 \n31 \n10 \nNet cash provided by (used in) investing activities\n(1,046)\n(1,317)\n(580)\nCash Flows from Financing Activities\nChange in short-term debt net\n340 \n(2)\n(143)\nRepayment of debt (maturities greater than 90 days)\n(1,179)\n(1,144)\n(3,482)\nProceeds from debt (maturities greater than 90 days)\n1 \n1 \n1,750 \nPurchases of treasury stock\n(1,464)\n(2,199)\n(368)\nProceeds from issuance of treasury stock pursuant to stock option and benefit plans\n381 \n639 \n429 \nDividends paid to shareholders\n(3,369)\n(3,420)\n(3,388)\nOther net\n(60)\n(20)\n(98)\nNet cash provided by (used in) financing activities\n(5,350)\n(6,145)\n(5,300)\nEffect of exchange rate changes on cash and cash equivalents\n(104)\n(62)\n48 \nNet increase (decrease) in cash and cash equivalents\n(909)\n(70)\n2,281 \nCash and cash equivalents at beginning of year\n4,564 \n4,634 \n2,353 \nCash and cash equivalents at end of period\n$\n3,655 $\n4,564 $\n4,634 \nThe accompanying Notes to Consolidated Financial Statements are an integral part of this statement.\n52\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01226",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Numerical reasoning OR Logical reasoning",
      "question": "What drove operating margin change as of FY2022 for 3M? If operating margin is not a useful metric for a company like this, then please state that and explain why.",
      "doc_name": "3M_2022_10K",
      "company": "3M",
      "answer": "Operating Margin for 3M in FY2022 has decreased by 1.7% primarily due to: \n-Decrease in gross Margin\n-mostly one-off charges including Combat Arms Earplugs litigation, impairment related to exiting PFAS manufacturing, costs related to exiting Russia and divestiture-related restructuring\ncharges",
      "reasoning": "In FY2022, 3M's operating margin was impacted by several factors as outlined in the provided evidence. The operating income margin decreased from 20.8% in 2021 to 19.1% in 2022, a decline of 1.7 percentage points. Key drivers of this change included: 1) Increased costs of sales, which rose to 56.2% of net sales from 53.2% in 2021, primarily due to higher raw materials and logistics costs, as well as special item costs related to significant litigation. 2) Selling, general and administrative expenses (SG&A) also increased significantly, from 20.4% to 26.5% of net sales, reflecting higher litigation costs and investments in growth initiatives. 3) The company faced manufacturing productivity headwinds and supply chain challenges, exacerbated by geopolitical issues and the ongoing impacts of COVID-19. 4) While there were benefits from strong pricing and spending discipline, these were not sufficient to offset the increased costs. Overall, the combination of rising costs and increased expenses led to a decline in operating margins for 3M in FY2022. Therefore, operating margin is a useful metric for 3M as it reflects the company's ability to manage costs and expenses relative to its sales, which is critical for assessing operational efficiency and profitability.",
      "generated_answer": "The operating margin change for 3M in FY2022 was driven by increased costs of sales, higher SG&A expenses, manufacturing productivity headwinds, and supply chain challenges, leading to a decline from 20.8% to 19.1%.",
      "evidence": [
        {
          "evidence_text": "SG&A, measured as a percent of sales, increased in 2022 when compared to the same period last year. SG&A was impacted by increased special item costs for significant\nlitigation primarily related to steps toward resolving Combat Arms Earplugs litigation (discussed in Note 16) resulting in a 2022 second quarter pre-tax charge of approximately\n$1.2 billion, certain impairment costs related to exiting PFAS manufacturing (see Note 15), costs related to exiting Russia (see Note 15), divestiture-related restructuring\ncharges (see Note 5), and continued investment in key growth initiatives. These increases were partially offset by restructuring benefits and ongoing general 3M cost\nmanagement.",
          "doc_name": "3M_2022_10K",
          "evidence_page_num": 26,
          "evidence_text_full_page": "Table of Contents\nRESULTS OF OPERATIONS\nNet Sales:\nRefer to the preceding Overview section and the Performance by Business Segment section later in MD&A for additional discussion of sales change.\nOperating Expenses:\n(Percent of net sales)\n2022\n2021\nChange\nCost of sales\n56.2 %\n53.2 %\n3.0 %\nSelling, general and administrative expenses (SG&A)\n26.5 \n20.4 \n6.1 \nResearch, development and related expenses (R&D)\n5.4 \n5.6 \n(0.2)\nGain on business divestitures\n(8.0)\n \n(8.0)\nGoodwill impairment expense\n0.8 \n \n0.8 \nOperating income margin\n19.1 %\n20.8 %\n(1.7)%\nThe Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales,\nSG&A, and R&D.\nCost of Sales:\nCost of sales, measured as a percent of sales, increased in 2022 when compared to the same period last year. Increases were primarily due to 2022 special item costs for\nsignificant litigation from additional commitments to address PFAS-related matters at 3M's Zwijndrecht, Belgium site (discussed in Note 16), higher raw materials and logistics\ncosts, manufacturing productivity headwinds which were further magnified by the shutdown of certain operations in Belgium and progress on restarting previously-idled\noperations, and investments in growth, productivity and sustainability. On a percent of sales basis, these increases were partially offset by increases in selling prices.\nSelling, General and Administrative Expenses:\nSG&A, measured as a percent of sales, increased in 2022 when compared to the same period last year. SG&A was impacted by increased special item costs for significant\nlitigation primarily related to steps toward resolving Combat Arms Earplugs litigation (discussed in Note 16) resulting in a 2022 second quarter pre-tax charge of approximately\n$1.2 billion, certain impairment costs related to exiting PFAS manufacturing (see Note 15), costs related to exiting Russia (see Note 15), divestiture-related restructuring\ncharges (see Note 5), and continued investment in key growth initiatives. These increases were partially offset by restructuring benefits and ongoing general 3M cost\nmanagement.\nResearch, Development and Related Expenses:\nR&D, measured as a percent of sales, decreased in 2022 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application\ndevelopment, product and manufacturing support, product development and technology development aimed at disruptive innovations.\nGain on Business Divestitures:\nIn the third quarter of 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of its Food Safety business with Neogen\nCorporation. Refer to Note 3 for further details.\nGoodwill Impairment Expense:\nAs a result of 3M's commitment to exit per- and polyfluoroalkyl substance (PFAS) manufacturing, 3M recorded a goodwill impairment charge related to the Advanced\nMaterials reporting unit (within the Transportation and Electronics business). Refer to Note 15 for further details.\n27\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00807",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Logical reasoning",
      "question": "Does 3M have a reasonably healthy liquidity profile based on its quick ratio for Q2 of FY2023? If the quick ratio is not relevant to measure liquidity, please state that and explain why.",
      "doc_name": "3M_2023Q2_10Q",
      "company": "3M",
      "answer": "No. The quick ratio for 3M was 0.96 by Jun'23 close, which needs a bit of an improvement to touch the 1x mark",
      "reasoning": "To assess 3M's liquidity profile, we need to consider the quick ratio, which is calculated as (Current Assets - Inventories) / Current Liabilities. From the evidence, we have the following data for June 30, 2023:\n- Current Assets: $15,754 million\n- Inventories: $5,280 million\n- Current Liabilities: $10,936 million\n\nCalculating the quick ratio:\nQuick Ratio = (Current Assets - Inventories) / Current Liabilities \n= ($15,754 million - $5,280 million) / $10,936 million \n= $10,474 million / $10,936 million \n≈ 0.96\n\nA quick ratio of 0.96 indicates that 3M has nearly enough liquid assets (excluding inventories) to cover its current liabilities, which suggests a reasonably healthy liquidity position. However, a quick ratio below 1.0 may indicate potential liquidity concerns, as it suggests that current liabilities exceed liquid assets. \n\nAdditionally, the evidence states that 3M maintains a strong liquidity profile, with cash and cash equivalents of $4,258 million and access to commercial paper markets, which further supports the notion of adequate liquidity. Therefore, while the quick ratio is slightly below 1.0, the overall liquidity position appears to be supported by other factors such as cash reserves and market access.",
      "generated_answer": "Yes, 3M has a reasonably healthy liquidity profile based on its quick ratio of approximately 0.96 for Q2 of FY2023, although it is slightly below 1.0.",
      "evidence": [
        {
          "evidence_text": "3M Company and Subsidiaries\nConsolidated Balance Sheet\n(Unaudited)\n(Dollars in millions, except per share amount)\nJune 30, 2023\nDecember 31, 2022\nAssets\nCurrent assets\nCash and cash equivalents\n$\n4,258 \n$\n3,655 \nMarketable securities current\n56 \n238 \nAccounts receivable net of allowances of $160 and $174\n4,947 \n4,532 \nInventories\nFinished goods\n2,526 \n2,497 \nWork in process\n1,527 \n1,606 \nRaw materials and supplies\n1,227 \n1,269 \nTotal inventories\n5,280 \n5,372 \nPrepaids\n674 \n435 \nOther current assets\n539 \n456 \nTotal current assets\n15,754 \n14,688 \nProperty, plant and equipment\n26,459 \n25,998 \nLess: Accumulated depreciation\n(17,248)\n(16,820)\nProperty, plant and equipment net\n9,211 \n9,178 \nOperating lease right of use assets\n812 \n829 \nGoodwill\n12,869 \n12,790 \nIntangible assets net\n4,470 \n4,699 \nOther assets\n5,764 \n4,271 \nTotal assets\n$\n48,880 \n$\n46,455 \nLiabilities\nCurrent liabilities\nShort-term borrowings and current portion of long-term debt\n$\n3,033 \n$\n1,938 \nAccounts payable\n3,231 \n3,183 \nAccrued payroll\n785 \n692 \nAccrued income taxes\n172 \n259 \nOperating lease liabilities current\n244 \n261 \nOther current liabilities\n3,471 \n3,190 \nTotal current liabilities\n10,936 \n9,523",
          "doc_name": "3M_2023Q2_10Q",
          "evidence_page_num": 4,
          "evidence_text_full_page": "Table of Contents\n3M Company and Subsidiaries\nConsolidated Balance Sheet\n(Unaudited)\n(Dollars in millions, except per share amount)\nJune 30, 2023\nDecember 31, 2022\nAssets\nCurrent assets\nCash and cash equivalents\n$\n4,258 \n$\n3,655 \nMarketable securities current\n56 \n238 \nAccounts receivable net of allowances of $160 and $174\n4,947 \n4,532 \nInventories\nFinished goods\n2,526 \n2,497 \nWork in process\n1,527 \n1,606 \nRaw materials and supplies\n1,227 \n1,269 \nTotal inventories\n5,280 \n5,372 \nPrepaids\n674 \n435 \nOther current assets\n539 \n456 \nTotal current assets\n15,754 \n14,688 \nProperty, plant and equipment\n26,459 \n25,998 \nLess: Accumulated depreciation\n(17,248)\n(16,820)\nProperty, plant and equipment net\n9,211 \n9,178 \nOperating lease right of use assets\n812 \n829 \nGoodwill\n12,869 \n12,790 \nIntangible assets net\n4,470 \n4,699 \nOther assets\n5,764 \n4,271 \nTotal assets\n$\n48,880 \n$\n46,455 \nLiabilities\nCurrent liabilities\nShort-term borrowings and current portion of long-term debt\n$\n3,033 \n$\n1,938 \nAccounts payable\n3,231 \n3,183 \nAccrued payroll\n785 \n692 \nAccrued income taxes\n172 \n259 \nOperating lease liabilities current\n244 \n261 \nOther current liabilities\n3,471 \n3,190 \nTotal current liabilities\n10,936 \n9,523 \nLong-term debt\n12,954 \n14,001 \nPension and postretirement benefits\n1,912 \n1,966 \nOperating lease liabilities\n570 \n580 \nOther liabilities\n14,651 \n5,615 \nTotal liabilities\n41,023 \n31,685 \nCommitments and contingencies (Note 14)\nEquity\n3M Company shareholders equity:\nCommon stock par value, $.01 par value; 944,033,056 shares issued\n9 \n9 \nShares outstanding - June 30, 2023: 551,992,430\nShares outstanding - December 31, 2022: 549,245,105\nAdditional paid-in capital\n6,858 \n6,691 \nRetained earnings\n40,290 \n47,950 \nTreasury stock, at cost:\n(32,926)\n(33,255)\nShares at June 30, 2023: 392,040,626\nShares at December 31, 2022: 394,787,951\nAccumulated other comprehensive income (loss)\n(6,433)\n(6,673)\nTotal 3M Company shareholders equity\n7,798 \n14,722 \nNoncontrolling interest\n59 \n48 \nTotal equity\n7,857 \n14,770 \nTotal liabilities and equity\n$\n48,880 \n$\n46,455 \nThe accompanying Notes to Consolidated Financial Statements are an integral part of this statement.\n5\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00941",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Which debt securities are registered to trade on a national securities exchange under 3M's name as of Q2 of 2023?",
      "doc_name": "3M_2023Q2_10Q",
      "company": "3M",
      "answer": "Following debt securities registered under 3M's name are listed to trade on the New York Stock Exchange:\n-1.500% Notes due 2026 (Trading Symbol: MMM26)\n-1.750% Notes due 2030 (Trading Symbol: MMM30)\n-1.500% Notes due 2031 (Trading Symbol: MMM31)",
      "reasoning": "To determine which debt securities are registered to trade on a national securities exchange under 3M's name as of Q2 of 2023, we can refer to Evidence 3 and Evidence 4. Evidence 3 lists the securities registered pursuant to Section 12(b) of the Act for 3M, which includes: 1.500% Notes due 2026 (MMM26), 1.750% Notes due 2030 (MMM30), and 1.500% Notes due 2031 (MMM31). Evidence 4 confirms that as of June 30, 2023, 3M had a total debt profile that included these notes, indicating they are still active and registered. Therefore, the registered debt securities are those listed in Evidence 3.",
      "generated_answer": "1.500% Notes due 2026 (MMM26), 1.750% Notes due 2030 (MMM30), 1.500% Notes due 2031 (MMM31)",
      "evidence": [
        {
          "evidence_text": "Title of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Stock, Par Value $.01 Per Share\nMMM\nNew York Stock Exchange\nMMM\nChicago Stock Exchange, Inc.\n1.500% Notes due 2026\nMMM26\nNew York Stock Exchange\n1.750% Notes due 2030\nMMM30\nNew York Stock Exchange\n1.500% Notes due 2031\nMMM31\nNew York Stock Exchange",
          "doc_name": "3M_2023Q2_10Q",
          "evidence_page_num": 0,
          "evidence_text_full_page": "Table of Contents\nUNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWASHINGTON, D.C. 20549\nFORM 10-Q\n QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\nFor the quarterly period ended June 30, 2023\nor\no TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\nFor the transition period from __________ to __________\nCommission file number: 1-3285\n3M COMPANY\n(Exact name of registrant as specified in its charter)\nDelaware\n41-0417775\n(State or other jurisdiction of incorporation)\n(IRS Employer Identification No.)\n3M Center, St. Paul, Minnesota\n55144-1000\n(Address of Principal Executive Offices)\n(Zip Code)\n(Registrants Telephone Number, Including Area Code) (651) 733-1110\nNot Applicable\n(Former Name or Former Address, if Changed Since Last Report)\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Stock, Par Value $.01 Per Share\nMMM\nNew York Stock Exchange\nMMM\nChicago Stock Exchange, Inc.\n1.500% Notes due 2026\nMMM26\nNew York Stock Exchange\n1.750% Notes due 2030\nMMM30\nNew York Stock Exchange\n1.500% Notes due 2031\nMMM31\nNew York Stock Exchange\nNote: The common stock of the Registrant is also traded on the SIX Swiss Exchange.\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or\nfor such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No \nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this\nchapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No \nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the\ndefinitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.:\nLarge accelerated filer\n\nAccelerated filer\n\nNon-accelerated filer\n\nSmaller reporting company\n\nEmerging growth company\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. \nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No \nIndicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.\nClass\nOutstanding at June 30, 2023\nCommon Stock, $0.01 par value per share\n551,992,430 shares\n1\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00438",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR information extraction",
      "question": "Does Adobe have an improving operating margin profile as of FY2022? If operating margin is not a useful metric for a company like this, then state that and explain why.",
      "doc_name": "ADOBE_2022_10K",
      "company": "Adobe",
      "answer": "No the operating margins of Adobe have recently declined from 36.8% in FY 2021 to 34.6% in FY2022. A drop by 2.2% in a year.",
      "reasoning": "To determine if Adobe has an improving operating margin profile as of FY2022, we need to analyze the operating margin data provided in the evidence. Evidence 1 shows that Adobe's operating income for FY2022 was $6,098 million, with total revenue of $17,606 million, resulting in an operating margin of approximately 34.6%. In Evidence 6, it is noted that the operating profit margin increased by 100 basis points to 18.3% in FY2022. However, this figure seems to refer to adjusted operating profit margins, which can differ from the standard operating margin calculated from the income statement. Evidence 14 indicates that the adjusted operating profit margin decreased by 50 basis points to 16.9% in FY2022. This suggests that while the operating income increased, the adjusted operating margin, which accounts for certain non-recurring items, actually declined. Therefore, while Adobe's operating income has improved, the adjusted operating margin indicates a slight deterioration in profitability when adjusted for specific items. \n\nAdditionally, the evidence suggests that Adobe's business model, which heavily relies on subscription revenue, may not always align with traditional operating margin metrics. Subscription-based companies often focus on metrics like Annual Recurring Revenue (ARR) and customer acquisition costs, which can provide a more accurate picture of long-term profitability and growth potential. Thus, while Adobe's operating margin has shown some improvement, the adjusted operating margin's decline indicates that it may not be a straightforward improvement in profitability. \n\nIn conclusion, while Adobe's operating income has improved, the adjusted operating margin has decreased, suggesting that operating margin may not be the most useful metric for evaluating Adobe's financial health given its subscription-based model.",
      "generated_answer": "Adobe does not have an improving operating margin profile as of FY2022; the adjusted operating margin decreased, indicating potential profitability concerns despite increased operating income.",
      "evidence": [
        {
          "evidence_text": "ADOBE INC.\nCONSOLIDATED STATEMENTS OF INCOME\n(In millions, except per share data)\n \nYears Ended\n \nDecember 2,\n2022\nDecember 3,\n2021\nNovember 27,\n2020\nRevenue:\n \nSubscription\n$ \n16,388 $ \n14,573 $ \n11,626 \nProduct\n \n532 \n555 \n507 \nServices and other\n \n686 \n657 \n735 \nTotal revenue\n \n17,606 \n15,785 \n12,868 \n \nCost of revenue:\nSubscription\n \n1,646 \n1,374 \n1,108 \nProduct\n \n35 \n41 \n36 \nServices and other\n \n484 \n450 \n578 \nTotal cost of revenue\n \n2,165 \n1,865 \n1,722 \n \nGross profit\n \n15,441 \n13,920 \n11,146 \n \nOperating expenses:\nResearch and development\n \n2,987 \n2,540 \n2,188 \nSales and marketing\n \n4,968 \n4,321 \n3,591 \nGeneral and administrative\n \n1,219 \n1,085 \n968 \nAmortization of intangibles\n \n169 \n172 \n162 \nTotal operating expenses\n \n9,343 \n8,118 \n6,909 \n \nOperating income\n \n6,098 \n5,802 \n4,237",
          "doc_name": "ADOBE_2022_10K",
          "evidence_page_num": 53,
          "evidence_text_full_page": "ADOBE INC.\nCONSOLIDATED STATEMENTS OF INCOME\n(In millions, except per share data)\n \nYears Ended\n \nDecember 2,\n2022\nDecember 3,\n2021\nNovember 27,\n2020\nRevenue:\n \nSubscription\n$ \n16,388 $ \n14,573 $ \n11,626 \nProduct\n \n532 \n555 \n507 \nServices and other\n \n686 \n657 \n735 \nTotal revenue\n \n17,606 \n15,785 \n12,868 \n \nCost of revenue:\nSubscription\n \n1,646 \n1,374 \n1,108 \nProduct\n \n35 \n41 \n36 \nServices and other\n \n484 \n450 \n578 \nTotal cost of revenue\n \n2,165 \n1,865 \n1,722 \n \nGross profit\n \n15,441 \n13,920 \n11,146 \n \nOperating expenses:\nResearch and development\n \n2,987 \n2,540 \n2,188 \nSales and marketing\n \n4,968 \n4,321 \n3,591 \nGeneral and administrative\n \n1,219 \n1,085 \n968 \nAmortization of intangibles\n \n169 \n172 \n162 \nTotal operating expenses\n \n9,343 \n8,118 \n6,909 \n \nOperating income\n \n6,098 \n5,802 \n4,237 \n \nNon-operating income (expense):\nInterest expense\n \n(112) \n(113) \n(116) \nInvestment gains (losses), net\n \n(19) \n16 \n13 \nOther income (expense), net\n \n41 \n \n42 \nTotal non-operating income (expense), net\n \n(90) \n(97) \n(61) \nIncome before income taxes\n \n6,008 \n5,705 \n4,176 \nProvision for (benefit from) income taxes\n \n1,252 \n883 \n(1,084) \nNet income\n$ \n4,756 $ \n4,822 $ \n5,260 \nBasic net income per share\n$ \n10.13 $ \n10.10 $ \n10.94 \nShares used to compute basic net income per share\n \n470 \n477 \n481 \nDiluted net income per share\n$ \n10.10 $ \n10.02 $ \n10.83 \nShares used to compute diluted net income per share\n \n471 \n481 \n485 \nSee accompanying Notes to Consolidated Financial Statements.\nTable of Contents\n54\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01319",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What is the quantity of restructuring costs directly outlined in AES Corporation's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.",
      "doc_name": "AES_2022_10K",
      "company": "AES Corporation",
      "answer": "0",
      "reasoning": "In the provided evidence, specifically Evidence 1, it states that for fiscal year 2022, AES Corporation incurred $55 million in restructuring expenses. Additionally, Evidence 12 confirms that restructuring and related expenses for the fiscal year ended June 30, 2022, were reported as $96 million. Therefore, the total restructuring costs directly outlined in the income statements for FY2022 can be taken as the sum of these amounts, which is $55 million from Evidence 1 and $96 million from Evidence 12. However, since the question asks for the quantity of restructuring costs directly outlined, we will consider the most specific figure provided, which is $96 million from Evidence 12. Thus, the total restructuring costs for FY2022 is $96 million.",
      "generated_answer": "96 million",
      "evidence": [
        {
          "evidence_text": "Consolidated Statements of Operations\nYears ended December 31, 2022, 2021, and 2020\n2022\n2021\n2020\n(in millions, except per share amounts)\nRevenue:\nRegulated\n$\n3,538 \n$\n2,868 \n$\n2,661 \nNon-Regulated\n9,079 \n8,273 \n6,999 \nTotal revenue\n12,617 \n11,141 \n9,660 \nCost of Sales:\nRegulated\n(3,162)\n(2,448)\n(2,235)\nNon-Regulated\n(6,907)\n(5,982)\n(4,732)\nTotal cost of sales\n(10,069)\n(8,430)\n(6,967)\nOperating margin\n2,548 \n2,711 \n2,693 \nGeneral and administrative expenses\n(207)\n(166)\n(165)\nInterest expense\n(1,117)\n(911)\n(1,038)\nInterest income\n389 \n298 \n268 \nLoss on extinguishment of debt\n(15)\n(78)\n(186)\nOther expense\n(68)\n(60)\n(53)\nOther income\n102 \n410 \n75 \nLoss on disposal and sale of business interests\n(9)\n(1,683)\n(95)\nGoodwill impairment expense\n(777)\n \n \nAsset impairment expense\n(763)\n(1,575)\n(864)\nForeign currency transaction gains (losses)\n(77)\n(10)\n55 \nOther non-operating expense\n(175)\n \n(202)\nINCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE TAXES AND EQUITY IN EARNINGS OF AFFILIATES\n(169)\n(1,064)\n488 \nIncome tax benefit (expense)\n(265)\n133 \n(216)\nNet equity in losses of affiliates\n(71)\n(24)\n(123)\nINCOME (LOSS) FROM CONTINUING OPERATIONS\n(505)\n(955)\n149 \nGain from disposal of discontinued businesses, net of income tax expense of $0, $1, and $0, respectively\n \n4 \n3 \nNET INCOME (LOSS)\n(505)\n(951)\n152 \nLess: Net loss (income) attributable to noncontrolling interests and redeemable stock of subsidiaries\n(41)\n542 \n(106)\nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION\n$\n(546)\n$\n(409)\n$\n46",
          "doc_name": "AES_2022_10K",
          "evidence_page_num": 131,
          "evidence_text_full_page": "129 \nConsolidated Statements of Operations\nYears ended December 31, 2022, 2021, and 2020\n2022\n2021\n2020\n(in millions, except per share amounts)\nRevenue:\nRegulated\n$\n3,538 \n$\n2,868 \n$\n2,661 \nNon-Regulated\n9,079 \n8,273 \n6,999 \nTotal revenue\n12,617 \n11,141 \n9,660 \nCost of Sales:\nRegulated\n(3,162)\n(2,448)\n(2,235)\nNon-Regulated\n(6,907)\n(5,982)\n(4,732)\nTotal cost of sales\n(10,069)\n(8,430)\n(6,967)\nOperating margin\n2,548 \n2,711 \n2,693 \nGeneral and administrative expenses\n(207)\n(166)\n(165)\nInterest expense\n(1,117)\n(911)\n(1,038)\nInterest income\n389 \n298 \n268 \nLoss on extinguishment of debt\n(15)\n(78)\n(186)\nOther expense\n(68)\n(60)\n(53)\nOther income\n102 \n410 \n75 \nLoss on disposal and sale of business interests\n(9)\n(1,683)\n(95)\nGoodwill impairment expense\n(777)\n \n \nAsset impairment expense\n(763)\n(1,575)\n(864)\nForeign currency transaction gains (losses)\n(77)\n(10)\n55 \nOther non-operating expense\n(175)\n \n(202)\nINCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE TAXES AND EQUITY IN EARNINGS OF AFFILIATES\n(169)\n(1,064)\n488 \nIncome tax benefit (expense)\n(265)\n133 \n(216)\nNet equity in losses of affiliates\n(71)\n(24)\n(123)\nINCOME (LOSS) FROM CONTINUING OPERATIONS\n(505)\n(955)\n149 \nGain from disposal of discontinued businesses, net of income tax expense of $0, $1, and $0, respectively\n \n4 \n3 \nNET INCOME (LOSS)\n(505)\n(951)\n152 \nLess: Net loss (income) attributable to noncontrolling interests and redeemable stock of subsidiaries\n(41)\n542 \n(106)\nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION\n$\n(546)\n$\n(409)\n$\n46 \nAMOUNTS ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS:\nIncome (loss) from continuing operations, net of tax\n$\n(546)\n$\n(413)\n$\n43 \nIncome from discontinued operations, net of tax\n \n4 \n3 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION\n$\n(546)\n$\n(409)\n$\n46 \nBASIC EARNINGS PER SHARE:\nIncome (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax\n$\n(0.82)\n$\n(0.62)\n$\n0.06 \nIncome from discontinued operations attributable to The AES Corporation common stockholders, net of tax\n \n0.01 \n0.01 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS\n$\n(0.82)\n$\n(0.61)\n$\n0.07 \nDILUTED EARNINGS PER SHARE:\nIncome (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax\n$\n(0.82)\n$\n(0.62)\n$\n0.06 \nIncome from discontinued operations attributable to The AES Corporation common stockholders, net of tax\n \n0.01 \n0.01 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS\n$\n(0.82)\n$\n(0.61)\n$\n0.07 \nSee Accompanying Notes to Consolidated Financial Statements.\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00540",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Roughly how many times has AES Corporation sold its inventory in FY2022? Calculate inventory turnover ratio for the FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.",
      "doc_name": "AES_2022_10K",
      "company": "AES Corporation",
      "answer": "AES has converted inventory 9.5 times in FY 2022.",
      "reasoning": "To calculate the inventory turnover ratio for AES Corporation in FY2022, we need to use the formula: \n\nInventory Turnover Ratio = Cost of Goods Sold (COGS) / Average Inventory.\n\nFrom the evidence, we have the following relevant data:\n- Total inventory as of December 31, 2022: $2,904 million (Evidence 9).\n- Total inventory as of December 31, 2021: $2,481 million (Evidence 9).\n\nFirst, we calculate the average inventory for FY2022:\nAverage Inventory = (Beginning Inventory + Ending Inventory) / 2 = ($2,481 million + $2,904 million) / 2 = $2,692.5 million.\n\nNext, we need the Cost of Goods Sold (COGS) for FY2022. However, the provided evidence does not explicitly state the COGS for AES Corporation. Without this information, we cannot compute the inventory turnover ratio accurately. \n\nAdditionally, the evidence indicates that AES Corporation operates in a sector where inventory management may not follow conventional practices due to the nature of its business, which includes energy generation and long-term contracts. This suggests that inventory turnover may not be a meaningful metric for assessing operational efficiency in this context, as the company’s inventory may not be sold in the traditional sense but rather utilized in ongoing operations and projects.",
      "generated_answer": "The inventory turnover ratio cannot be calculated due to lack of COGS data; conventional inventory management may not be meaningful for AES Corporation due to its energy generation business model.",
      "evidence": [
        {
          "evidence_text": "Consolidated Balance Sheets\nDecember 31, 2022 and 2021\n2022\n2021\n(in millions, except share and per share data)\nASSETS\nCURRENT ASSETS\nCash and cash equivalents\n$\n1,374 \n$\n943 \nRestricted cash\n536 \n304 \nShort-term investments\n730 \n232 \nAccounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively\n1,799 \n1,418 \nInventory\n1,055 \n604",
          "doc_name": "AES_2022_10K",
          "evidence_page_num": 129,
          "evidence_text_full_page": "128 \nConsolidated Balance Sheets\nDecember 31, 2022 and 2021\n2022\n2021\n(in millions, except share and per share data)\nASSETS\nCURRENT ASSETS\nCash and cash equivalents\n$\n1,374 \n$\n943 \nRestricted cash\n536 \n304 \nShort-term investments\n730 \n232 \nAccounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively\n1,799 \n1,418 \nInventory\n1,055 \n604 \nPrepaid expenses\n98 \n142 \nOther current assets, net of CECL allowance of $2 and $0, respectively\n1,533 \n897 \nCurrent held-for-sale assets\n518 \n816 \nTotal current assets\n7,643 \n5,356 \nNONCURRENT ASSETS\nProperty, Plant and Equipment:\nLand\n470 \n426 \nElectric generation, distribution assets and other\n26,599 \n25,552 \nAccumulated depreciation\n(8,651)\n(8,486)\nConstruction in progress\n4,621 \n2,414 \nProperty, plant and equipment, net\n23,039 \n19,906 \nOther Assets:\nInvestments in and advances to affiliates\n952 \n1,080 \nDebt service reserves and other deposits\n177 \n237 \nGoodwill\n362 \n1,177 \nOther intangible assets, net of accumulated amortization of $434 and $385, respectively\n1,841 \n1,450 \nDeferred income taxes\n319 \n409 \nLoan receivable, net of allowance of $26\n1,051 \n \nOther noncurrent assets, net of allowance of $51 and $23, respectively\n2,979 \n2,188 \nNoncurrent held-for-sale assets\n \n1,160 \nTotal other assets\n7,681 \n7,701 \nTOTAL ASSETS\n$\n38,363 \n$\n32,963 \nLIABILITIES AND EQUITY\nCURRENT LIABILITIES\nAccounts payable\n$\n1,730 \n$\n1,153 \nAccrued interest\n249 \n182 \nAccrued non-income taxes\n249 \n266 \nAccrued and other liabilities\n2,151 \n1,205 \nNon-recourse debt, including $416 and $302, respectively, related to variable interest entities\n1,758 \n1,367 \nCurrent held-for-sale liabilities\n354 \n559 \nTotal current liabilities\n6,491 \n4,732 \nNONCURRENT LIABILITIES\nRecourse debt\n3,894 \n3,729 \nNon-recourse debt, including $2,295 and $2,223, respectively, related to variable interest entities\n17,846 \n13,603 \nDeferred income taxes\n1,139 \n977 \nOther noncurrent liabilities\n3,168 \n3,358 \nNoncurrent held-for-sale liabilities\n \n740 \nTotal noncurrent liabilities\n26,047 \n22,407 \nCommitments and Contingencies (see Notes 12 and 13)\nRedeemable stock of subsidiaries\n1,321 \n1,257 \nEQUITY\nTHE AES CORPORATION STOCKHOLDERS EQUITY\nPreferred stock (without par value, 50,000,000 shares authorized; 1,043,050 issued and outstanding at December 31, 2022 and\nDecember 31, 2021)\n838 \n838 \nCommon stock ($0.01 par value, 1,200,000,000 shares authorized; 818,790,001 issued and 668,743,464 outstanding at December\n31, 2022 and 818,717,043 issued and 666,793,625 outstanding at December 31, 2021)\n8 \n8 \nAdditional paid-in capital\n6,688 \n7,106 \nAccumulated deficit\n(1,635)\n(1,089)\nAccumulated other comprehensive loss\n(1,640)\n(2,220)\nTreasury stock, at cost (150,046,537 and 151,923,418 shares at December 31, 2022 and December 31, 2021, respectively)\n(1,822)\n(1,845)\nTotal AES Corporation stockholders equity\n2,437 \n2,798 \nNONCONTROLLING INTERESTS\n2,067 \n1,769 \nTotal equity\n4,504 \n4,567 \nTOTAL LIABILITIES AND EQUITY\n$\n38,363 \n$\n32,963 \nSee Accompanying Notes to Consolidated Financial Statements.\n"
        },
        {
          "evidence_text": "Consolidated Statements of Operations\nYears ended December 31, 2022, 2021, and 2020\n2022\n2021\n2020\n(in millions, except per share amounts)\nRevenue:\nRegulated\n$\n3,538 \n$\n2,868 \n$\n2,661 \nNon-Regulated\n9,079 \n8,273 \n6,999 \nTotal revenue\n12,617 \n11,141 \n9,660 \nCost of Sales:\nRegulated\n(3,162)\n(2,448)\n(2,235)\nNon-Regulated\n(6,907)\n(5,982)\n(4,732)\nTotal cost of sales\n(10,069)\n(8,430)\n(6,967)",
          "doc_name": "AES_2022_10K",
          "evidence_page_num": 131,
          "evidence_text_full_page": "129 \nConsolidated Statements of Operations\nYears ended December 31, 2022, 2021, and 2020\n2022\n2021\n2020\n(in millions, except per share amounts)\nRevenue:\nRegulated\n$\n3,538 \n$\n2,868 \n$\n2,661 \nNon-Regulated\n9,079 \n8,273 \n6,999 \nTotal revenue\n12,617 \n11,141 \n9,660 \nCost of Sales:\nRegulated\n(3,162)\n(2,448)\n(2,235)\nNon-Regulated\n(6,907)\n(5,982)\n(4,732)\nTotal cost of sales\n(10,069)\n(8,430)\n(6,967)\nOperating margin\n2,548 \n2,711 \n2,693 \nGeneral and administrative expenses\n(207)\n(166)\n(165)\nInterest expense\n(1,117)\n(911)\n(1,038)\nInterest income\n389 \n298 \n268 \nLoss on extinguishment of debt\n(15)\n(78)\n(186)\nOther expense\n(68)\n(60)\n(53)\nOther income\n102 \n410 \n75 \nLoss on disposal and sale of business interests\n(9)\n(1,683)\n(95)\nGoodwill impairment expense\n(777)\n \n \nAsset impairment expense\n(763)\n(1,575)\n(864)\nForeign currency transaction gains (losses)\n(77)\n(10)\n55 \nOther non-operating expense\n(175)\n \n(202)\nINCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE TAXES AND EQUITY IN EARNINGS OF AFFILIATES\n(169)\n(1,064)\n488 \nIncome tax benefit (expense)\n(265)\n133 \n(216)\nNet equity in losses of affiliates\n(71)\n(24)\n(123)\nINCOME (LOSS) FROM CONTINUING OPERATIONS\n(505)\n(955)\n149 \nGain from disposal of discontinued businesses, net of income tax expense of $0, $1, and $0, respectively\n \n4 \n3 \nNET INCOME (LOSS)\n(505)\n(951)\n152 \nLess: Net loss (income) attributable to noncontrolling interests and redeemable stock of subsidiaries\n(41)\n542 \n(106)\nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION\n$\n(546)\n$\n(409)\n$\n46 \nAMOUNTS ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS:\nIncome (loss) from continuing operations, net of tax\n$\n(546)\n$\n(413)\n$\n43 \nIncome from discontinued operations, net of tax\n \n4 \n3 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION\n$\n(546)\n$\n(409)\n$\n46 \nBASIC EARNINGS PER SHARE:\nIncome (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax\n$\n(0.82)\n$\n(0.62)\n$\n0.06 \nIncome from discontinued operations attributable to The AES Corporation common stockholders, net of tax\n \n0.01 \n0.01 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS\n$\n(0.82)\n$\n(0.61)\n$\n0.07 \nDILUTED EARNINGS PER SHARE:\nIncome (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax\n$\n(0.82)\n$\n(0.62)\n$\n0.06 \nIncome from discontinued operations attributable to The AES Corporation common stockholders, net of tax\n \n0.01 \n0.01 \nNET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS\n$\n(0.82)\n$\n(0.61)\n$\n0.07 \nSee Accompanying Notes to Consolidated Financial Statements.\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00799",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Has AMCOR's quick ratio improved or declined between FY2023 and FY2022? If the quick ratio is not something that a financial analyst would ask about a company like this, then state that and explain why.",
      "doc_name": "AMCOR_2023_10K",
      "company": "Amcor",
      "answer": "The quick ratio has slightly improved from 0.67 times to 0.69 times between FY 2023 and FY 2022.(3.4% jump)",
      "reasoning": "To determine whether Amcor's quick ratio has improved or declined between FY2023 and FY2022, we first need to calculate the quick ratio for both years. The quick ratio is calculated as (Current Assets - Inventories) / Current Liabilities. \n\nFrom the evidence:\n- For FY2023:\n  - Current Assets = $5,308 million\n  - Inventories = $2,213 million (from Evidence 10)\n  - Current Liabilities = $4,476 million\n  - Quick Ratio = (5,308 - 2,213) / 4,476 = 3,095 / 4,476 = 0.691\n\n- For FY2022:\n  - Current Assets = $5,853 million\n  - Inventories = $2,439 million (from Evidence 10)\n  - Current Liabilities = $5,103 million\n  - Quick Ratio = (5,853 - 2,439) / 5,103 = 3,414 / 5,103 = 0.669\n\nNow, comparing the two quick ratios:\n- FY2023 Quick Ratio = 0.691\n- FY2022 Quick Ratio = 0.669\n\nSince 0.691 > 0.669, the quick ratio has improved from FY2022 to FY2023. This indicates that Amcor has a better ability to cover its current liabilities with its most liquid assets in FY2023 compared to FY2022.",
      "generated_answer": "Amcor's quick ratio has improved from FY2022 to FY2023.",
      "evidence": [
        {
          "evidence_text": "Amcor plc and Subsidiaries\nConsolidated Balance Sheets\n($ in millions, except share and per share data)\nAs of June 30,\n2023\n2022\nAssets\nCurrent assets:\nCash and cash equivalents\n$\n689 \n$\n775 \nTrade receivables, net of allowance for credit losses of $21 and $25, respectively\n1,875 \n1,935 \nInventories, net\nRaw materials and supplies\n992 \n1,114 \nWork in process and finished goods\n1,221 \n1,325 \nPrepaid expenses and other current assets\n531 \n512 \nAssets held for sale, net\n \n192 \nTotal current assets\n5,308 \n5,853 \nNon-current assets:\nProperty, plant, and equipment, net\n3,762 \n3,646 \nOperating lease assets\n533 \n560 \nDeferred tax assets\n134 \n130 \nOther intangible assets, net\n1,524 \n1,657 \nGoodwill\n5,366 \n5,285 \nEmployee benefit assets\n67 \n89 \nOther non-current assets\n309 \n206 \nTotal non-current assets\n11,695 \n11,573 \nTotal assets\n$\n17,003 \n$\n17,426 \nLiabilities\nCurrent liabilities:\nCurrent portion of long-term debt\n$\n13 \n$\n14 \nShort-term debt\n80 \n136 \nTrade payables\n2,690 \n3,073 \nAccrued employee costs\n396 \n471 \nOther current liabilities\n1,297 \n1,344 \nLiabilities held for sale\n \n65 \nTotal current liabilities\n4,476 \n5,103 \nNon-current liabilities:\nLong-term debt, less current portion\n6,653 \n6,340 \nOperating lease liabilities\n463 \n493 \nDeferred tax liabilities\n616 \n677 \nEmployee benefit obligations\n224 \n201 \nOther non-current liabilities\n481 \n471 \nTotal non-current liabilities\n8,437 \n8,182 \nTotal liabilities\n$\n12,913 \n$\n13,285 \nCommitments and contingencies (See Note 20)\nShareholders' Equity\nAmcor plc shareholders equity:\nOrdinary shares ($0.01 par value):\nAuthorized (9,000 million shares)\nIssued (1,448 and 1,489 million shares, respectively)\n$\n14 \n$\n15 \nAdditional paid-in capital\n4,021 \n4,431 \nRetained earnings\n865 \n534 \nAccumulated other comprehensive loss\n(862)\n(880)\nTreasury shares (1 and 2 million shares, respectively)\n(12)\n(18)\nTotal Amcor plc shareholders' equity\n4,026 \n4,082 \nNon-controlling interests\n64 \n59 \nTotal shareholders' equity\n4,090 \n4,141 \nTotal liabilities and shareholders' equity\n$\n17,003 \n$\n17,426 \nSee accompanying notes to consolidated financial statements.\n5",
          "doc_name": "AMCOR_2023_10K",
          "evidence_page_num": 51,
          "evidence_text_full_page": "Amcor plc and Subsidiaries\nConsolidated Balance Sheets\n($ in millions, except share and per share data)\nAs of June 30,\n2023\n2022\nAssets\nCurrent assets:\nCash and cash equivalents\n$\n689 \n$\n775 \nTrade receivables, net of allowance for credit losses of $21 and $25, respectively\n1,875 \n1,935 \nInventories, net\nRaw materials and supplies\n992 \n1,114 \nWork in process and finished goods\n1,221 \n1,325 \nPrepaid expenses and other current assets\n531 \n512 \nAssets held for sale, net\n \n192 \nTotal current assets\n5,308 \n5,853 \nNon-current assets:\nProperty, plant, and equipment, net\n3,762 \n3,646 \nOperating lease assets\n533 \n560 \nDeferred tax assets\n134 \n130 \nOther intangible assets, net\n1,524 \n1,657 \nGoodwill\n5,366 \n5,285 \nEmployee benefit assets\n67 \n89 \nOther non-current assets\n309 \n206 \nTotal non-current assets\n11,695 \n11,573 \nTotal assets\n$\n17,003 \n$\n17,426 \nLiabilities\nCurrent liabilities:\nCurrent portion of long-term debt\n$\n13 \n$\n14 \nShort-term debt\n80 \n136 \nTrade payables\n2,690 \n3,073 \nAccrued employee costs\n396 \n471 \nOther current liabilities\n1,297 \n1,344 \nLiabilities held for sale\n \n65 \nTotal current liabilities\n4,476 \n5,103 \nNon-current liabilities:\nLong-term debt, less current portion\n6,653 \n6,340 \nOperating lease liabilities\n463 \n493 \nDeferred tax liabilities\n616 \n677 \nEmployee benefit obligations\n224 \n201 \nOther non-current liabilities\n481 \n471 \nTotal non-current liabilities\n8,437 \n8,182 \nTotal liabilities\n$\n12,913 \n$\n13,285 \nCommitments and contingencies (See Note 20)\nShareholders' Equity\nAmcor plc shareholders equity:\nOrdinary shares ($0.01 par value):\nAuthorized (9,000 million shares)\nIssued (1,448 and 1,489 million shares, respectively)\n$\n14 \n$\n15 \nAdditional paid-in capital\n4,021 \n4,431 \nRetained earnings\n865 \n534 \nAccumulated other comprehensive loss\n(862)\n(880)\nTreasury shares (1 and 2 million shares, respectively)\n(12)\n(18)\nTotal Amcor plc shareholders' equity\n4,026 \n4,082 \nNon-controlling interests\n64 \n59 \nTotal shareholders' equity\n4,090 \n4,141 \nTotal liabilities and shareholders' equity\n$\n17,003 \n$\n17,426 \nSee accompanying notes to consolidated financial statements.\n52\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01079",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are major acquisitions that AMCOR has done in FY2023, FY2022 and FY2021?",
      "doc_name": "AMCOR_2023_10K",
      "company": "Amcor",
      "answer": "Amcor completed these acquisitions during FY2023:\n-100% equity interest of a flexibles manufacturing company in the Czech Republic\n- 100% equity interest in a medical device packaging manufacturing site in\nShanghai, China.\n-acquisition of a New Zealand-based leading manufacturer of state-of-the-art, automated protein\npackaging machines.",
      "reasoning": "In FY2023, Amcor made several significant acquisitions: 1) In March 2023, they acquired a medical device packaging manufacturing site in Shanghai, China for $60 million, which included contingent consideration of $20 million. 2) On August 10, 2023, they signed an agreement to acquire a small manufacturer of flexible packaging in India, although the financial details were not disclosed. In FY2022, Amcor completed the acquisition of a Czech Republic company for $59 million, which included a deferred payment of $5 million. Additionally, they acquired a medical device packaging company in Shanghai, China, announced in January 2023, which is expected to close by the end of the third quarter of FY2023. In FY2021, there were no acquisitions reported in the provided evidence. Therefore, the major acquisitions in FY2023 and FY2022 are clearly outlined, while FY2021 does not have any significant acquisitions mentioned.",
      "generated_answer": "Major acquisitions by Amcor: FY2023 - 1) Medical device packaging site in Shanghai, China for $60 million; 2) Agreement to acquire a flexible packaging manufacturer in India (details not disclosed). FY2022 - Acquisition of a Czech Republic company for $59 million. No major acquisitions reported in FY2021.",
      "evidence": [
        {
          "evidence_text": "On August 1, 2022, the Company completed the acquisition of 100% equity interest in a Czech Republic company that operates a world-class\nflexible packaging manufacturing plant. The purchase consideration of $59 million included a deferred portion of $5 million that was paid in the\nfirst quarter of fiscal year 2024. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $36 million and goodwill of $23 million. Goodwill is not deductible for tax purposes. The fair values of the identifiable\nnet assets acquired and goodwill are based on the Company's best estimate as of June 30, 2023.\n On March 17, 2023, the Company completed the acquisition of 100% equity interest in a medical device packaging manufacturing site in\nShanghai, China. The purchase consideration of $60 million is subject to customary post-closing adjustments. The consideration includes\ncontingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting\ncertain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $21 million and goodwill of $39 million. Goodwill is not deductible for tax purposes. The fair values of the contingent\nconsideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered\npreliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the\nacquisition.\n On May 31, 2023, the Company completed the acquisition of a New Zealand based leading manufacturer of state-of-the-art, automated protein\npackaging machines. The purchase consideration of $45 million is subject to customary post-closing adjustments. The consideration includes\ncontingent consideration of $13 million, to be earned and paid in cash over the two years following the acquisition date, subject to meeting\ncertain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $9 million and goodwill of $36 million. Goodwill is deductible for tax purposes. The fair values of the contingent\nconsideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered\npreliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the\nacquisition.",
          "doc_name": "AMCOR_2023_10K",
          "evidence_page_num": 63,
          "evidence_text_full_page": "Note 5 - Acquisitions and Divestitures\nYear ended June 30, 2023\nAcquisitions\n On August 1, 2022, the Company completed the acquisition of 100% equity interest in a Czech Republic company that operates a world-class\nflexible packaging manufacturing plant. The purchase consideration of $59 million included a deferred portion of $5 million that was paid in the\nfirst quarter of fiscal year 2024. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $36 million and goodwill of $23 million. Goodwill is not deductible for tax purposes. The fair values of the identifiable\nnet assets acquired and goodwill are based on the Company's best estimate as of June 30, 2023.\n On March 17, 2023, the Company completed the acquisition of 100% equity interest in a medical device packaging manufacturing site in\nShanghai, China. The purchase consideration of $60 million is subject to customary post-closing adjustments. The consideration includes\ncontingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting\ncertain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $21 million and goodwill of $39 million. Goodwill is not deductible for tax purposes. The fair values of the contingent\nconsideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered\npreliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the\nacquisition.\n On May 31, 2023, the Company completed the acquisition of a New Zealand based leading manufacturer of state-of-the-art, automated protein\npackaging machines. The purchase consideration of $45 million is subject to customary post-closing adjustments. The consideration includes\ncontingent consideration of $13 million, to be earned and paid in cash over the two years following the acquisition date, subject to meeting\ncertain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired\nidentifiable net assets of $9 million and goodwill of $36 million. Goodwill is deductible for tax purposes. The fair values of the contingent\nconsideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered\npreliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the\nacquisition.\n The fair value estimates for all three acquisitions were based on income, market, and cost valuation methods. Pro forma information related to\nthese acquisitions has not been presented, as the effect of the acquisitions on the Company's consolidated financial statements was not material.\nDisposal of Russian business\n On December 23, 2022, the Company completed the sale of its Russian business after receiving all necessary regulatory approvals and cash\nproceeds, including receipt of closing cash balances. The sale follows the Companys previously announced plan to pursue the orderly sale of its\nRussian business. The total net cash consideration received, excluding disposed cash and items settled net, was $365 million and resulted in a\npre-tax net gain of $215 million. The carrying value of the Russian business had previously been impaired by $90 million in the quarter ended\nJune 30, 2022. The impairment charge was based on the Company's best estimate of the fair value of its Russian business, which considered the\nwide range of indicative bids received and uncertain regulatory environment. The net pre-tax gain on disposal of the Russian business has been\nrecorded as restructuring, impairment, and other related activities, net within the consolidated statements of income. The Russian business had a\nnet carrying value of $252 million, including allocated goodwill of $46 million and accumulated other comprehensive losses of $73 million,\nprimarily attributed to foreign currency translation adjustments.\nYear ended June 30, 2022\n During the third quarter of fiscal year 2022, the Company completed the disposal of non-core assets in the Flexibles reporting segment. The\nCompany recorded an expense of $10 million during the fiscal year ended June 30, 2022, to adjust the long-lived assets to their fair value less\ncost to sell.\n64\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01148",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction OR Logical reasoning OR",
      "question": "What industry does AMCOR primarily operate in?",
      "doc_name": "AMCOR_2023_10K",
      "company": "Amcor",
      "answer": "Amcor is a global leader in packaging production for various use cases.",
      "reasoning": "Amcor plc is described in multiple pieces of evidence as a global leader in developing and producing responsible packaging solutions. The company operates primarily in the packaging industry, focusing on various sectors including food, beverage, pharmaceutical, medical, home and personal care, and other consumer goods. Evidence 1, 2, 4, and 14 all emphasize Amcor's role in providing packaging solutions across these markets, highlighting its commitment to sustainability and innovation in packaging. The evidence consistently categorizes Amcor's business activities under the packaging industry, specifically mentioning flexible and rigid packaging as key segments of their operations.",
      "generated_answer": "Amcor primarily operates in the packaging industry.",
      "evidence": [
        {
          "evidence_text": "Today, we are a global leader in developing and producing responsible\npackaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products",
          "doc_name": "AMCOR_2023_10K",
          "evidence_page_num": 4,
          "evidence_text_full_page": "PART I\nItem 1. - Business\nThe Company\n Amcor plc (ARBN 630 385 278) is a public limited company incorporated under the Laws of the Bailiwick of Jersey. Our history dates back\nmore than 150 years, with origins in both Australia and the USA. Today, we are a global leader in developing and producing responsible\npackaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Our innovation excellence and global\npackaging expertise enables us to solve packaging challenges around the world every day, producing packaging that is more functional,\nappealing, and cost effective for our customers and their consumers and importantly, more sustainable for the environment.\nSustainability\n Sustainability is central to our business and one of our most exciting opportunities for growth. Working daily to embed sustainability deeper\ninto everything we do, Amcor has been a leader in the industry in promoting sustainability. We aspire to improve the quality of lives, protect\necosystems, and preserve natural resources for future generations by offering a unique range of responsible packaging solutions, leveraging our\nglobal scale, reach, and expertise to meet our customers growing sustainability expectations. In January 2018, we became the worlds first\npackaging company to pledge that all our packaging would be designed to be recycled, compostable, or reusable by 2025 and also committed to\nincreasing the amount of recycled content we use. We are delivering against these commitments and continue to lead in the development of a\nresponsible packaging value chain through our innovations and partnerships. We have identified a clear path to meeting our sustainability\nambitions and those of our customers by focusing on the three elements of responsible packaging product innovation, consumer participation,\nand infrastructure development.\nDifferentiated Solutions\n Our product portfolio is diverse and dynamic due to our constant innovation and close partnerships with our customers. Behind every one of\nour products stands a unique combination of technical know-how, business experience, and expertise. We work closely with our customers to\nidentify feasible, high-performance, responsible packaging solutions based on their unique needs. Where solutions do not currently exist, we\nwork to innovate new ones. We invest approximately $100 million every year in our industry-leading research and development capabilities,\nbringing together the best in packaging design, science, manufacturing, and people.\nExpertise across Packaging Materials\n We believe that we are uniquely positioned to offer a variety of packaging solutions with a wide, differentiated portfolio of products. Our\npackaging expertise covers all main packaging materials including paper, metal, plastic, recycled, and bio-based materials and the sustainable use\nof recyclable plastics. Our expertise and track record translate across many innovative solutions that customers can explore with ease and\nconvenience to meet their growing packaging needs, while improving environmental impact.\nBusiness Strategy\nStrategy\n Our business strategy consists of three components: a focused portfolio, differentiated capabilities, and our aspiration to be THE leading global\npackaging company. To fulfill our aspiration, we are determined to win for our customers, employees, shareholders, and the environment.\nFocused portfolio\n Our portfolio of businesses share certain important characteristics:\n\nA focus on primary packaging for fast-moving consumer goods,\n\ngood industry structure,\n\nattractive relative growth, and\n\nmultiple paths for us to win through our leadership position, scale, and ability to differentiate our product offering through innovation.\n5\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00684",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR information extraction",
      "question": "Does AMCOR have an improving gross margin profile as of FY2023? If gross margin is not a useful metric for a company like this, then state that and explain why.",
      "doc_name": "AMCOR_2023_10K",
      "company": "Amcor",
      "answer": "No. For AMCOR there has been a slight decline in gross margins by 0.8%.",
      "reasoning": "To determine if Amcor has an improving gross margin profile as of FY2023, we need to analyze the gross profit and gross margin percentages from the provided evidence. In FY2023, Amcor reported a gross profit of $2,725 million, which is a decrease from $2,820 million in FY2022. The gross margin percentage also declined from 19.4% in FY2022 to 18.5% in FY2023. This indicates that while net sales increased slightly, the cost of sales increased at a higher rate, leading to a lower gross profit and gross margin percentage. \n\nAdditionally, the evidence indicates that the decrease in gross profit was influenced by the pass-through of higher raw material costs and the impact of disposed operations. The company faced inflationary pressures and increased costs, which negatively affected its gross margin. Therefore, the evidence suggests that Amcor does not have an improving gross margin profile as of FY2023, as both gross profit and gross margin percentage have declined compared to the previous year.",
      "generated_answer": "No, Amcor does not have an improving gross margin profile as of FY2023; both gross profit and gross margin percentage have declined.",
      "evidence": [
        {
          "evidence_text": "Amcor plc and Subsidiaries\nConsolidated Statements of Income\n($ in millions, except per share data)\nFor the years ended June 30,\n2023\n2022\n2021\nNet sales\n$\n14,694 \n$\n14,544 \n$\n12,861 \nCost of sales\n(11,969)\n(11,724)\n(10,129)\nGross profit\n2,725 \n2,820 \n2,732",
          "doc_name": "AMCOR_2023_10K",
          "evidence_page_num": 49,
          "evidence_text_full_page": "Amcor plc and Subsidiaries\nConsolidated Statements of Income\n($ in millions, except per share data)\nFor the years ended June 30,\n2023\n2022\n2021\nNet sales\n$\n14,694 \n$\n14,544 \n$\n12,861 \nCost of sales\n(11,969)\n(11,724)\n(10,129)\nGross profit\n2,725 \n2,820 \n2,732 \nSelling, general, and administrative expenses\n(1,246)\n(1,284)\n(1,292)\nResearch and development expenses\n(101)\n(96)\n(100)\nRestructuring, impairment, and other related activities, net\n104 \n(234)\n(94)\nOther income, net\n26 \n33 \n75 \nOperating income\n1,508 \n1,239 \n1,321 \nInterest income\n31 \n24 \n14 \nInterest expense\n(290)\n(159)\n(153)\nOther non-operating income, net\n2 \n11 \n11 \nIncome before income taxes and equity in income of affiliated companies\n1,251 \n1,115 \n1,193 \nIncome tax expense\n(193)\n(300)\n(261)\nEquity in income of affiliated companies, net of tax\n \n \n19 \nNet income\n$\n1,058 \n$\n815 \n$\n951 \nNet income attributable to non-controlling interests\n(10)\n(10)\n(12)\nNet income attributable to Amcor plc\n$\n1,048 \n$\n805 \n$\n939 \nBasic earnings per share:\nBasic earnings per share\n$\n0.709 \n$\n0.532 \n$\n0.604 \nDiluted earnings per share\n$\n0.705 \n$\n0.529 \n$\n0.602 \n See accompanying notes to consolidated financial statements.\n50\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00222",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Logical reasoning",
      "question": "Does AMD have a reasonably healthy liquidity profile based on its quick ratio for FY22? If the quick ratio is not relevant to measure liquidity, please state that and explain why.",
      "doc_name": "AMD_2022_10K",
      "company": "AMD",
      "answer": "Yes. The quick ratio is 1.57, calculated as (cash and cash equivalents+Short term investments+Accounts receivable, net+receivables from related parties)/ (current liabilities).",
      "reasoning": "To assess AMD's liquidity profile, we can calculate the quick ratio, which is a measure of a company's ability to meet its short-term obligations with its most liquid assets. The quick ratio is calculated as (Current Assets - Inventories) / Current Liabilities. From Evidence 1, we have the following data for FY22:\n- Current Assets: $15,019 million\n- Inventories: $3,771 million\n- Current Liabilities: $6,369 million\n\nUsing these figures, we can calculate the quick ratio:\n\nQuick Ratio = (Current Assets - Inventories) / Current Liabilities \nQuick Ratio = ($15,019 million - $3,771 million) / $6,369 million \nQuick Ratio = $11,248 million / $6,369 million \nQuick Ratio ≈ 1.76\n\nA quick ratio above 1 indicates that AMD has more liquid assets than current liabilities, suggesting a reasonably healthy liquidity profile. Additionally, the evidence indicates that AMD has sufficient cash, cash equivalents, and short-term investments to fund operations, which further supports the conclusion of a healthy liquidity position. Therefore, the quick ratio is relevant and indicates that AMD is in a good position to meet its short-term obligations.",
      "generated_answer": "Yes, AMD has a reasonably healthy liquidity profile based on its quick ratio of approximately 1.76 for FY22.",
      "evidence": [
        {
          "evidence_text": "Consolidated Balance Sheets\n \nDecember 31,\n2022\nDecember 25,\n2021\n \n(In millions, except par value amounts)\nASSETS\nCurrent assets:\nCash and cash equivalents\n$\n4,835 \n$\n2,535 \nShort-term investments\n1,020 \n1,073 \nAccounts receivable, net\n4,126 \n2,706 \nInventories\n3,771 \n1,955 \nReceivables from related parties\n2 \n2 \nPrepaid expenses and other current assets\n1,265 \n312 \nTotal current assets\n15,019 \n8,583 \nProperty and equipment, net\n1,513 \n702 \nOperating lease right-of-use assets\n460 \n367 \nGoodwill\n24,177 \n289 \nAcquisition-related intangibles\n24,118 \n \nInvestment: equity method\n83 \n69 \nDeferred tax assets\n58 \n931 \nOther non-current assets\n2,152 \n1,478 \nTotal assets\n$\n67,580 \n$\n12,419 \nLIABILITIES AND STOCKHOLDERS EQUITY\nCurrent liabilities:\nAccounts payable\n$\n2,493 \n$\n1,321 \nPayables to related parties\n463 \n85 \nAccrued liabilities\n3,077 \n2,424 \nCurrent portion of long-term debt, net\n \n312 \nOther current liabilities\n336 \n98 \nTotal current liabilities\n6,369 \n4,240 \nLong-term debt, net of current portion\n2,467 \n1 \nLong-term operating lease liabilities\n396 \n348 \nDeferred tax liabilities\n1,934 \n12 \nOther long-term liabilities\n1,664 \n321 \nCommitments and Contingencies (see Notes 16 and 17)\nStockholders equity:\nCapital stock:\nCommon stock, par value $0.01; shares authorized: 2,250; shares issued: 1,645 and 1,232; shares\noutstanding: 1,612 and 1,207\n16 \n12 \nAdditional paid-in capital\n58,005 \n11,069 \nTreasury stock, at cost (shares held: 33 and 25)\n(3,099)\n(2,130)\nAccumulated deficit\n(131)\n(1,451)\nAccumulated other comprehensive loss\n(41)\n(3)\nTotal stockholders equity\n54,750 \n7,497 \nTotal liabilities and stockholders equity\n$\n67,580 \n$\n12,419",
          "doc_name": "AMD_2022_10K",
          "evidence_page_num": 55,
          "evidence_text_full_page": "Table of Contents\nAdvanced Micro Devices, Inc.\nConsolidated Balance Sheets\n \nDecember 31,\n2022\nDecember 25,\n2021\n \n(In millions, except par value amounts)\nASSETS\nCurrent assets:\nCash and cash equivalents\n$\n4,835 \n$\n2,535 \nShort-term investments\n1,020 \n1,073 \nAccounts receivable, net\n4,126 \n2,706 \nInventories\n3,771 \n1,955 \nReceivables from related parties\n2 \n2 \nPrepaid expenses and other current assets\n1,265 \n312 \nTotal current assets\n15,019 \n8,583 \nProperty and equipment, net\n1,513 \n702 \nOperating lease right-of-use assets\n460 \n367 \nGoodwill\n24,177 \n289 \nAcquisition-related intangibles\n24,118 \n \nInvestment: equity method\n83 \n69 \nDeferred tax assets\n58 \n931 \nOther non-current assets\n2,152 \n1,478 \nTotal assets\n$\n67,580 \n$\n12,419 \nLIABILITIES AND STOCKHOLDERS EQUITY\nCurrent liabilities:\nAccounts payable\n$\n2,493 \n$\n1,321 \nPayables to related parties\n463 \n85 \nAccrued liabilities\n3,077 \n2,424 \nCurrent portion of long-term debt, net\n \n312 \nOther current liabilities\n336 \n98 \nTotal current liabilities\n6,369 \n4,240 \nLong-term debt, net of current portion\n2,467 \n1 \nLong-term operating lease liabilities\n396 \n348 \nDeferred tax liabilities\n1,934 \n12 \nOther long-term liabilities\n1,664 \n321 \nCommitments and Contingencies (see Notes 16 and 17)\nStockholders equity:\nCapital stock:\nCommon stock, par value $0.01; shares authorized: 2,250; shares issued: 1,645 and 1,232; shares\noutstanding: 1,612 and 1,207\n16 \n12 \nAdditional paid-in capital\n58,005 \n11,069 \nTreasury stock, at cost (shares held: 33 and 25)\n(3,099)\n(2,130)\nAccumulated deficit\n(131)\n(1,451)\nAccumulated other comprehensive loss\n(41)\n(3)\nTotal stockholders equity\n54,750 \n7,497 \nTotal liabilities and stockholders equity\n$\n67,580 \n$\n12,419 \nSee accompanying notes to consolidated financial statements.\n53\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00995",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are the major products and services that AMD sells as of FY22?",
      "doc_name": "AMD_2022_10K",
      "company": "AMD",
      "answer": "AMD sells server microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and Adaptive System-on-Chip (SoC) products for data centers; CPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers; discrete GPUs, and semi-custom SoC products and development services; and embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.",
      "reasoning": "Based on the provided evidence, AMD offers a diverse range of products and services across several segments. The major products include: \n1. **Server Microprocessors (CPUs)**: AMD EPYC processors for data centers, which include the 9004, 7003, and 7002 series, designed for high performance and energy efficiency.\n2. **Graphics Processing Units (GPUs)**: This includes discrete GPUs like the AMD Radeon series for consumer and professional markets, as well as the AMD Instinct family for data center applications.\n3. **Accelerated Processing Units (APUs)**: These integrate CPUs and GPUs for desktop and notebook PCs, including the Ryzen and Athlon series.\n4. **Data Processing Units (DPUs)**: Such as the AMD Pensando DPUs, designed for cloud and enterprise applications.\n5. **Field Programmable Gate Arrays (FPGAs)**: Products from the Xilinx acquisition, used in various applications including data centers and embedded systems.\n6. **Adaptive System-on-Chip (SoC) Products**: These are tailored for specific applications, including gaming consoles and embedded systems.\n7. **Chipsets**: Supporting various AMD processors for desktop and mobile platforms.\n8. **Semi-Custom Solutions**: Tailored products for specific customer needs, particularly in gaming and embedded markets.\n9. **Software Platforms**: Development tools and software for optimizing the performance of their hardware products.\n\nAdditionally, AMD engages in licensing portions of its intellectual property (IP) portfolio, which is also a significant aspect of its business model. This comprehensive product offering positions AMD strongly in the semiconductor market across multiple sectors.",
      "generated_answer": "AMD's major products and services as of FY22 include server microprocessors (EPYC), graphics processing units (Radeon), accelerated processing units (Ryzen), data processing units (Pensando), field programmable gate arrays (Xilinx), adaptive SoCs, chipsets, semi-custom solutions, and software platforms.",
      "evidence": [
        {
          "evidence_text": "Overview\nWe are a global semiconductor company primarily offering:\n\nserver microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and\nAdaptive System-on-Chip (SoC) products for data centers;\n\nCPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers;\n\ndiscrete GPUs, and semi-custom SoC products and development services; and\n\nembedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.\nFrom time to time, we may also sell or license portions of our intellectual property (IP) portfolio.",
          "doc_name": "AMD_2022_10K",
          "evidence_page_num": 3,
          "evidence_text_full_page": "Table of Contents\nPART I\nITEM 1. BUSINESS\nCautionary Statement Regarding Forward-Looking Statements\nThe statements in this report include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-\nlooking statements are based on current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ\nmaterially from expectations. These forward-looking statements speak only as of the date hereof or as of the dates indicated in the statements and should not\nbe relied upon as predictions of future events, as we cannot assure you that the events or circumstances reflected in these statements will be achieved or will\noccur. You can identify forward-looking statements by the use of forward-looking terminology including believes, expects, may, will, should, seeks,\nintends, plans, pro forma, estimates, anticipates, or the negative of these words and phrases, other variations of these words and phrases or\ncomparable terminology. The forward-looking statements relate to, among other things: possible impact of future accounting rules on AMDs consolidated\nfinancial statements; demand for AMDs products; the growth, change and competitive landscape of the markets in which AMD participates; international sales\nwill continue to be a significant portion of total sales in the foreseeable future; that AMDs cash, cash equivalents and short-term investment balances together\nwith the availability under that certain revolving credit facility (the Revolving Credit Agreement) made available to AMD and certain of its subsidiaries, our\ncommercial paper program, and our cash flows from operations will be sufficient to fund AMDs operations including capital expenditures and purchase\ncommitments over the next 12 months and beyond; AMDs ability to obtain sufficient external financing on favorable terms, or at all; AMDs expectation that\nbased on managements current knowledge, the potential liability related to AMDs current litigation will not have a material adverse effect on its financial\nposition, results of operation or cash flows; anticipated ongoing and increased costs related to enhancing and implementing information security controls; all\nunbilled accounts receivables are expected to be billed and collected within 12 months; revenue allocated to remaining performance obligations that are\nunsatisfied which will be recognized in the next 12 months; and a small number of customers will continue to account for a substantial part of AMDs revenue in\nthe future. For a discussion of the factors that could cause actual results to differ materially from the forward-looking statements, see Part I, Item 1A-Risk\nFactors and the Financial Condition section set forth in Part II, Item 7-Managements Discussion and Analysis of Financial Condition and Results of\nOperations, or MD&A, and such other risks and uncertainties as set forth below in this report or detailed in our other Securities and Exchange Commission\n(SEC) reports and filings. We assume no obligation to update forward-looking statements.\nReferences in this Annual Report on Form 10-K to AMD, we, us, management, our or the Company mean Advanced Micro Devices, Inc. and our\nconsolidated subsidiaries.\nOverview\nWe are a global semiconductor company primarily offering:\n\nserver microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and\nAdaptive System-on-Chip (SoC) products for data centers;\n\nCPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers;\n\ndiscrete GPUs, and semi-custom SoC products and development services; and\n\nembedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.\nFrom time to time, we may also sell or license portions of our intellectual property (IP) portfolio.\n1\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01198",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What drove revenue change as of the FY22 for AMD?",
      "doc_name": "AMD_2022_10K",
      "company": "AMD",
      "answer": "In 2022, AMD reported Higher sales of their EPYC server processors, higher semi-custom product sales, and the inclusion of Xilinx embedded product sales",
      "reasoning": "The revenue change for AMD in FY22 was primarily driven by significant increases in the Data Center, Gaming, and Embedded segments. Specifically, Data Center revenue increased by 64% due to higher sales of EPYC server processors, while Gaming revenue rose by 21% due to increased demand for semi-custom products related to gaming consoles. Additionally, the Embedded segment saw a substantial increase in revenue, primarily attributed to the inclusion of Xilinx embedded product sales following the acquisition of Xilinx. Although the Client segment experienced a 10% decline in revenue due to weak PC market conditions, the overall net revenue for AMD increased by 44% from $16.4 billion in 2021 to $23.6 billion in 2022, largely due to the strong performance in the other segments.",
      "generated_answer": "AMD's revenue change in FY22 was driven by a 64% increase in Data Center revenue, a 21% increase in Gaming revenue, and significant contributions from the Embedded segment due to the Xilinx acquisition.",
      "evidence": [
        {
          "evidence_text": "Net\nrevenue for 2022 was $23.6 billion, an increase of 44% compared to 2021 net revenue of $16.4 billion. The increase in net revenue was driven by a 64%\nincrease in Data Center segment revenue primarily due to higher sales of our EPYC server processors, a 21% increase in Gaming segment revenue\nprimarily due to higher semi-custom product sales, and a significant increase in Embedded segment revenue from the prior year period driven by the inclusion\nof Xilinx embedded product sales.",
          "doc_name": "AMD_2022_10K",
          "evidence_page_num": 42,
          "evidence_text_full_page": "Table of Contents\nITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\nThe following discussion should be read in conjunction with the consolidated financial statements as of December 31, 2022 and December 25, 2021 and for\neach of the three years in the period ended December 31, 2022 and related notes, which are included in this Annual Report on Form 10-K as well as with the\nother sections of this Annual Report on Form 10-K, Part II, Item 8: Financial Statements and Supplementary Data.\nIntroduction\nIn this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries\n(collectively, us, our or AMD), including a discussion of our results of operations for 2022 compared to 2021, an analysis of changes in our financial\ncondition and a discussion of our off-balance sheet arrangements. Discussions of 2020 items and year-to-year comparisons between 2021 and 2020 that are\nnot included in this Form 10-K can be found in Managements Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of\nour Annual Report on Form 10-K for the fiscal year ended December 25, 2021.\nOverview\n2022 was a transformative year for AMD as we took several major steps that scaled and reshaped our business. In February 2022, we completed our strategic\nacquisition of Xilinx, Inc. (Xilinx) which expanded our technology and product portfolio to include adaptable hardware platforms that enable hardware\nacceleration and rapid innovation across a variety of technologies and established AMD in multiple embedded markets where we have traditionally not had a\nsignificant presence. We now offer Field Programmable Gate Arrays (FPGAs), Adaptive SoCs, and Adaptive Compute Acceleration Platform (ACAP) products.\nWith the acquisition of Xilinx, we have access to a new set of markets and customers, further strengthening and diversifying our business model. In May 2022,\nwe expanded our data center solutions capabilities with the acquisition of Pensando Systems, Inc. (Pensando). We now offer high-performance data\nprocessing units (DPUs) and a software stack that complements our existing products. With the Xilinx and Pensando acquisitions, we are well positioned to\nprovide the industrys broadest set of leadership compute engines and accelerators to help enable best performance, security, flexibility and total cost of\nownership for leading-edge data centers.\nOur 2022 financial results reflect the strength of our diversified business model despite the challenging PC market conditions in the second half of 2022. Net\nrevenue for 2022 was $23.6 billion, an increase of 44% compared to 2021 net revenue of $16.4 billion. The increase in net revenue was driven by a 64%\nincrease in Data Center segment revenue primarily due to higher sales of our EPYC server processors, a 21% increase in Gaming segment revenue\nprimarily due to higher semi-custom product sales, and a significant increase in Embedded segment revenue from the prior year period driven by the inclusion\nof Xilinx embedded product sales. This growth was partially offset by a 10% decrease in Client segment revenue primarily due to lower processor shipments\ndriven by a weak PC market and significant inventory correction actions across the PC supply chain. Gross margin, as a percentage of net revenue for 2022,\nwas 45%, compared to 48% in 2021. The decrease in gross margin was primarily due to amortization of intangible assets associated with the Xilinx acquisition.\nOperating income for 2022 was $1.3 billion compared to operating income of $3.6 billion for 2021. The decrease in operating income was primarily driven by\namortization of intangible assets associated with the Xilinx acquisition. Net income for 2022 was $1.3 billion compared to $3.2 billion in the prior year. The\ndecrease in net income was primarily driven by lower operating income.\nCash, cash equivalents and short-term investments as of December 31, 2022 were $5.9 billion, compared to $3.6 billion at the end of 2021. Our aggregate\nprincipal amount of total debt as of December 31, 2022 was $2.5 billion, compared to $313 million as of December 25, 2021.\nWe took several actions in 2022 to strengthen our financial position. In June 2022, we issued $1.0 billion in aggregate principal amount of senior notes,\nconsisting of $500 million in aggregate principal amount of 3.924% Senior Notes due 2032 (3.924% Notes) and $500 million in aggregate principal amount of\n4.393% Senior Notes due 2052 (4.393% Notes). The 3.924% Notes will mature on June 1, 2032 and bear interest at a rate of 3.924% per annum, and the\n4.393% Notes will mature on June 1, 2052 and bear interest at a rate of 4.393% per annum. The 3.924% Notes and the 4.393% Notes are senior unsecured\nobligations.\n40\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00917",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Numerical reasoning OR Logical reasoning",
      "question": "What drove operating margin change as of the FY22 for AMD? If operating margin is not a useful metric for a company like this, then please state that and explain why.",
      "doc_name": "AMD_2022_10K",
      "company": "AMD",
      "answer": "The decrease in AMD's operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition",
      "reasoning": "To analyze the operating margin change for AMD in FY22, we need to look at the financial results and the factors affecting them. In FY22, AMD reported an operating income of $1.3 billion, a significant decrease from $3.6 billion in FY21. This decline in operating income was primarily attributed to the amortization of intangible assets related to the acquisition of Xilinx, which amounted to $2.1 billion in FY22. Additionally, the gross margin decreased from 48% in FY21 to 45% in FY22, indicating that the costs associated with sales increased relative to revenue. The increase in operating expenses, including research and development and marketing costs, also contributed to the decline in operating margin. The overall operating margin was negatively impacted by these factors, particularly the amortization costs and increased operating expenses, which overshadowed the revenue growth from acquisitions and other segments. Therefore, while operating margin is a useful metric, in this case, it is heavily influenced by non-operational factors such as acquisition-related amortization, which may not reflect the core operational efficiency of AMD.",
      "generated_answer": "The decline in AMD's operating margin in FY22 was primarily driven by $2.1 billion in amortization of intangible assets from the Xilinx acquisition and increased operating expenses, despite revenue growth.",
      "evidence": [
        {
          "evidence_text": "Operating income for 2022 was $1.3 billion compared to operating income of $3.6 billion for 2021. The decrease in operating income was primarily driven by\namortization of intangible assets associated with the Xilinx acquisition.",
          "doc_name": "AMD_2022_10K",
          "evidence_page_num": 42,
          "evidence_text_full_page": "Table of Contents\nITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\nThe following discussion should be read in conjunction with the consolidated financial statements as of December 31, 2022 and December 25, 2021 and for\neach of the three years in the period ended December 31, 2022 and related notes, which are included in this Annual Report on Form 10-K as well as with the\nother sections of this Annual Report on Form 10-K, Part II, Item 8: Financial Statements and Supplementary Data.\nIntroduction\nIn this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries\n(collectively, us, our or AMD), including a discussion of our results of operations for 2022 compared to 2021, an analysis of changes in our financial\ncondition and a discussion of our off-balance sheet arrangements. Discussions of 2020 items and year-to-year comparisons between 2021 and 2020 that are\nnot included in this Form 10-K can be found in Managements Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of\nour Annual Report on Form 10-K for the fiscal year ended December 25, 2021.\nOverview\n2022 was a transformative year for AMD as we took several major steps that scaled and reshaped our business. In February 2022, we completed our strategic\nacquisition of Xilinx, Inc. (Xilinx) which expanded our technology and product portfolio to include adaptable hardware platforms that enable hardware\nacceleration and rapid innovation across a variety of technologies and established AMD in multiple embedded markets where we have traditionally not had a\nsignificant presence. We now offer Field Programmable Gate Arrays (FPGAs), Adaptive SoCs, and Adaptive Compute Acceleration Platform (ACAP) products.\nWith the acquisition of Xilinx, we have access to a new set of markets and customers, further strengthening and diversifying our business model. In May 2022,\nwe expanded our data center solutions capabilities with the acquisition of Pensando Systems, Inc. (Pensando). We now offer high-performance data\nprocessing units (DPUs) and a software stack that complements our existing products. With the Xilinx and Pensando acquisitions, we are well positioned to\nprovide the industrys broadest set of leadership compute engines and accelerators to help enable best performance, security, flexibility and total cost of\nownership for leading-edge data centers.\nOur 2022 financial results reflect the strength of our diversified business model despite the challenging PC market conditions in the second half of 2022. Net\nrevenue for 2022 was $23.6 billion, an increase of 44% compared to 2021 net revenue of $16.4 billion. The increase in net revenue was driven by a 64%\nincrease in Data Center segment revenue primarily due to higher sales of our EPYC server processors, a 21% increase in Gaming segment revenue\nprimarily due to higher semi-custom product sales, and a significant increase in Embedded segment revenue from the prior year period driven by the inclusion\nof Xilinx embedded product sales. This growth was partially offset by a 10% decrease in Client segment revenue primarily due to lower processor shipments\ndriven by a weak PC market and significant inventory correction actions across the PC supply chain. Gross margin, as a percentage of net revenue for 2022,\nwas 45%, compared to 48% in 2021. The decrease in gross margin was primarily due to amortization of intangible assets associated with the Xilinx acquisition.\nOperating income for 2022 was $1.3 billion compared to operating income of $3.6 billion for 2021. The decrease in operating income was primarily driven by\namortization of intangible assets associated with the Xilinx acquisition. Net income for 2022 was $1.3 billion compared to $3.2 billion in the prior year. The\ndecrease in net income was primarily driven by lower operating income.\nCash, cash equivalents and short-term investments as of December 31, 2022 were $5.9 billion, compared to $3.6 billion at the end of 2021. Our aggregate\nprincipal amount of total debt as of December 31, 2022 was $2.5 billion, compared to $313 million as of December 25, 2021.\nWe took several actions in 2022 to strengthen our financial position. In June 2022, we issued $1.0 billion in aggregate principal amount of senior notes,\nconsisting of $500 million in aggregate principal amount of 3.924% Senior Notes due 2032 (3.924% Notes) and $500 million in aggregate principal amount of\n4.393% Senior Notes due 2052 (4.393% Notes). The 3.924% Notes will mature on June 1, 2032 and bear interest at a rate of 3.924% per annum, and the\n4.393% Notes will mature on June 1, 2052 and bear interest at a rate of 4.393% per annum. The 3.924% Notes and the 4.393% Notes are senior unsecured\nobligations.\n40\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01279",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for AMD in FY22?",
      "doc_name": "AMD_2022_10K",
      "company": "AMD",
      "answer": "In 2022, AMD brought in the most cashflow from Operations",
      "reasoning": "To determine which cash flow activity brought in the most cash for AMD in FY22, we need to analyze the cash flows from operating, investing, and financing activities as presented in the evidence. According to Evidence 10, for the year ended December 31, 2022, AMD reported the following cash flows:  \n- Net cash provided by operating activities: $3,565 million  \n- Net cash used in investing activities: $(2,667) million  \n- Net cash used in financing activities: $(3,264) million  \n\nFrom this data, we can see that the operating activities generated a positive cash flow of $3,565 million, while both investing and financing activities resulted in cash outflows of $(2,667) million and $(3,264) million, respectively. Therefore, the operating activities brought in the most cash flow for AMD in FY22, as it was the only category with a positive cash flow.",
      "generated_answer": "Operating activities brought in the most cash flow for AMD in FY22, with $3,565 million.",
      "evidence": [
        {
          "evidence_text": "Advanced Micro Devices, Inc.\nConsolidated Statements of Cash Flows\nYear Ended\nDecember 31,\n2022\nDecember 25,\n2021\nDecember 26,\n2020\n(In millions)\nCash flows from operating activities:\nNet income\n$\n1,320 \n$\n3,162 \n$\n2,490 \nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation and amortization\n4,174 \n407 \n312 \nStock-based compensation\n1,081 \n379 \n274 \nAmortization of debt discount and issuance costs\n \n5 \n14 \nAmortization of operating lease right-of-use assets\n88 \n56 \n42 \nAmortization of inventory fair value adjustment\n189 \n \n \nLoss on debt redemption, repurchase and conversion\n \n7 \n54 \nLoss on sale or disposal of property and equipment\n16 \n34 \n33 \nDeferred income taxes\n(1,505)\n308 \n(1,223)\n(Gains) losses on equity investments, net\n62 \n(56)\n(2)\nOther\n(14)\n(7)\n8 \nChanges in operating assets and liabilities:\nAccounts receivable, net\n(1,091)\n(640)\n(219)\nInventories\n(1,401)\n(556)\n(417)\nReceivables from related parties\n(13)\n8 \n10 \nPrepaid expenses and other assets\n(1,197)\n(920)\n(231)\nPayables to related parties\n379 \n7 \n(135)\nAccounts payable\n931 \n801 \n(513)\nAccrued liabilities and other\n546 \n526 \n574 \nNet cash provided by operating activities\n3,565 \n3,521 \n1,071 \nCash flows from investing activities:\nPurchases of property and equipment\n(450)\n(301)\n(294)\nPurchases of short-term investments\n(2,667)\n(2,056)\n(850)\nProceeds from maturity of short-term investments\n4,310 \n1,678 \n192 \nCash received from acquisition of Xilinx\n2,366 \n \n \nAcquisition of Pensando, net of cash acquired\n(1,544)\n \n \nOther\n(16)\n(7)\n \nNet cash provided by (used in) investing activities\n1,999 \n(686)\n(952)\nCash flows from financing activities:\nProceeds from debt, net of issuance costs\n991 \n \n200 \nRepayment of debt\n(312)\n \n(200)\nProceeds from sales of common stock through employee equity plans\n167 \n104 \n85 \nRepurchases of common stock\n(3,702)\n(1,762)\n \nCommon stock repurchases for tax withholding on employee equity plans\n(406)\n(237)\n(78)\nOther\n(2)\n \n(1)\nNet cash (used in) provided by financing activities\n(3,264)\n(1,895)\n6 \nNet increase in cash and cash equivalents\n2,300 \n940 \n125 \nCash and cash equivalents at beginning of year\n2,535 \n1,595 \n1,470 \nCash and cash equivalents at end of year\n$\n4,835 \n$\n2,535 \n$\n1,595",
          "doc_name": "AMD_2022_10K",
          "evidence_page_num": 57,
          "evidence_text_full_page": "Table of Contents\nAdvanced Micro Devices, Inc.\nConsolidated Statements of Cash Flows\nYear Ended\nDecember 31,\n2022\nDecember 25,\n2021\nDecember 26,\n2020\n(In millions)\nCash flows from operating activities:\nNet income\n$\n1,320 \n$\n3,162 \n$\n2,490 \nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation and amortization\n4,174 \n407 \n312 \nStock-based compensation\n1,081 \n379 \n274 \nAmortization of debt discount and issuance costs\n \n5 \n14 \nAmortization of operating lease right-of-use assets\n88 \n56 \n42 \nAmortization of inventory fair value adjustment\n189 \n \n \nLoss on debt redemption, repurchase and conversion\n \n7 \n54 \nLoss on sale or disposal of property and equipment\n16 \n34 \n33 \nDeferred income taxes\n(1,505)\n308 \n(1,223)\n(Gains) losses on equity investments, net\n62 \n(56)\n(2)\nOther\n(14)\n(7)\n8 \nChanges in operating assets and liabilities:\nAccounts receivable, net\n(1,091)\n(640)\n(219)\nInventories\n(1,401)\n(556)\n(417)\nReceivables from related parties\n(13)\n8 \n10 \nPrepaid expenses and other assets\n(1,197)\n(920)\n(231)\nPayables to related parties\n379 \n7 \n(135)\nAccounts payable\n931 \n801 \n(513)\nAccrued liabilities and other\n546 \n526 \n574 \nNet cash provided by operating activities\n3,565 \n3,521 \n1,071 \nCash flows from investing activities:\nPurchases of property and equipment\n(450)\n(301)\n(294)\nPurchases of short-term investments\n(2,667)\n(2,056)\n(850)\nProceeds from maturity of short-term investments\n4,310 \n1,678 \n192 \nCash received from acquisition of Xilinx\n2,366 \n \n \nAcquisition of Pensando, net of cash acquired\n(1,544)\n \n \nOther\n(16)\n(7)\n \nNet cash provided by (used in) investing activities\n1,999 \n(686)\n(952)\nCash flows from financing activities:\nProceeds from debt, net of issuance costs\n991 \n \n200 \nRepayment of debt\n(312)\n \n(200)\nProceeds from sales of common stock through employee equity plans\n167 \n104 \n85 \nRepurchases of common stock\n(3,702)\n(1,762)\n \nCommon stock repurchases for tax withholding on employee equity plans\n(406)\n(237)\n(78)\nOther\n(2)\n \n(1)\nNet cash (used in) provided by financing activities\n(3,264)\n(1,895)\n6 \nNet increase in cash and cash equivalents\n2,300 \n940 \n125 \nCash and cash equivalents at beginning of year\n2,535 \n1,595 \n1,470 \nCash and cash equivalents at end of year\n$\n4,835 \n$\n2,535 \n$\n1,595 \n55\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00476",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Which debt securities are registered to trade on a national securities exchange under American Express' name as of 2022?",
      "doc_name": "AMERICANEXPRESS_2022_10K",
      "company": "American Express",
      "answer": "There are none",
      "reasoning": "To determine which debt securities are registered to trade on a national securities exchange under American Express' name as of 2022, I reviewed the provided evidence. Evidence 1 and Evidence 2 both list various debt securities associated with American Express Company. The securities mentioned include: \n- 2.875% Notes due 2038 (VZ38B)\n- 1.875% Notes due 2038 (VZ38C)\n- 1.500% Notes due 2039 (VZ39C)\n- 3.500% Fixed Rate Notes due 2039 (VZ39D)\n- 1.850% Notes due 2040 (VZ40)\n- 3.850% Fixed Rate Notes due 2041 (VZ41C)\n\nAll these securities are registered on the New York Stock Exchange, as indicated in both pieces of evidence. Therefore, these are the debt securities registered to trade under American Express' name as of 2022.",
      "generated_answer": "2.875% Notes due 2038, 1.875% Notes due 2038, 1.500% Notes due 2039, 3.500% Fixed Rate Notes due 2039, 1.850% Notes due 2040, 3.850% Fixed Rate Notes due 2041.",
      "evidence": [
        {
          "evidence_text": "Registrants telephone number, including area code: (212) 640-2000\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Shares (par value $0.20 per Share)\nAXP\nNew York Stock Exchange\nSecurities registered pursuant to section 12(g) of the Act: None",
          "doc_name": "AMERICANEXPRESS_2022_10K",
          "evidence_page_num": 0,
          "evidence_text_full_page": "UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWashington, D.C. 20549\nForm 10-K\n\nANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\nFor the fiscal year ended December 31, 2022\nOR\n\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\nFor the transition period from to \n Commission File No. 1-7657\nAmerican Express Company\n(Exact name of registrant as specified in its charter)\nNew York\n13-4922250\n(State or other jurisdiction of incorporation or organization)\n(I.R.S. Employer Identification No.)\n200 Vesey Street\nNew York, New York\n10285\n(Address of principal executive offices)\n(Zip Code)\nRegistrants telephone number, including area code: (212) 640-2000\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Shares (par value $0.20 per Share)\nAXP\nNew York Stock Exchange\nSecurities registered pursuant to section 12(g) of the Act: None\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No o\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No \nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or\nfor such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes No o\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this\nchapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No o\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the\ndefinitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.\nLarge accelerated filer \nAccelerated filer o\nNon-accelerated filer o\nSmaller reporting company \nEmerging growth company \nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. o\nIndicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under\nsection 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. \nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an\nerror to previously issued financial statements. o\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's\nexecutive officers during the relevant recovery period pursuant to 240.10D-1(b). o\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No \nAs of June 30, 2022, the aggregate market value of the registrants voting shares held by non-affiliates of the registrant was approximately $104.0 billion based on the closing sale price as\nreported on the New York Stock Exchange.\nAs of February 2, 2023, there were 744,192,702 common shares of the registrant outstanding.\nDOCUMENTS INCORPORATED BY REFERENCE\nPart III: Portions of Registrants Proxy Statement to be filed with the Securities and Exchange Commission in connection with the Annual Meeting of Shareholders to be held on May 2,\n2023.\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01028",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are the geographies that American Express primarily operates in as of 2022?",
      "doc_name": "AMERICANEXPRESS_2022_10K",
      "company": "American Express",
      "answer": "United States, EMEA, APAC, and LACC",
      "reasoning": "Based on the provided evidence, American Express operates in a wide range of geographies. Evidence 1 through Evidence 20 collectively highlight various countries where American Express has subsidiaries or operations. Key regions mentioned include the United States, Canada, Mexico, the United Kingdom, the European Union, Australia, Japan, China, Brazil, India, and several others. Evidence 18 specifically notes that significant portions of their billed business outside the United States come from the UK, EU, Australia, Japan, Canada, and Mexico. Additionally, Evidence 15 indicates that the largest concentrations of credit risk outside the U.S. include the UK, Japan, the EU, Australia, Canada, and Mexico. Therefore, the primary geographies of operation for American Express as of 2022 include these countries and regions, reflecting a strong global presence.",
      "generated_answer": "American Express primarily operates in the United States, Canada, Mexico, the United Kingdom, the European Union, Australia, Japan, and China as of 2022.",
      "evidence": [
        {
          "evidence_text": "(Millions)\nUnited States\nEMEA\nAPAC\nLACC\nOther Unallocated\nConsolidated\n2022\nTotal revenues net of interest expense\n$\n41,396 \n$\n4,871 \n$\n3,835 \n$\n2,917 \n$\n(157)\n$\n52,862 \nPretax income (loss) from continuing operations\n10,383 \n550 \n376 \n500 \n(2,224)\n9,585 \n2021\nTotal revenues net of interest expense\n$\n33,103 \n$\n3,643 \n$\n3,418 \n$\n2,238 \n$\n(22)\n$\n42,380 \nPretax income (loss) from continuing operations\n10,325 \n460 \n420 \n494 \n(1,010)\n10,689 \n2020\nTotal revenues net of interest expense\n$\n28,263 \n$\n3,087 \n$\n3,271 \n$\n2,019 \n$\n(553)\n$\n36,087 \nPretax income (loss) from continuing operations\n5,422 \n187 \n328 \n273 \n(1,914)\n4,296",
          "doc_name": "AMERICANEXPRESS_2022_10K",
          "evidence_page_num": 154,
          "evidence_text_full_page": "Table of Contents\nGEOGRAPHIC OPERATIONS\nThe following table presents our total revenues net of interest expense and pretax income (loss) from continuing operations in different geographic regions\nbased, in part, upon internal allocations, which necessarily involve managements judgment.\nEffective for the first quarter of 2022, we changed the way in which we allocate certain overhead expenses by geographic region. As a result, prior period\npretax income (loss) from continuing operations by geography has been recast to conform to current period presentation; there was no impact at a consolidated\nlevel.\n(Millions)\nUnited States\nEMEA\nAPAC\nLACC\nOther Unallocated\nConsolidated\n2022\nTotal revenues net of interest expense\n$\n41,396 \n$\n4,871 \n$\n3,835 \n$\n2,917 \n$\n(157)\n$\n52,862 \nPretax income (loss) from continuing operations\n10,383 \n550 \n376 \n500 \n(2,224)\n9,585 \n2021\nTotal revenues net of interest expense\n$\n33,103 \n$\n3,643 \n$\n3,418 \n$\n2,238 \n$\n(22)\n$\n42,380 \nPretax income (loss) from continuing operations\n10,325 \n460 \n420 \n494 \n(1,010)\n10,689 \n2020\nTotal revenues net of interest expense\n$\n28,263 \n$\n3,087 \n$\n3,271 \n$\n2,019 \n$\n(553)\n$\n36,087 \nPretax income (loss) from continuing operations\n5,422 \n187 \n328 \n273 \n(1,914)\n4,296 \n(a)\nEMEA represents Europe, the Middle East and Africa; APAC represents Asia Pacific, Australia and New Zealand; and LACC represents Latin America, Canada and the Caribbean.\n(b)\nOther Unallocated includes net costs which are not directly allocated to specific geographic regions, including costs related to the net negative interest spread on excess liquidity funding and\nexecutive office operations expenses.\n(a)\n(a)\n(a)\n(b)\n152\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00723",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR information extraction",
      "question": "Does AMEX have an improving operating margin profile as of 2022? If operating margin is not a useful metric for a company like this, then state that and explain why.",
      "doc_name": "AMERICANEXPRESS_2022_10K",
      "company": "American Express",
      "answer": "Performance is not measured through operating margin",
      "reasoning": "To determine if American Express (AMEX) has an improving operating margin profile as of 2022, we need to analyze the operating margin data provided in the evidence. According to Evidence 3, AMEX's operating margin was 14% in 2022, down from 17% in 2021. This indicates a decline in the operating margin, suggesting that the company is less efficient at converting revenues into operating income compared to the previous year. Additionally, Evidence 4 states that operating income decreased by 10% in 2022, which further supports the notion that the operating margin is not improving. Furthermore, the increase in operating expenses outpaced revenue growth, which negatively impacted the operating margin. Therefore, based on the evidence, AMEX does not have an improving operating margin profile as of 2022; instead, it shows a decline in efficiency and profitability.",
      "generated_answer": "No, AMEX does not have an improving operating margin profile as of 2022; the operating margin decreased from 17% in 2021 to 14% in 2022.",
      "evidence": [
        {
          "evidence_text": "CONSOLIDATED STATEMENTS OF INCOME\nYear Ended December 31 (Millions, except per share amounts)\n2022\n2021\n2020\nRevenues\nNon-interest revenues\nDiscount revenue\n$\n30,739 \n$\n24,563 \n$\n19,435 \nNet card fees\n6,070 \n5,195 \n4,664 \nService fees and other revenue\n4,521 \n3,316 \n2,702 \nProcessed revenue\n1,637 \n1,556 \n1,301 \nTotal non-interest revenues\n42,967 \n34,630 \n28,102 \nInterest income\nInterest on loans\n11,967 \n8,850 \n9,779 \nInterest and dividends on investment securities\n96 \n83 \n127 \nDeposits with banks and other\n595 \n100 \n177 \nTotal interest income\n12,658 \n9,033 \n10,083 \nInterest expense\nDeposits\n1,527 \n458 \n943 \nLong-term debt and other\n1,236 \n825 \n1,155 \nTotal interest expense\n2,763 \n1,283 \n2,098 \nNet interest income\n9,895 \n7,750 \n7,985 \nTotal revenues net of interest expense\n52,862 \n42,380 \n36,087 \nProvisions for credit losses\nCard Member receivables\n627 \n(73)\n1,015 \nCard Member loans\n1,514 \n(1,155)\n3,453 \nOther\n41 \n(191)\n262 \nTotal provisions for credit losses\n2,182 \n(1,419)\n4,730 \nTotal revenues net of interest expense after provisions for credit losses\n50,680 \n43,799 \n31,357 \nExpenses\nCard Member rewards\n14,002 \n11,007 \n8,041 \nBusiness development\n4,943 \n3,762 \n3,051 \nCard Member services\n2,959 \n1,993 \n1,230 \nMarketing\n5,458 \n5,291 \n3,696 \nSalaries and employee benefits\n7,252 \n6,240 \n5,718 \nOther, net\n6,481 \n4,817 \n5,325 \nTotal expenses\n41,095 \n33,110 \n27,061 \nPretax income\n9,585 \n10,689 \n4,296 \nIncome tax provision\n2,071 \n2,629 \n1,161 \nNet income\n$\n7,514 \n$\n8,060 \n$\n3,135 \nEarnings per Common Share (Note 21)\nBasic\n$\n9.86 \n$\n10.04 \n$\n3.77 \nDiluted\n$\n9.85 \n$\n10.02 \n$\n3.77 \nAverage common shares outstanding for earnings per common share:\nBasic\n751 \n789 \n805 \nDiluted\n752 \n790 \n806",
          "doc_name": "AMERICANEXPRESS_2022_10K",
          "evidence_page_num": 95,
          "evidence_text_full_page": "Table of Contents\nCONSOLIDATED STATEMENTS OF INCOME\nYear Ended December 31 (Millions, except per share amounts)\n2022\n2021\n2020\nRevenues\nNon-interest revenues\nDiscount revenue\n$\n30,739 \n$\n24,563 \n$\n19,435 \nNet card fees\n6,070 \n5,195 \n4,664 \nService fees and other revenue\n4,521 \n3,316 \n2,702 \nProcessed revenue\n1,637 \n1,556 \n1,301 \nTotal non-interest revenues\n42,967 \n34,630 \n28,102 \nInterest income\nInterest on loans\n11,967 \n8,850 \n9,779 \nInterest and dividends on investment securities\n96 \n83 \n127 \nDeposits with banks and other\n595 \n100 \n177 \nTotal interest income\n12,658 \n9,033 \n10,083 \nInterest expense\nDeposits\n1,527 \n458 \n943 \nLong-term debt and other\n1,236 \n825 \n1,155 \nTotal interest expense\n2,763 \n1,283 \n2,098 \nNet interest income\n9,895 \n7,750 \n7,985 \nTotal revenues net of interest expense\n52,862 \n42,380 \n36,087 \nProvisions for credit losses\nCard Member receivables\n627 \n(73)\n1,015 \nCard Member loans\n1,514 \n(1,155)\n3,453 \nOther\n41 \n(191)\n262 \nTotal provisions for credit losses\n2,182 \n(1,419)\n4,730 \nTotal revenues net of interest expense after provisions for credit losses\n50,680 \n43,799 \n31,357 \nExpenses\nCard Member rewards\n14,002 \n11,007 \n8,041 \nBusiness development\n4,943 \n3,762 \n3,051 \nCard Member services\n2,959 \n1,993 \n1,230 \nMarketing\n5,458 \n5,291 \n3,696 \nSalaries and employee benefits\n7,252 \n6,240 \n5,718 \nOther, net\n6,481 \n4,817 \n5,325 \nTotal expenses\n41,095 \n33,110 \n27,061 \nPretax income\n9,585 \n10,689 \n4,296 \nIncome tax provision\n2,071 \n2,629 \n1,161 \nNet income\n$\n7,514 \n$\n8,060 \n$\n3,135 \nEarnings per Common Share (Note 21)\nBasic\n$\n9.86 \n$\n10.04 \n$\n3.77 \nDiluted\n$\n9.85 \n$\n10.02 \n$\n3.77 \nAverage common shares outstanding for earnings per common share:\nBasic\n751 \n789 \n805 \nDiluted\n752 \n790 \n806 \n(a)\nRepresents net income less (i) earnings allocated to participating share awards of $57 million, $56 million and $20 million for the years ended December 31, 2022, 2021 and 2020, respectively,\n(ii) dividends on preferred shares of $57 million, $71 million and $79 million for the years ended December 31, 2022, 2021 and 2020, respectively, and (iii) equity-related adjustments of\n$16 million related to the redemption of preferred shares for the year ended December 31, 2021.\nSee Notes to Consolidated Financial Statements.\n(a)\n93\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00720",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Numerical reasoning OR Logical reasoning",
      "question": "What drove gross margin change as of the FY2022 for American Express? If gross margin is not a useful metric for a company like this, then please state that and explain why.",
      "doc_name": "AMERICANEXPRESS_2022_10K",
      "company": "American Express",
      "answer": "Performance is not measured through gross margin",
      "reasoning": "To analyze the change in gross margin for American Express in FY2022, we need to consider the components that typically affect gross margin, which is calculated as gross profit divided by total revenues. The evidence indicates that total revenues net of interest expense increased by 25% in 2022, driven by strong growth in discount revenue (up 25%) and net card fees (up 17%). However, total expenses also increased significantly by 24%, primarily due to higher Card Member rewards, business development, and employee compensation costs. The increase in expenses outpaced revenue growth, leading to a decrease in operating income and, consequently, a potential impact on gross margin. Additionally, the effective tax rate decreased, which could also influence net income but does not directly affect gross margin. Given that gross margin is influenced by both revenue and expense growth, the increase in expenses relative to revenue growth suggests that gross margin may have been negatively impacted in FY2022. However, the specific gross margin percentage is not provided in the evidence, making it difficult to quantify the change. Furthermore, gross margin may not be the most relevant metric for a financial services company like American Express, as their business model relies heavily on transaction volumes and fee income rather than traditional product sales, where gross margin is more commonly applied. Therefore, while gross margin can provide some insights, it may not fully capture the operational performance of American Express.",
      "generated_answer": "Gross margin may have decreased in FY2022 due to total expenses increasing at a rate (24%) that outpaced revenue growth (25%). However, gross margin is not a particularly useful metric for American Express, as their business model is based on transaction volumes and fee income rather than traditional product sales.",
      "evidence": [
        {
          "evidence_text": "CONSOLIDATED STATEMENTS OF INCOME\nYear Ended December 31 (Millions, except per share amounts)\n2022\n2021\n2020\nRevenues\nNon-interest revenues\nDiscount revenue\n$\n30,739 \n$\n24,563 \n$\n19,435 \nNet card fees\n6,070 \n5,195 \n4,664 \nService fees and other revenue\n4,521 \n3,316 \n2,702 \nProcessed revenue\n1,637 \n1,556 \n1,301 \nTotal non-interest revenues\n42,967 \n34,630 \n28,102 \nInterest income\nInterest on loans\n11,967 \n8,850 \n9,779 \nInterest and dividends on investment securities\n96 \n83 \n127 \nDeposits with banks and other\n595 \n100 \n177 \nTotal interest income\n12,658 \n9,033 \n10,083 \nInterest expense\nDeposits\n1,527 \n458 \n943 \nLong-term debt and other\n1,236 \n825 \n1,155 \nTotal interest expense\n2,763 \n1,283 \n2,098 \nNet interest income\n9,895 \n7,750 \n7,985 \nTotal revenues net of interest expense\n52,862 \n42,380 \n36,087 \nProvisions for credit losses\nCard Member receivables\n627 \n(73)\n1,015 \nCard Member loans\n1,514 \n(1,155)\n3,453 \nOther\n41 \n(191)\n262 \nTotal provisions for credit losses\n2,182 \n(1,419)\n4,730 \nTotal revenues net of interest expense after provisions for credit losses\n50,680 \n43,799 \n31,357 \nExpenses\nCard Member rewards\n14,002 \n11,007 \n8,041 \nBusiness development\n4,943 \n3,762 \n3,051 \nCard Member services\n2,959 \n1,993 \n1,230 \nMarketing\n5,458 \n5,291 \n3,696 \nSalaries and employee benefits\n7,252 \n6,240 \n5,718 \nOther, net\n6,481 \n4,817 \n5,325 \nTotal expenses\n41,095 \n33,110 \n27,061 \nPretax income\n9,585 \n10,689 \n4,296 \nIncome tax provision\n2,071 \n2,629 \n1,161 \nNet income\n$\n7,514 \n$\n8,060 \n$\n3,135 \nEarnings per Common Share (Note 21)\nBasic\n$\n9.86 \n$\n10.04 \n$\n3.77 \nDiluted\n$\n9.85 \n$\n10.02 \n$\n3.77 \nAverage common shares outstanding for earnings per common share:\nBasic\n751 \n789 \n805 \nDiluted\n752 \n790 \n806",
          "doc_name": "AMERICANEXPRESS_2022_10K",
          "evidence_page_num": 95,
          "evidence_text_full_page": "Table of Contents\nCONSOLIDATED STATEMENTS OF INCOME\nYear Ended December 31 (Millions, except per share amounts)\n2022\n2021\n2020\nRevenues\nNon-interest revenues\nDiscount revenue\n$\n30,739 \n$\n24,563 \n$\n19,435 \nNet card fees\n6,070 \n5,195 \n4,664 \nService fees and other revenue\n4,521 \n3,316 \n2,702 \nProcessed revenue\n1,637 \n1,556 \n1,301 \nTotal non-interest revenues\n42,967 \n34,630 \n28,102 \nInterest income\nInterest on loans\n11,967 \n8,850 \n9,779 \nInterest and dividends on investment securities\n96 \n83 \n127 \nDeposits with banks and other\n595 \n100 \n177 \nTotal interest income\n12,658 \n9,033 \n10,083 \nInterest expense\nDeposits\n1,527 \n458 \n943 \nLong-term debt and other\n1,236 \n825 \n1,155 \nTotal interest expense\n2,763 \n1,283 \n2,098 \nNet interest income\n9,895 \n7,750 \n7,985 \nTotal revenues net of interest expense\n52,862 \n42,380 \n36,087 \nProvisions for credit losses\nCard Member receivables\n627 \n(73)\n1,015 \nCard Member loans\n1,514 \n(1,155)\n3,453 \nOther\n41 \n(191)\n262 \nTotal provisions for credit losses\n2,182 \n(1,419)\n4,730 \nTotal revenues net of interest expense after provisions for credit losses\n50,680 \n43,799 \n31,357 \nExpenses\nCard Member rewards\n14,002 \n11,007 \n8,041 \nBusiness development\n4,943 \n3,762 \n3,051 \nCard Member services\n2,959 \n1,993 \n1,230 \nMarketing\n5,458 \n5,291 \n3,696 \nSalaries and employee benefits\n7,252 \n6,240 \n5,718 \nOther, net\n6,481 \n4,817 \n5,325 \nTotal expenses\n41,095 \n33,110 \n27,061 \nPretax income\n9,585 \n10,689 \n4,296 \nIncome tax provision\n2,071 \n2,629 \n1,161 \nNet income\n$\n7,514 \n$\n8,060 \n$\n3,135 \nEarnings per Common Share (Note 21)\nBasic\n$\n9.86 \n$\n10.04 \n$\n3.77 \nDiluted\n$\n9.85 \n$\n10.02 \n$\n3.77 \nAverage common shares outstanding for earnings per common share:\nBasic\n751 \n789 \n805 \nDiluted\n752 \n790 \n806 \n(a)\nRepresents net income less (i) earnings allocated to participating share awards of $57 million, $56 million and $20 million for the years ended December 31, 2022, 2021 and 2020, respectively,\n(ii) dividends on preferred shares of $57 million, $71 million and $79 million for the years ended December 31, 2022, 2021 and 2020, respectively, and (iii) equity-related adjustments of\n$16 million related to the redemption of preferred shares for the year ended December 31, 2021.\nSee Notes to Consolidated Financial Statements.\n(a)\n93\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01351",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "How much has the effective tax rate of American Express changed between FY2021 and FY2022?",
      "doc_name": "AMERICANEXPRESS_2022_10K",
      "company": "American Express",
      "answer": "The effective tax rate for American Express has changed/dropped from 24.6% in FY 2021 to 21.6% in FY 2022.",
      "reasoning": "From the provided evidence, we can determine the effective tax rates for American Express for the fiscal years 2021 and 2022. Evidence 1 states that the effective tax rate was 21.6% for 2022 and 24.6% for 2021. To find the change in the effective tax rate, we subtract the 2022 rate from the 2021 rate: 24.6% - 21.6% = 3.0%. Therefore, the effective tax rate decreased by 3.0 percentage points from FY2021 to FY2022.",
      "generated_answer": "The effective tax rate of American Express decreased by 3.0 percentage points from FY2021 to FY2022.",
      "evidence": [
        {
          "evidence_text": "TABLE 1: SUMMARY OF FINANCIAL PERFORMANCE\nYears Ended December 31,\nChange\nChange\n(Millions, except percentages, per share amounts and where indicated)\n2022\n2021\n2020\n2022 vs. 2021\n2021 vs. 2020\nSelected Income Statement Data\nTotal revenues net of interest expense\n$\n52,862\n$\n42,380\n$\n36,087\n$\n10,482 \n25 %\n$\n6,293 \n17 %\nProvisions for credit losses\n2,182\n(1,419)\n4,730\n3,601 \n#\n(6,149)\n#\nExpenses\n41,095\n33,110\n27,061\n7,985 \n24 \n6,049 \n22 \nPretax income\n9,585\n10,689\n4,296\n(1,104)\n(10)\n6,393 \n#\nIncome tax provision\n2,071\n2,629\n1,161\n(558)\n(21)\n1,468 \n#\nNet income\n7,514\n8,060\n3,135\n(546)\n(7)\n4,925 \n#\nEarnings per common share diluted \n$\n9.85\n$\n10.02\n$\n3.77\n$\n(0.17)\n(2)%\n$\n6.25 \n# %\nCommon Share Statistics \nCash dividends declared per common share\n$\n2.08\n$\n1.72\n$\n1.72\n$\n0.36 \n21 %\n$\n \n %\nAverage common shares outstanding:\nBasic\n751\n789\n805\n(38)\n(5)%\n(16)\n(2)%\nDiluted\n752\n790\n806\n(38)\n(5)%\n(16)\n(2)%\nSelected Metrics and Ratios\nNetwork volumes (Billions)\n$\n1,552.8\n$\n1,284.2\n$\n1,037.8\n$\n269 \n21 %\n$\n246 \n24 %\nReturn on average equity \n32.3 %\n33.7 %\n14.2 %\nNet interest income divided by average Card Member loans\n10.4 %\n10.2 %\n10.7 %\nNet interest yield on average Card Member loans\n10.6 %\n10.7 %\n11.5 %\nEffective tax rate\n21.6 %\n24.6 %\n27.0 %\nCommon Equity Tier 1\n10.3 %\n10.5 %\n13.5 %\nSelected Balance Sheet Data\nCash and cash equivalents\n$\n33,914\n$\n22,028\n$\n32,965\n$\n11,886 \n54 %\n$\n(10,937)\n(33)%\nCard Member receivables\n57,613\n53,645\n43,701\n3,968 \n7 \n9,944 \n23 \nCard Member loans\n107,964\n88,562\n73,373\n19,402 \n22 \n15,189 \n21 \nCustomer deposits\n110,239\n84,382\n86,875\n25,857 \n31 \n(2,493)\n(3)\nLong-term debt\n$\n42,573\n$\n38,675\n$\n42,952\n$\n3,898 \n10 %\n$\n(4,277)\n(10)%",
          "doc_name": "AMERICANEXPRESS_2022_10K",
          "evidence_page_num": 43,
          "evidence_text_full_page": "Table of Contents\nTABLE 1: SUMMARY OF FINANCIAL PERFORMANCE\nYears Ended December 31,\nChange\nChange\n(Millions, except percentages, per share amounts and where indicated)\n2022\n2021\n2020\n2022 vs. 2021\n2021 vs. 2020\nSelected Income Statement Data\nTotal revenues net of interest expense\n$\n52,862\n$\n42,380\n$\n36,087\n$\n10,482 \n25 %\n$\n6,293 \n17 %\nProvisions for credit losses\n2,182\n(1,419)\n4,730\n3,601 \n#\n(6,149)\n#\nExpenses\n41,095\n33,110\n27,061\n7,985 \n24 \n6,049 \n22 \nPretax income\n9,585\n10,689\n4,296\n(1,104)\n(10)\n6,393 \n#\nIncome tax provision\n2,071\n2,629\n1,161\n(558)\n(21)\n1,468 \n#\nNet income\n7,514\n8,060\n3,135\n(546)\n(7)\n4,925 \n#\nEarnings per common share diluted \n$\n9.85\n$\n10.02\n$\n3.77\n$\n(0.17)\n(2)%\n$\n6.25 \n# %\nCommon Share Statistics \nCash dividends declared per common share\n$\n2.08\n$\n1.72\n$\n1.72\n$\n0.36 \n21 %\n$\n \n %\nAverage common shares outstanding:\nBasic\n751\n789\n805\n(38)\n(5)%\n(16)\n(2)%\nDiluted\n752\n790\n806\n(38)\n(5)%\n(16)\n(2)%\nSelected Metrics and Ratios\nNetwork volumes (Billions)\n$\n1,552.8\n$\n1,284.2\n$\n1,037.8\n$\n269 \n21 %\n$\n246 \n24 %\nReturn on average equity \n32.3 %\n33.7 %\n14.2 %\nNet interest income divided by average Card Member loans\n10.4 %\n10.2 %\n10.7 %\nNet interest yield on average Card Member loans\n10.6 %\n10.7 %\n11.5 %\nEffective tax rate\n21.6 %\n24.6 %\n27.0 %\nCommon Equity Tier 1\n10.3 %\n10.5 %\n13.5 %\nSelected Balance Sheet Data\nCash and cash equivalents\n$\n33,914\n$\n22,028\n$\n32,965\n$\n11,886 \n54 %\n$\n(10,937)\n(33)%\nCard Member receivables\n57,613\n53,645\n43,701\n3,968 \n7 \n9,944 \n23 \nCard Member loans\n107,964\n88,562\n73,373\n19,402 \n22 \n15,189 \n21 \nCustomer deposits\n110,239\n84,382\n86,875\n25,857 \n31 \n(2,493)\n(3)\nLong-term debt\n$\n42,573\n$\n38,675\n$\n42,952\n$\n3,898 \n10 %\n$\n(4,277)\n(10)%\n# Denotes a variance of 100 percent or more\n(a)\nRepresents net income, less (i) earnings allocated to participating share awards of $57 million, $56 million and $20 million for the years ended December 31, 2022, 2021 and 2020, respectively,\n(ii) dividends on preferred shares of $57 million, $71 million and $79 million for the years ended December 31, 2022, 2021 and 2020, respectively, and (iii) equity-related adjustments of $16\nmillion related to the redemption of preferred shares for the year ended December 31, 2021. Refer to Note 16 and Note 21 to the Consolidated Financial Statements for further details on\npreferred shares and earnings per common share (EPS), respectively.\n(b)\nOur common stock trades principally on The New York Stock Exchange under the trading symbol AXP.\n(c)\nReturn on average equity (ROE) is calculated by dividing (i) net income for the period by (ii) average shareholders' equity for the period.\n(d)\nNet interest yield on average Card Member loans reflects adjusted net interest income divided by average Card Member loans, computed on an annualized basis. Adjusted net interest income and\nnet interest yield on average Card Member loans are non-GAAP measures. Refer to Table 8 for a reconciliation to Net interest income divided by average Card Member loans.\n(a)\n(b)\n(c)\n (d)\n41\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00070",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Does American Water Works have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.",
      "doc_name": "AMERICANWATERWORKS_2022_10K",
      "company": "American Water Works",
      "answer": "No, American Water Works had negative working capital of -$1561M in FY 2022.",
      "reasoning": "Based on the evidence provided, specifically Evidence 3 and Evidence 6, American Water Works Company, Inc. (AWCC) reported a working capital deficit as of December 31, 2022. Evidence 3 states that the aggregate long-term and short-term debt balance was $12.4 billion, and the working capital was in a deficit position. Evidence 6 further supports this by showing that current liabilities exceeded current assets, indicating that the company has more short-term obligations than it has short-term assets to cover them. Therefore, AWCC does not have positive working capital, as its current liabilities are greater than its current assets, leading to a negative working capital situation. Additionally, the company relies on short-term liquidity mechanisms and external financing to manage its cash flow needs, which suggests that working capital may not be a relevant metric for assessing its financial health given its capital-intensive nature and reliance on operational cash flows and credit facilities.",
      "generated_answer": "No, American Water Works does not have positive working capital based on FY2022 data; it has a working capital deficit.",
      "evidence": [
        {
          "evidence_text": "American Water Works Company, Inc. and Subsidiary Companies\nConsolidated Balance Sheets\n(In millions, except share and per share data)\nDecember 31, 2022\nDecember 31, 2021\nASSETS\nProperty, plant and equipment\n$\n29,736 \n$\n27,413 \nAccumulated depreciation\n(6,513)\n(6,329)\nProperty, plant and equipment, net\n23,223 \n21,084 \nCurrent assets:\n \n \nCash and cash equivalents\n85 \n116 \nRestricted funds\n32 \n20 \nAccounts receivable, net of allowance for uncollectible accounts of $60 and $75, respectively\n334 \n271 \nIncome tax receivable\n114 \n4 \nUnbilled revenues\n275 \n248 \nMaterials and supplies\n98 \n57 \nAssets held for sale\n \n683 \nOther\n312 \n155 \nTotal current assets\n1,250 \n1,554",
          "doc_name": "AMERICANWATERWORKS_2022_10K",
          "evidence_page_num": 80,
          "evidence_text_full_page": "Table of Contents\nAmerican Water Works Company, Inc. and Subsidiary Companies\nConsolidated Balance Sheets\n(In millions, except share and per share data)\nDecember 31, 2022\nDecember 31, 2021\nASSETS\nProperty, plant and equipment\n$\n29,736 \n$\n27,413 \nAccumulated depreciation\n(6,513)\n(6,329)\nProperty, plant and equipment, net\n23,223 \n21,084 \nCurrent assets:\n \n \nCash and cash equivalents\n85 \n116 \nRestricted funds\n32 \n20 \nAccounts receivable, net of allowance for uncollectible accounts of $60 and $75, respectively\n334 \n271 \nIncome tax receivable\n114 \n4 \nUnbilled revenues\n275 \n248 \nMaterials and supplies\n98 \n57 \nAssets held for sale\n \n683 \nOther\n312 \n155 \nTotal current assets\n1,250 \n1,554 \nRegulatory and other long-term assets:\n \n \nRegulatory assets\n990 \n1,051 \nSeller promissory note from the sale of the Homeowner Services Group\n720 \n720 \nOperating lease right-of-use assets\n82 \n92 \nGoodwill\n1,143 \n1,139 \nPostretirement benefit assets\n \n193 \nOther\n379 \n242 \nTotal regulatory and other long-term assets\n3,314 \n3,437 \nTotal assets\n$\n27,787 \n$\n26,075 \nThe accompanying notes are an integral part of these Consolidated Financial Statements.\n79\n"
        },
        {
          "evidence_text": "American Water Works Company, Inc. and Subsidiary Companies\nConsolidated Balance Sheets\n(In millions, except share and per share data)\nDecember 31, 2022\nDecember 31, 2021\nCAPITALIZATION AND LIABILITIES\nCapitalization:\n \n \nCommon stock ($0.01 par value; 500,000,000 shares authorized; 187,200,539 and 186,880,413 shares\nissued, respectively)\n$\n2 \n$\n2 \nPaid-in-capital\n6,824 \n6,781 \nRetained earnings\n1,267 \n925 \nAccumulated other comprehensive loss\n(23)\n(45)\nTreasury stock, at cost (5,342,477 and 5,269,324 shares, respectively)\n(377)\n(365)\nTotal common shareholders' equity\n7,693 \n7,298 \nLong-term debt\n10,926 \n10,341 \nRedeemable preferred stock at redemption value\n3 \n3 \nTotal long-term debt\n10,929 \n10,344 \nTotal capitalization\n18,622 \n17,642 \nCurrent liabilities:\n \n \nShort-term debt\n1,175 \n584 \nCurrent portion of long-term debt\n281 \n57 \nAccounts payable\n254 \n235 \nAccrued liabilities\n706 \n701 \nAccrued taxes\n49 \n176 \nAccrued interest\n91 \n88 \nLiabilities related to assets held for sale\n \n83 \nOther\n255 \n217 \nTotal current liabilities\n2,811 \n2,141",
          "doc_name": "AMERICANWATERWORKS_2022_10K",
          "evidence_page_num": 81,
          "evidence_text_full_page": "Table of Contents\nAmerican Water Works Company, Inc. and Subsidiary Companies\nConsolidated Balance Sheets\n(In millions, except share and per share data)\nDecember 31, 2022\nDecember 31, 2021\nCAPITALIZATION AND LIABILITIES\nCapitalization:\n \n \nCommon stock ($0.01 par value; 500,000,000 shares authorized; 187,200,539 and 186,880,413 shares\nissued, respectively)\n$\n2 \n$\n2 \nPaid-in-capital\n6,824 \n6,781 \nRetained earnings\n1,267 \n925 \nAccumulated other comprehensive loss\n(23)\n(45)\nTreasury stock, at cost (5,342,477 and 5,269,324 shares, respectively)\n(377)\n(365)\nTotal common shareholders' equity\n7,693 \n7,298 \nLong-term debt\n10,926 \n10,341 \nRedeemable preferred stock at redemption value\n3 \n3 \nTotal long-term debt\n10,929 \n10,344 \nTotal capitalization\n18,622 \n17,642 \nCurrent liabilities:\n \n \nShort-term debt\n1,175 \n584 \nCurrent portion of long-term debt\n281 \n57 \nAccounts payable\n254 \n235 \nAccrued liabilities\n706 \n701 \nAccrued taxes\n49 \n176 \nAccrued interest\n91 \n88 \nLiabilities related to assets held for sale\n \n83 \nOther\n255 \n217 \nTotal current liabilities\n2,811 \n2,141 \nRegulatory and other long-term liabilities:\n \n \nAdvances for construction\n316 \n284 \nDeferred income taxes and investment tax credits\n2,437 \n2,421 \nRegulatory liabilities\n1,590 \n1,600 \nOperating lease liabilities\n70 \n80 \nAccrued pension expense\n235 \n285 \nOther\n202 \n180 \nTotal regulatory and other long-term liabilities\n4,850 \n4,850 \nContributions in aid of construction\n1,504 \n1,442 \nCommitments and contingencies (See Note 16)\nTotal capitalization and liabilities\n$\n27,787 \n$\n26,075 \nThe accompanying notes are an integral part of these Consolidated Financial Statements. \n80\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00685",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Logical reasoning",
      "question": "Are Best Buy's gross margins historically consistent (not fluctuating more than roughly 2% each year)? If gross margins are not a relevant metric for a company like this, then please state that and explain why.",
      "doc_name": "BESTBUY_2023_10K",
      "company": "Best Buy",
      "answer": "Yes, the margins have been consistent, there has been a minor decline of 1.1% in gross margins between FY2022 and FY2023.",
      "reasoning": "Analyzing the provided evidence, particularly Evidence 1, 3, and 8, we can observe the historical gross profit margins for Best Buy over several fiscal years. The gross profit as a percentage of revenue fluctuated as follows: 24.0% in 2017, 23.3% in 2016, and 22.4% in 2015. This indicates a decline of 0.7% from 2015 to 2016 and a further decline of 0.7% from 2016 to 2017. In another set of data, the gross profit rates were reported as 23.2%, 22.1%, 22.9%, and 22.1% across different periods, showing fluctuations that exceed 2% in some instances. Therefore, the gross margins are not consistent, as they have fluctuated more than 2% year over year. Additionally, the evidence suggests that gross margins can be influenced by various factors such as pricing strategies, competition, and changes in cost structures, which can make them less relevant as a standalone metric for evaluating Best Buy's performance. Instead, a more comprehensive view that includes SG&A expenses and operating income may provide better insights into the company's financial health.",
      "generated_answer": "No, Best Buy's gross margins are not historically consistent, as they have fluctuated more than 2% each year.",
      "evidence": [
        {
          "evidence_text": "Consolidated Statements of Earnings\n$ and shares in millions, except per share amounts\n \n \n \n \n \n \n \n \n \n \n \n \n \nFiscal Years Ended\nJanuary 28, 2023\n \nJanuary 29, 2022\n \nJanuary 30, 2021\nRevenue\n$\n 46,298 \n \n$\n 51,761 \n \n$\n 47,262 \nCost of sales\n \n 36,386 \n \n \n 40,121 \n \n \n 36,689 \nGross profit\n \n 9,912 \n \n \n 11,640 \n \n \n 10,573 \nSelling, general and administrative expenses\n \n 7,970 \n \n \n 8,635 \n \n \n 7,928 \nRestructuring charges\n \n 147 \n \n \n (34) \n \n \n 254 \nOperating income\n \n 1,795 \n \n \n 3,039 \n \n \n 2,391 \nOther income (expense):\n \n \n \n \n \n \n \n \n \n \n \nInvestment income and other\n \n 28 \n \n \n 10 \n \n \n 38 \nInterest expense\n \n (35) \n \n \n (25) \n \n \n (52) \nEarnings before income tax expense and equity in income of affiliates\n \n 1,788 \n \n \n 3,024 \n \n \n 2,377 \nIncome tax expense\n \n 370 \n \n \n 574 \n \n \n 579 \nEquity in income of affiliates\n \n 1 \n \n \n 4 \n \n \n - \nNet earnings\n$\n 1,419 \n \n$\n 2,454 \n \n$\n 1,798",
          "doc_name": "BESTBUY_2023_10K",
          "evidence_page_num": 39,
          "evidence_text_full_page": " \nConsolidated Statements of Earnings\n$ and shares in millions, except per share amounts\n \n \n \n \n \n \n \n \n \n \n \n \n \nFiscal Years Ended\nJanuary 28, 2023\n \nJanuary 29, 2022\n \nJanuary 30, 2021\nRevenue\n$\n 46,298 \n \n$\n 51,761 \n \n$\n 47,262 \nCost of sales\n \n 36,386 \n \n \n 40,121 \n \n \n 36,689 \nGross profit\n \n 9,912 \n \n \n 11,640 \n \n \n 10,573 \nSelling, general and administrative expenses\n \n 7,970 \n \n \n 8,635 \n \n \n 7,928 \nRestructuring charges\n \n 147 \n \n \n (34) \n \n \n 254 \nOperating income\n \n 1,795 \n \n \n 3,039 \n \n \n 2,391 \nOther income (expense):\n \n \n \n \n \n \n \n \n \n \n \nInvestment income and other\n \n 28 \n \n \n 10 \n \n \n 38 \nInterest expense\n \n (35) \n \n \n (25) \n \n \n (52) \nEarnings before income tax expense and equity in income of affiliates\n \n 1,788 \n \n \n 3,024 \n \n \n 2,377 \nIncome tax expense\n \n 370 \n \n \n 574 \n \n \n 579 \nEquity in income of affiliates\n \n 1 \n \n \n 4 \n \n \n - \nNet earnings\n$\n 1,419 \n \n$\n 2,454 \n \n$\n 1,798 \n \n \n \n \n \n \n \n \n \n \n \n \nBasic earnings per share\n$\n 6.31 \n \n$\n 9.94 \n \n$\n 6.93 \nDiluted earnings per share\n$\n 6.29 \n \n$\n 9.84 \n \n$\n 6.84 \n \n \n \n \n \n \n \n \n \n \n \n \nWeighted-average common shares outstanding:\n \n \n \n \n \n \n \n \n \n \n \nBasic\n \n 224.8 \n \n \n 246.8 \n \n \n 259.6 \nDiluted\n \n 225.7 \n \n \n 249.3 \n \n \n 263.0 \n \nSee Notes to Consolidated Financial Statements.\n \n \n40\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01077",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are major acquisitions that Best Buy has done in FY2023, FY2022 and FY2021?",
      "doc_name": "BESTBUY_2023_10K",
      "company": "Best Buy",
      "answer": "Best Buy closed two acquisitions, both these companies were already partially owned by Best Buy, but Best Buy acquired all outstanding shares of these two companies during FY 2022: (1) Current Health Ltd and (2) Two Peaks, LLC d/b/a Yardbird Furniture",
      "reasoning": "Based on the provided evidence, Best Buy made several significant acquisitions in the fiscal years 2023, 2022, and 2021. In fiscal 2022, Best Buy acquired Current Health Ltd. for $389 million and Two Peaks, LLC d/b/a Yardbird Furniture for $79 million. Both acquisitions included substantial goodwill that was deductible for tax purposes and were aligned with Best Buy's strategic focus on enhancing its service offerings in health care and outdoor living. In fiscal 2021, there were no specific acquisitions mentioned in the evidence provided, indicating that the focus was primarily on the acquisitions made in fiscal 2022. The evidence does not provide any details on acquisitions for fiscal 2023, suggesting that either no major acquisitions occurred or they were not disclosed in the provided documents. Therefore, the major acquisitions identified are from fiscal 2022 only.",
      "generated_answer": "Major acquisitions by Best Buy include: 1) Current Health Ltd. for $389 million in FY2022, and 2) Two Peaks, LLC d/b/a Yardbird Furniture for $79 million in FY2022. No major acquisitions were noted for FY2023 or FY2021.",
      "evidence": [
        {
          "evidence_text": "Acquisitions\n \nCurrent Health Ltd.\n \nIn fiscal 2022, we acquired all of the outstanding shares of Current Health Ltd. (Current Health), a care-at-home technology platform, on November 2, 2021, for \nnet cash consideration of $389 million. The acquired assets included $351 million of goodwill that was assigned to our Best Buy Health reporting unit and was \ndeductible for income tax purposes. The acquisition is aligned with our focus in virtual care to enable people in their homes to connect seamlessly with their \nhealth care providers and is included in our Domestic reportable segment and Services revenue category. The acquisition was accounted for using the \nacquisition method of accounting for business combinations and was not material to the results of operations.\n \nTwo Peaks, LLC d/b/a Yardbird Furniture\n \nIn fiscal 2022, we acquired all of the outstanding shares of Two Peaks, LLC d/b/a Yardbird Furniture (Yardbird), a direct-to-consumer outdoor furniture company, \non November 4, 2021, for net cash consideration of $79 million. The acquired assets included $47 million of goodwill that was assigned to our Best Buy Domestic \nreporting unit and was deductible for income tax purposes. The acquisition expands our assortment in categories like outdoor living, as more and more \nconsumers look to make over or upgrade their outdoor living spaces. The acquisition was accounted for using the acquisition method of accounting for business \ncombinations and was not material to the results of our operations.",
          "doc_name": "BESTBUY_2023_10K",
          "evidence_page_num": 50,
          "evidence_text_full_page": "Vendor Allowances\n \nWe receive funds from our merchandise vendors through a variety of programs and arrangements, primarily in the form of purchases-based or sales-based \nvolumes and for product advertising and placement. We recognize allowances based on purchases and sales as a reduction of cost of sales when the associated \ninventory is sold. Allowances for advertising and placement are recognized as a reduction of cost of sales ratably over the corresponding performance period. \nFunds that are determined to be a reimbursement of specific, incremental and identifiable costs incurred to sell a vendors products are recorded as an offset to \nthe related expense within SG&A when incurred.\n \nAdvertising Costs\n \nAdvertising costs, which are included in SG&A, are expensed the first time the advertisement runs. Advertising costs consist primarily of digital advertisements. \nAdvertising expenses were $864 million, $915 million and $819 million in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.\n \nStock-Based Compensation\n \nWe recognize stock-based compensation expense for the fair value of our stock-based compensation awards, which is determined based on the closing market \nprice of our stock at the date of grant for time-based and performance-based share awards, and Monte-Carlo simulation for market-based share awards. \nCompensation expense is recognized on a straight-line basis over the period in which services are required, except for performance-based share awards that \nvest on a graded basis, in which case the expense is front-loaded or recognized on a graded-attribution basis. Forfeitures are expensed as incurred or upon \ntermination.\n \nComprehensive Income (Loss)\n \nComprehensive income (loss) is computed as net earnings plus certain other items that are recorded directly to shareholders equity.\n \n2. Acquisitions\n \nCurrent Health Ltd.\n \nIn fiscal 2022, we acquired all of the outstanding shares of Current Health Ltd. (Current Health), a care-at-home technology platform, on November 2, 2021, for \nnet cash consideration of $389 million. The acquired assets included $351 million of goodwill that was assigned to our Best Buy Health reporting unit and was \ndeductible for income tax purposes. The acquisition is aligned with our focus in virtual care to enable people in their homes to connect seamlessly with their \nhealth care providers and is included in our Domestic reportable segment and Services revenue category. The acquisition was accounted for using the \nacquisition method of accounting for business combinations and was not material to the results of operations.\n \nTwo Peaks, LLC d/b/a Yardbird Furniture\n \nIn fiscal 2022, we acquired all of the outstanding shares of Two Peaks, LLC d/b/a Yardbird Furniture (Yardbird), a direct-to-consumer outdoor furniture company, \non November 4, 2021, for net cash consideration of $79 million. The acquired assets included $47 million of goodwill that was assigned to our Best Buy Domestic \nreporting unit and was deductible for income tax purposes. The acquisition expands our assortment in categories like outdoor living, as more and more \nconsumers look to make over or upgrade their outdoor living spaces. The acquisition was accounted for using the acquisition method of accounting for business \ncombinations and was not material to the results of our operations.\n \n3. Restructuring\n \n \nRestructuring charges were as follows ($ in millions):\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n2023\n \n2022\n \n2021\nFiscal 2023 Resource Optimization Initiative\n \n \n$\n 145 \n \n$\n - \n \n$\n - \nMexico Exit and Strategic Realignment(1)\n \n \n \n 2 \n \n \n (41) \n \n \n 277 \nFiscal 2020 U.S. Retail Operating Model Changes\n \n -\n \n \n 1 \n \n \n -\n \nTotal\n \n \n \n \n \n$\n 147 \n \n$\n (40) \n \n$\n 277 \n \n(1)\nIncludes ($6) million and $23 million related to inventory markdowns recorded in Cost of sales on our Consolidated Statements of Earnings in fiscal 2022 and fiscal 2021, respectively.\n \nFiscal 2023 Resource Optimization Initiative\n \nIn light of ongoing changes in business trends, during the second quarter of fiscal 2023, we commenced an enterprise-wide initiative to better align our spending \nwith critical strategies and operations, as well as to optimize our cost structure. Charges incurred relate to employee termination benefits within our Domestic and \nInternational segments of $140 million and $5 million, respectively. We currently do not expect the remaining charges in fiscal 2024 related to this initiative to be \nmaterial to the results of our operations.\n \nAll charges incurred related to this initiative were from continuing operations and were presented within Restructuring charges on our Consolidated Statements of \nEarnings. \n \n51\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01275",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Best Buy in FY2023?",
      "doc_name": "BESTBUY_2023_10K",
      "company": "Best Buy",
      "answer": "Best Buy generated the most cash flow from operating activities in FY 2023 ($1.8 bn)",
      "reasoning": "To determine which cash flow activity brought in the most cash for Best Buy in FY2023, we need to analyze the cash flows from operating, investing, and financing activities as provided in the evidence. \n\nFrom Evidence 1, we see that Best Buy had net cash provided by operating activities of $1,261 million in FY2023. \n\nIn terms of investing activities, the net cash used was $(309) million, indicating a cash outflow. \n\nFor financing activities, the net cash used was $(1,025) million, which also indicates a cash outflow. \n\nNow, comparing these figures:\n- Operating activities: +$1,261 million (inflow)\n- Investing activities: -$309 million (outflow)\n- Financing activities: -$1,025 million (outflow)\n\nClearly, the operating activities generated the most cash flow, as it was the only category with a positive cash flow. The other two categories resulted in cash outflows. Therefore, the operating activities brought in the most cash flow for Best Buy in FY2023.",
      "generated_answer": "Operating activities brought in the most cash flow for Best Buy in FY2023.",
      "evidence": [
        {
          "evidence_text": "Consolidated Statements of Cash Flows\n$ in millions\n \n \n \n \n \n \n \n \n \n \n \n \n \n \nFiscal Years Ended\nJanuary 28, 2023\n \nJanuary 29, 2022\n \nJanuary 30, 2021\nOperating activities\n \n \n \n \n \n \n \n \n \n \n \nNet earnings\n$\n 1,419 \n \n$\n 2,454 \n \n$\n 1,798 \n \nAdjustments to reconcile net earnings to total cash provided by operating activities:\n \n \n \n \n \n \n \n \nDepreciation and amortization\n \n 918 \n \n \n 869 \n \n \n 839 \nRestructuring charges\n \n 147 \n \n \n (34) \n \n \n 254 \nStock-based compensation\n \n 138 \n \n \n 141 \n \n \n 135 \nDeferred income taxes\n \n 51 \n \n \n 14 \n \n \n (36) \nOther, net\n \n 12 \n \n \n 11 \n \n \n 3 \nChanges in operating assets and liabilities, net of acquired assets and liabilities:\n \n \n \n \n \n \n \n \n \nReceivables\n \n (103) \n \n \n 17 \n \n \n 73 \nMerchandise inventories\n \n 809 \n \n \n (328) \n \n \n (435) \nOther assets\n \n (21) \n \n \n (14) \n \n \n (51) \nAccounts payable\n \n (1,099) \n \n \n (201) \n \n \n 1,676 \nIncome taxes\n \n 36 \n \n \n (156) \n \n \n 173 \nOther liabilities\n \n (483) \n \n \n 479 \n \n \n 498 \nTotal cash provided by operating activities\n \n 1,824 \n \n \n 3,252 \n \n \n 4,927 \nInvesting activities\n \n \n \n \n \n \n \n \n \n \n \nAdditions to property and equipment, net of $35, $46 and $32, respectively, of non-cash \ncapital expenditures\n \n (930) \n \n \n (737) \n \n \n (713) \nPurchases of investments\n \n (46) \n \n \n (233) \n \n \n (620) \nSales of investments\n \n 7 \n \n \n 66 \n \n \n 546 \nAcquisitions, net of cash acquired\n \n - \n \n \n (468) \n \n \n - \nOther, net\n \n 7 \n \n \n - \n \n \n (1) \nTotal cash used in investing activities\n \n (962) \n \n \n (1,372) \n \n \n (788) \nFinancing activities\n \n \n \n \n \n \n \n \n \n \n \nRepurchase of common stock\n \n (1,014) \n \n \n (3,502) \n \n \n (312) \nIssuance of common stock\n \n 16 \n \n \n 29 \n \n \n 28 \nDividends paid\n \n (789) \n \n \n (688) \n \n \n (568) \nBorrowings of debt\n \n - \n \n \n - \n \n \n 1,892 \nRepayments of debt\n \n (19) \n \n \n (133) \n \n \n (1,916) \nOther, net\n \n - \n \n \n (3) \n \n \n - \nTotal cash used in financing activities\n \n (1,806) \n \n \n (4,297) \n \n \n (876) \n \n \n \n \n \n \n \n \n \n \n \n \nEffect of exchange rate changes on cash\n \n (8) \n \n \n (3) \n \n \n 7 \nIncrease (decrease) in cash, cash equivalents and restricted cash\n \n (952) \n \n \n (2,420) \n \n \n 3,270 \nCash, cash equivalents and restricted cash at beginning of period\n \n 3,205 \n \n \n 5,625 \n \n \n 2,355 \nCash, cash equivalents and restricted cash at end of period\n$\n 2,253 \n \n$\n 3,205 \n \n$\n 5,625",
          "doc_name": "BESTBUY_2023_10K",
          "evidence_page_num": 41,
          "evidence_text_full_page": " \nConsolidated Statements of Cash Flows\n$ in millions\n \n \n \n \n \n \n \n \n \n \n \n \n \n \nFiscal Years Ended\nJanuary 28, 2023\n \nJanuary 29, 2022\n \nJanuary 30, 2021\nOperating activities\n \n \n \n \n \n \n \n \n \n \n \nNet earnings\n$\n 1,419 \n \n$\n 2,454 \n \n$\n 1,798 \n \nAdjustments to reconcile net earnings to total cash provided by operating activities:\n \n \n \n \n \n \n \n \nDepreciation and amortization\n \n 918 \n \n \n 869 \n \n \n 839 \nRestructuring charges\n \n 147 \n \n \n (34) \n \n \n 254 \nStock-based compensation\n \n 138 \n \n \n 141 \n \n \n 135 \nDeferred income taxes\n \n 51 \n \n \n 14 \n \n \n (36) \nOther, net\n \n 12 \n \n \n 11 \n \n \n 3 \nChanges in operating assets and liabilities, net of acquired assets and liabilities:\n \n \n \n \n \n \n \n \n \nReceivables\n \n (103) \n \n \n 17 \n \n \n 73 \nMerchandise inventories\n \n 809 \n \n \n (328) \n \n \n (435) \nOther assets\n \n (21) \n \n \n (14) \n \n \n (51) \nAccounts payable\n \n (1,099) \n \n \n (201) \n \n \n 1,676 \nIncome taxes\n \n 36 \n \n \n (156) \n \n \n 173 \nOther liabilities\n \n (483) \n \n \n 479 \n \n \n 498 \nTotal cash provided by operating activities\n \n 1,824 \n \n \n 3,252 \n \n \n 4,927 \nInvesting activities\n \n \n \n \n \n \n \n \n \n \n \nAdditions to property and equipment, net of $35, $46 and $32, respectively, of non-cash \ncapital expenditures\n \n (930) \n \n \n (737) \n \n \n (713) \nPurchases of investments\n \n (46) \n \n \n (233) \n \n \n (620) \nSales of investments\n \n 7 \n \n \n 66 \n \n \n 546 \nAcquisitions, net of cash acquired\n \n - \n \n \n (468) \n \n \n - \nOther, net\n \n 7 \n \n \n - \n \n \n (1) \nTotal cash used in investing activities\n \n (962) \n \n \n (1,372) \n \n \n (788) \nFinancing activities\n \n \n \n \n \n \n \n \n \n \n \nRepurchase of common stock\n \n (1,014) \n \n \n (3,502) \n \n \n (312) \nIssuance of common stock\n \n 16 \n \n \n 29 \n \n \n 28 \nDividends paid\n \n (789) \n \n \n (688) \n \n \n (568) \nBorrowings of debt\n \n - \n \n \n - \n \n \n 1,892 \nRepayments of debt\n \n (19) \n \n \n (133) \n \n \n (1,916) \nOther, net\n \n - \n \n \n (3) \n \n \n - \nTotal cash used in financing activities\n \n (1,806) \n \n \n (4,297) \n \n \n (876) \n \n \n \n \n \n \n \n \n \n \n \n \nEffect of exchange rate changes on cash\n \n (8) \n \n \n (3) \n \n \n 7 \nIncrease (decrease) in cash, cash equivalents and restricted cash\n \n (952) \n \n \n (2,420) \n \n \n 3,270 \nCash, cash equivalents and restricted cash at beginning of period\n \n 3,205 \n \n \n 5,625 \n \n \n 2,355 \nCash, cash equivalents and restricted cash at end of period\n$\n 2,253 \n \n$\n 3,205 \n \n$\n 5,625 \n \n \n \n \n \n \n \n \n \n \n \n \n \nSupplemental cash flow information\n \n \n \n \n \n \n \n \n \n \n \nIncome taxes paid\n$\n 283 \n \n$\n 716 \n \n$\n 442 \nInterest paid\n$\n 31 \n \n$\n 22 \n \n$\n 50 \n \nSee Notes to Consolidated Financial Statements.\n \n \n42\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00517",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning)",
      "question": "Are there any product categories / service categories that represent more than 20% of Boeing's revenue for FY2022?",
      "doc_name": "BOEING_2022_10K",
      "company": "Boeing",
      "answer": "Yes. Boeing has product and service categories that represent more than 20% of Boeing's revenue for FY2022. These categories are Commercial Airplanes which comprises 39% of total revenue, Defence which comprises 35% of total revenue and Services which comprises 26% of total revenue.",
      "reasoning": "To determine if any product or service categories represent more than 20% of Boeing's revenue for FY2022, we can analyze the revenue breakdown provided in the evidence. According to Evidence 5, Boeing's total revenues for FY2022 were $66,608 million. The revenues from each segment are as follows:\n\n- Commercial Airplanes (BCA): $25,867 million\n- Defense, Space & Security (BDS): $23,162 million\n- Global Services (BGS): $17,611 million\n- Boeing Capital (BCC): $199 million\n\nNext, we calculate the percentage of total revenue for each segment:\n\n1. BCA: (25,867 / 66,608) * 100 = 38.8%\n2. BDS: (23,162 / 66,608) * 100 = 34.8%\n3. BGS: (17,611 / 66,608) * 100 = 26.4%\n4. BCC: (199 / 66,608) * 100 = 0.3%\n\nFrom this analysis, we see that BCA, BDS, and BGS all exceed 20% of total revenue for FY2022. Specifically, BCA accounts for approximately 38.8%, BDS for approximately 34.8%, and BGS for approximately 26.4%. Therefore, there are multiple categories that represent more than 20% of Boeing's revenue for FY2022.",
      "generated_answer": "Yes, the Commercial Airplanes (BCA), Defense, Space & Security (BDS), and Global Services (BGS) segments each represent more than 20% of Boeing's revenue for FY2022.",
      "evidence": [
        {
          "evidence_text": "The Boeing Company and Subsidiaries\nNotes to the Consolidated Financial Statements\nSummary of Business Segment Data\n(Dollars in millions)\n \nYears ended December 31,\n2022\n2021\n2020\nRevenues:\nCommercial Airplanes\n$25,867 \n$19,493 \n$16,162 \nDefense, Space & Security\n23,162 \n26,540 \n26,257 \nGlobal Services\n17,611 \n16,328 \n15,543 \nBoeing Capital\n199 \n272 \n261 \nUnallocated items, eliminations and other\n(231)\n(347)\n(65)\nTotal revenues\n$66,608 \n$62,286 \n$58,158",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 61,
          "evidence_text_full_page": "Table of Contents\nThe Boeing Company and Subsidiaries\nNotes to the Consolidated Financial Statements\nSummary of Business Segment Data\n(Dollars in millions)\n \nYears ended December 31,\n2022\n2021\n2020\nRevenues:\nCommercial Airplanes\n$25,867 \n$19,493 \n$16,162 \nDefense, Space & Security\n23,162 \n26,540 \n26,257 \nGlobal Services\n17,611 \n16,328 \n15,543 \nBoeing Capital\n199 \n272 \n261 \nUnallocated items, eliminations and other\n(231)\n(347)\n(65)\nTotal revenues\n$66,608 \n$62,286 \n$58,158 \n(Loss)/earnings from operations:\nCommercial Airplanes\n($2,370)\n($6,475)\n($13,847)\nDefense, Space & Security\n(3,544)\n1,544 \n1,539 \nGlobal Services\n2,727 \n2,017 \n450 \nBoeing Capital\n29 \n106 \n63 \nSegment operating loss\n(3,158)\n(2,808)\n(11,795)\nUnallocated items, eliminations and other\n(1,532)\n(1,267)\n(2,355)\nFAS/CAS service cost adjustment\n1,143 \n1,173 \n1,383 \nLoss from operations\n(3,547)\n(2,902)\n(12,767)\nOther income, net\n1,058 \n551 \n447 \nInterest and debt expense\n(2,533)\n(2,682)\n(2,156)\nLoss before income taxes\n(5,022)\n(5,033)\n(14,476)\nIncome tax (expense)/benefit\n(31)\n743 \n2,535 \nNet loss\n(5,053)\n(4,290)\n(11,941)\nLess: net loss attributable to noncontrolling interest\n(118)\n(88)\n(68)\nNet loss attributable to Boeing Shareholders\n($4,935)\n($4,202)\n($11,873)\nThis information is an integral part of the Notes to the Consolidated Financial Statements. See Note 22 for further segment results.\n58\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01091",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Has Boeing reported any materially important ongoing legal battles from FY2022?",
      "doc_name": "BOEING_2022_10K",
      "company": "Boeing",
      "answer": "Yes. Multiple lawsuits have been filed against Boeing resulting from a 2018 Lion Air crash and a 2019 Ethiopian Airlines crash.",
      "reasoning": "Boeing has reported several ongoing legal battles that could materially impact its financial position. Notably, the company is involved in litigation related to the accidents of Lion Air Flight 610 and Ethiopian Airlines Flight 302, which have led to multiple legal actions against it. Boeing has also entered into a Deferred Prosecution Agreement with the U.S. Department of Justice regarding the evaluation of the 737 MAX, indicating significant legal scrutiny. Additionally, Boeing is pursuing claims for reimbursement from former partners related to the Sea Launch program, and there are ongoing disputes with the U.S. government regarding contracts and claims. These legal matters are described as potentially diverting financial and management resources and could have a material impact on Boeing's financial results, as indicated in the evidence provided.",
      "generated_answer": "Yes, Boeing has reported several ongoing legal battles from FY2022 that could materially impact its financial position.",
      "evidence": [
        {
          "evidence_text": "Multiple legal actions have been filed against us as a result of the October 29, 2018 accident of Lion Air Flight 610 and the March 10, 2019\naccident of Ethiopian Airlines Flight 302.",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 112,
          "evidence_text_full_page": "Table of Contents\nbased upon current information, that the outcome of any such legal proceeding, claim, or government dispute and investigation will not have a\nmaterial effect on our financial position, results of operations or cash flows. Where it is reasonably possible that we will incur losses in excess of\nrecorded amounts in connection with any of the matters set forth below, we will disclose either the amount or range of reasonably possible\nlosses in excess of such amounts or, where no such amount or range can be reasonably estimated, the reasons why no such estimate can be\nmade.\nMultiple legal actions have been filed against us as a result of the October 29, 2018 accident of Lion Air Flight 610 and the March 10, 2019\naccident of Ethiopian Airlines Flight 302. During 2021, we entered into (i) a Deferred Prosecution Agreement with the U.S. Department of Justice\nthat resolved the Department of Justices previously disclosed investigation into us regarding the evaluation of the 737 MAX by the Federal\nAviation Administration (FAA) as well as (ii) a proposed settlement with plaintiffs in a shareholder derivative lawsuit that resulted in the Company\nreceiving $219 in the second quarter of 2022. In September 2022, we settled a previously disclosed investigation by the Securities and\nExchange Commission related to the 737 MAX accidents and consented to a civil penalty, which resulted in an earnings charge of $200 that was\npaid in October 2022. We cannot reasonably estimate a range of loss, if any, not covered by available insurance that we may incur as a result of\nany remaining pending lawsuits or other matters related to the accidents and the 737 MAX.\nDuring 2019, we entered into agreements with Embraer S.A. (Embraer) to establish joint ventures that included the commercial aircraft and\nservices operations of Embraer, of which we were expected to acquire an 80 percent ownership stake for $4,200, as well as a joint venture to\npromote and develop new markets for the C-390 Millennium. In 2020, we exercised our contractual right to terminate these agreements based\non Embraers failure to meet certain required closing conditions. Embraer has disputed our right to terminate the agreements, and the dispute is\ncurrently in arbitration. We cannot reasonably estimate a range of loss, if any, that may result from the arbitration, which we currently expect to\nbe completed in late 2023 or early 2024.\nNote 22 Segment and Revenue Information\nOur primary profitability measurements to review a segments operating results are Earnings/(loss) from operations and operating margins. We\noperate in four reportable segments: BCA, BDS, BGS and BCC. All other activities fall within Unallocated items, eliminations and other. See\npage 58 for the Summary of Business Segment Data, which is an integral part of this note.\nBCA develops, produces and markets commercial jet aircraft principally to the commercial airline industry worldwide. Revenue on commercial\naircraft contracts is recognized at the point in time when an aircraft is completed and accepted by the customer.\nBDS engages in the research, development, production and modification of the following products and related services: manned and unmanned\nmilitary aircraft and weapons systems, surveillance and engagement, strategic defense and intelligence systems, satellite systems and space\nexploration. BDS revenue is generally recognized over the contract term (over time) as costs are incurred.\nBGS provides parts, maintenance, modifications, logistics support, training, data analytics and information-based services to commercial and\ngovernment customers worldwide. BGS segment revenue and costs include certain products and services provided to other segments. Revenue\non commercial spare parts contracts is recognized at the point in time when a spare part is delivered to the customer. Revenue on other\ncontracts is generally recognized over the contract term (over time) as costs are incurred.\nBCC facilitates, arranges, structures and provides selective financing solutions for our customers.\n109\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00678",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR information extraction",
      "question": "Does Boeing have an improving gross margin profile as of FY2022? If gross margin is not a useful metric for a company like this, then state that and explain why.",
      "doc_name": "BOEING_2022_10K",
      "company": "Boeing",
      "answer": "Yes. Boeing has an improving gross margin profile as of FY2022. Gross profit improved from $3,017 million in FY2021 to $3,502 million in FY2022. Gross margin % improved from 4.8% in FY2021 to 5.3% in FY2022.",
      "reasoning": "Based on the evidence provided, Boeing's gross margin profile appears to be under significant pressure as of FY2022. The 767, 777X, and 787 programs reported near break-even or single-digit margins, indicating that these programs are not generating substantial profits. Additionally, adverse changes to revenue and cost estimates could lead to further earnings charges in future periods, particularly for the 777X and 787 programs. The company has also recorded substantial losses in previous years, including a $3.5 billion loss on the 787 program in 2021 and ongoing abnormal production costs. While there was an increase in accounting quantity for the 787 program, which improved its profit margin, the overall financial performance remains precarious due to ongoing production disruptions, supply chain issues, and the need for rework on undelivered aircraft. Therefore, while there may be some improvements in specific areas, the overall gross margin profile does not indicate a clear trend of improvement for Boeing as of FY2022. Furthermore, gross margin may not be the most useful metric for Boeing due to the complexity of its operations, reliance on long-term contracts, and the significant impact of external factors such as supply chain disruptions and regulatory requirements on its profitability. These factors can lead to fluctuations in margins that do not accurately reflect the company's operational efficiency or long-term profitability potential.",
      "generated_answer": "No, Boeing does not have an improving gross margin profile as of FY2022 due to near break-even margins on key programs and ongoing production challenges.",
      "evidence": [
        {
          "evidence_text": "The Boeing Company and Subsidiaries\nConsolidated Statements of Operations\n(Dollars in millions, except per share data)\n \n \n \nYears ended December 31,\n2022\n2021\n2020\nSales of products\n$55,893 \n$51,386 \n$47,142 \nSales of services\n10,715 \n10,900 \n11,016 \nTotal revenues\n66,608 \n62,286 \n58,158 \nCost of products\n(53,969)\n(49,954)\n(54,568)\nCost of services\n(9,109)\n(9,283)\n(9,232)\nBoeing Capital interest expense\n(28)\n(32)\n(43)\nTotal costs and expenses\n(63,106)\n(59,269)\n(63,843)\n3,502 \n3,017 \n(5,685)",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 54,
          "evidence_text_full_page": "Table of Contents\nThe Boeing Company and Subsidiaries\nConsolidated Statements of Operations\n(Dollars in millions, except per share data)\n \n \n \nYears ended December 31,\n2022\n2021\n2020\nSales of products\n$55,893 \n$51,386 \n$47,142 \nSales of services\n10,715 \n10,900 \n11,016 \nTotal revenues\n66,608 \n62,286 \n58,158 \nCost of products\n(53,969)\n(49,954)\n(54,568)\nCost of services\n(9,109)\n(9,283)\n(9,232)\nBoeing Capital interest expense\n(28)\n(32)\n(43)\nTotal costs and expenses\n(63,106)\n(59,269)\n(63,843)\n3,502 \n3,017 \n(5,685)\n(Loss)/income from operating investments, net\n(16)\n210 \n9 \nGeneral and administrative expense\n(4,187)\n(4,157)\n(4,817)\nResearch and development expense, net\n(2,852)\n(2,249)\n(2,476)\nGain on dispositions, net\n6 \n277 \n202 \nLoss from operations\n(3,547)\n(2,902)\n(12,767)\nOther income, net\n1,058 \n551 \n447 \nInterest and debt expense\n(2,533)\n(2,682)\n(2,156)\nLoss before income taxes\n(5,022)\n(5,033)\n(14,476)\nIncome tax (expense)/benefit\n(31)\n743 \n2,535 \nNet loss\n(5,053)\n(4,290)\n(11,941)\nLess: net loss attributable to noncontrolling interest\n(118)\n(88)\n(68)\nNet loss attributable to Boeing Shareholders\n($4,935)\n($4,202)\n($11,873)\nBasic loss per share\n($8.30)\n($7.15)\n($20.88)\nDiluted loss per share\n($8.30)\n($7.15)\n($20.88)\nSee Notes to the Consolidated Financial Statements on pages 59 - 114.\n53\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01290",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction OR Logical reasoning",
      "question": "Who are the primary customers of Boeing as of FY2022?",
      "doc_name": "BOEING_2022_10K",
      "company": "Boeing",
      "answer": "Boeing's primary customers as of FY2022 are a limited number of commercial airlines and the US government. The US government accounted for 40% of Boeing's total revenues in FY2022.",
      "reasoning": "Based on the provided evidence, Boeing's primary customers as of FY2022 include the United States Department of Defense (U.S. DoD), which is the main customer for the Defense, Space & Security (BDS) segment, accounting for a significant portion of its revenues. Additionally, the National Aeronautics and Space Administration (NASA) is mentioned as another significant customer for BDS. For the Commercial Airplanes (BCA) segment, Boeing serves a global customer base, including commercial airlines worldwide, with a notable presence in Asia, Europe, and the Middle East. Furthermore, non-U.S. customers accounted for approximately 41% of Boeing's revenues, indicating a strong international customer base. Overall, the U.S. government, particularly through the DoD, and international commercial airlines are identified as the primary customers of Boeing.",
      "generated_answer": "The primary customers of Boeing as of FY2022 are the United States Department of Defense (U.S. DoD) and international commercial airlines.",
      "evidence": [
        {
          "evidence_text": "We derive a significant portion of our revenues from a limited number of commercial airlines.",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 7,
          "evidence_text_full_page": "Table of Contents\nForward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to\nbe accurate. These statements are not guarantees and are subject to risks, uncertainties and changes in circumstances that are difficult to\npredict. Many factors, including those set forth in the Risk Factors section below and other important factors disclosed in this report and from\ntime to time in our other filings with the SEC, could cause actual results to differ materially and adversely from these forward-looking statements.\nAny forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise any forward-\nlooking statement whether as a result of new information, future events or otherwise, except as required by law.\nItem 1A. Risk Factors\nAn investment in our common stock or debt securities involves risks and uncertainties and our actual results and future trends may differ\nmaterially from our past or projected future performance. We urge investors to consider carefully the risk factors described below in evaluating\nthe information contained in this report.\nRisks Related to Our Business and Operations\nWe depend heavily on commercial airlines, subjecting us to unique risks.\nMarket conditions have a significant impact on demand for our commercial aircraft and related services. The commercial aircraft market is\npredominantly driven by long-term trends in airline passenger and cargo traffic. The principal factors underlying long-term traffic growth are\nsustained economic growth and political stability both in developed and emerging markets. Demand for our commercial aircraft is further\ninfluenced by airline profitability, availability of aircraft financing, world trade policies, government-to-government relations, technological\nadvances, price and other competitive factors, fuel prices, terrorism, pandemics, epidemics and environmental regulations. Historically, the\nairline industry has been cyclical and very competitive and has experienced significant profit swings and constant challenges to be more cost\ncompetitive. Significant deterioration in the global economic environment, the airline industry generally or the financial stability of one or more of\nour major customers could result in fewer new orders for aircraft or services, or could cause customers to seek to postpone or cancel contractual\norders and/or payments to us, which could result in lower revenues, profitability and cash flows and a reduction in our contractual backlog. In\naddition, because our commercial aircraft backlog consists of aircraft scheduled for delivery over a period of several years, any of these\nmacroeconomic, industry or customer impacts could unexpectedly affect deliveries over a long period.\nWe enter into firm fixed-price aircraft sales contracts with indexed price escalation clauses, which could subject us to losses if we have cost\noverruns or if increases in our costs exceed the applicable escalation rate. Commercial aircraft sales contracts are often entered into years\nbefore the aircraft are delivered. In order to help account for economic fluctuations between the contract date and delivery date, aircraft pricing\ngenerally consists of a fixed amount as modified by price escalation formulas derived from labor, commodity and other price indices. Our\nrevenue estimates are based on current expectations with respect to these escalation formulas, but the actual escalation amounts are outside of\nour control. Escalation factors can fluctuate significantly from period to period. Changes in escalation amounts can significantly impact revenues\nand operating margins in our Commercial Airplanes business.\nWe derive a significant portion of our revenues from a limited number of commercial airlines. We can make no assurance that any customer will\nexercise purchase options, fulfill existing purchase commitments or purchase additional products or services from us. In addition, fleet decisions,\nairline consolidations or financial challenges involving any of our major commercial airline customers could significantly reduce our revenues and\nlimit our opportunity to generate profits from those customers.\n6\n"
        },
        {
          "evidence_text": "We derive a substantial portion of our revenue from the U.S. government",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 9,
          "evidence_text_full_page": "Table of Contents\ncommercial aircraft assembly facilities are delayed or create significant disruption to our production system, or if our suppliers cannot timely\ndeliver components to us at the cost and rates necessary to achieve our targets, we may be unable to meet delivery schedules and/or the\nfinancial performance of one or more of our programs may suffer.\nOperational challenges impacting the production system for one or more of our commercial aircraft programs could result in additional production\ndelays and/or failure to meet customer demand for new aircraft, either of which would negatively impact our revenues and operating margins.\nOur commercial aircraft production system is extremely complex. Operational issues, including delays or defects in supplier components, failure\nto meet internal performance plans, or delays or failures to achieve required regulatory approval, could result in additional out-of-sequence work\nand increased production costs, as well as delayed deliveries to customers, impacts to aircraft performance and/or increased warranty or fleet\nsupport costs. We and our suppliers are experiencing supply chain disruptions as a result of the lingering impacts of COVID-19, global supply\nchain constraints, and labor instability. We and our suppliers are also experiencing inflationary pressures. We continue to monitor the health and\nstability of the supply chain as we ramp up production. These factors have reduced overall productivity and adversely impacted our financial\nposition, results of operations and cash flows.\nIf our commercial aircraft fail to satisfy performance and reliability requirements and/or potentially required sustainability standards, we could\nface additional costs and/or lower revenues. Developing and manufacturing commercial aircraft that meet or exceed our performance and\nreliability standards and/or potentially required sustainability standards, as well as those of customers and regulatory agencies, can be costly\nand technologically challenging. These challenges are particularly significant with newer aircraft programs. Any failure of any Boeing aircraft to\nsatisfy performance or reliability requirements could result in disruption to our operations, higher costs and/or lower revenues.\nChanges in levels of U.S. government defense spending or acquisition priorities could negatively impact our financial position and\nresults of operations.\nWe derive a substantial portion of our revenue from the U.S. government, primarily from defense related programs with the United States\nDepartment of Defense (U.S. DoD). Levels of U.S. defense spending are very difficult to predict and may be impacted by numerous factors such\nas the evolving nature of the national security threat environment, U.S. national security strategy, U.S. foreign policy, the domestic political\nenvironment, macroeconomic conditions and the ability of the U.S. government to enact relevant legislation such as authorization and\nappropriations bills.\nThe timeliness of FY24 and future appropriations for government departments and agencies remains a recurrent risk. A lapse in appropriations\nfor government departments or agencies would result in a full or partial government shutdown, which could impact the Companys operations.\nAlternatively, Congress may fund government departments and agencies with one or more Continuing Resolutions; however, this would restrict\nthe execution of certain program activities and delay new programs or competitions. In addition, long-term uncertainty remains with respect to\noverall levels of defense spending in FY24 and beyond. U.S. government discretionary spending, including defense spending, is likely to\ncontinue to be subject to pressure.\nThere continues to be uncertainty with respect to future acquisition priorities and program-level appropriations for the U.S. DoD and other\ngovernment agencies (including NASA), including changes to national security and defense priorities, and tension between modernization\ninvestments, sustainment investments, and investments in new technologies or emergent capabilities. Future investment priority changes or\nbudget cuts, including changes associated with the authorizations and appropriations process, could result in reductions, cancellations, and/or\ndelays of existing contracts or programs, or future program opportunities. Any of these impacts could have a material effect on the results of the\nCompanys financial position, results of operations and/or cash flows.\n8\n"
        },
        {
          "evidence_text": "In 2022, 40% of our revenues were earned pursuant to U.S. government contracts",
          "doc_name": "BOEING_2022_10K",
          "evidence_page_num": 13,
          "evidence_text_full_page": "Table of Contents\nguarantees, partner performance and indemnifications. Consolidations of joint ventures could also impact our reported results of operations or\nfinancial position. While we believe that we have established appropriate and adequate procedures and processes to mitigate these risks, there\nis no assurance that these transactions will be successful. We also may make strategic divestitures from time to time. These transactions may\nresult in continued financial involvement in the divested businesses, such as through guarantees or other financial arrangements, following the\ntransaction. Nonperformance by those divested businesses could affect our future financial results through additional payment obligations,\nhigher costs or asset write-downs.\nRisks Related to Our Contracts\nWe conduct a significant portion of our business pursuant to U.S. government contracts, which are subject to unique risks.\nIn 2022, 40% of our revenues were earned pursuant to U.S. government contracts, which include FMS through the U.S. government. Business\nconducted pursuant to such contracts is subject to extensive procurement regulations and other unique risks.\nOur sales to the U.S. government are subject to extensive procurement regulations, and changes to those regulations could increase our costs.\nNew procurement regulations or climate or cyber-related contractual disclosures, or changes to existing requirements, could increase our\ncompliance costs or otherwise have a material impact on the operating margins of our BDS and BGS businesses. These requirements may also\nresult in withheld payments and/or reduced future business if we fail to comply. For example, proposals to raise domestic content thresholds for\nour U.S. government contracts could have negative impacts on our business. Compliance costs attributable to current and potential future\nprocurement regulations such as these could negatively impact our financial position, results of operations and/or cash flows.\nThe U.S. government may modify, curtail or terminate one or more of our contracts. The U.S. government contracting party may modify, curtail or\nterminate its contracts and subcontracts with us, without prior notice and either at its convenience or for default based on performance. In\naddition, funding pursuant to our U.S. government contracts may be reduced or withheld as part of the U.S. Congressional appropriations\nprocess due to fiscal constraints, changes in U.S. national security strategy and/or priorities or other reasons. Further uncertainty with respect to\nongoing programs could also result in the event that the U.S. government finances its operations through temporary funding measures such as\ncontinuing resolutions rather than full-year appropriations. Any loss or anticipated loss or reduction of expected funding and/or modification,\ncurtailment or termination of one or more large programs could have a material adverse effect on our financial position, results of operations\nand/or cash flows.\nWe are subject to U.S. government inquiries and investigations, including periodic audits of costs that we determine are reimbursable under U.S.\ngovernment contracts. U.S. government agencies, including the Defense Contract Audit Agency and the Defense Contract Management Agency,\nroutinely audit government contractors. These agencies review our performance under contracts, cost structure and compliance with applicable\nlaws, regulations and standards, as well as the adequacy of and our compliance with our internal control systems and policies. Any costs found\nto be misclassified or inaccurately allocated to a specific contract will be deemed non-reimbursable, and to the extent already reimbursed, must\nbe refunded. Any inadequacies in our systems and policies could result in withholds on billed receivables, penalties and reduced future business.\nFurthermore, if any audit, inquiry or investigation uncovers improper or illegal activities, we could be subject to civil and criminal penalties and\nadministrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments, fines and suspension or debarment\nfrom doing business with the U.S. government. We also\n12\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01346",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "How much has the effective tax rate of Corning changed between FY2021 and FY2022?",
      "doc_name": "CORNING_2022_10K",
      "company": "Corning",
      "answer": "The effective tax rate of Corning has changed from 20% in FY2021 to 23% in FY 2022.",
      "reasoning": "The effective tax rate for Corning Incorporated for the fiscal year 2021 was reported as 17.8% (Evidence 6). For the fiscal year 2022, the effective tax rate decreased to 9.6% (Evidence 7). To find the change in the effective tax rate, we subtract the 2022 rate from the 2021 rate: 17.8% - 9.6% = 8.2%. Therefore, the effective tax rate decreased by 8.2 percentage points from FY2021 to FY2022.",
      "generated_answer": "The effective tax rate of Corning decreased by 8.2 percentage points between FY2021 and FY2022.",
      "evidence": [
        {
          "evidence_text": "RESULTS OF OPERATIONS\n \nThe following table presents selected highlights from our operations (in millions):\n \n \n \nYear ended December 31,\n \n% change\n \n \n \n2022\n \n2021\n \n22 vs. 21\n \n \n \n \n \n \nNet sales\n $\n14,189 $\n14,082 \n1%\n \n \n \n \n \nGross margin\n $\n4,506 $\n5,063 \n(11%)\n(gross margin %)\n \n32% \n36% \n \n \n \n \n \n \nSelling, general and administrative expenses\n $\n1,898 $\n1,827 \n4%\n(as a % of net sales)\n \n13% \n13% \n \n \n \n \n \n \nResearch, development and engineering expenses\n $\n1,047 $\n995 \n5%\n(as a % of net sales)\n \n7% \n7% \n \n \n \n \n \n \nTranslated earnings contract gain, net\n $\n351 $\n354 \n(1%)\n(as a % of net sales)\n \n2% \n3% \n \n \n \n \n \n \nIncome before income taxes\n $\n1,797 $\n2,426 \n(26%)\n(as a % of net sales)\n \n13% \n17% \n \n \n \n \n \n \nProvision for income taxes\n $\n(411) $\n(491) \n16%\nEffective tax rate\n \n23% \n20% \n \n \n \n \n \n \nNet income attributable to Corning Incorporated\n $\n1,316 $\n1,906 \n(31%)\n(as a % of net sales)\n \n9% \n14% \n \n \n \n \n \n \nComprehensive income attributable to Corning Incorporated\n $\n661 $\n1,471 \n(55%)",
          "doc_name": "CORNING_2022_10K",
          "evidence_page_num": 23,
          "evidence_text_full_page": "Table of Contents\n \n2022 Results\n \nNet sales for the year ended December 31, 2022 were $14.2 billion, a net increase of $107 million, or 1%, when compared to the year ended December 31, 2021. This is\ndriven by 15% growth in segment net sales in Optical Communications of $674 million and 34% growth in Hemlock and Emerging Growth Businesses of $419 million,\nwhich helped offset a $394 million decrease in Display Technologies. In addition, movements in foreign exchange rates adversely impacted Cornings consolidated net\nsales by $616 million for the year ended December 31, 2022, when compared to the same period in 2021.\n \nFor the year ended December 31, 2022, we generated net income attributable to Corning Incorporated of $1,316 million, or $1.54 per diluted share, compared to net\nincome attributable to Corning Incorporated of $1,906 million, or $1.28 per diluted share, for the year ended December 31, 2021. When compared to 2021, the $590\nmillion decrease was primarily driven by a $238 million increase in severance, accelerated depreciation, asset write-offs and other related charges, a $50 million increase\nin litigation, regulatory and other legal matters and a $120 million adverse impact from foreign currency translation.\n \nDiluted earnings per share for the year ended December 31, 2022 increased by $0.26 per diluted share, or 20%, when compared to the year ended December 31, 2021,\nprimarily driven by the immediate repurchase and retirement of 35 million common shares which resulted in an $803 million one-time reduction to net income available\nto common shareholders in 2021, partially offset by the decrease in net income attributable to Corning Incorporated as described above. Refer to Note 16 (Shareholders\nEquity) and Note 17 (Earnings per Common Share) in the accompanying notes to the consolidated financial statements for additional information.\n \n2023 Corporate Outlook\n \nFor the first quarter 2023, we anticipate core sales in the range of $3.2 billion to $3.4 billion.\n \n \nRESULTS OF OPERATIONS\n \nThe following table presents selected highlights from our operations (in millions):\n \n \n \nYear ended December 31,\n \n% change\n \n \n \n2022\n \n2021\n \n22 vs. 21\n \n \n \n \n \n \nNet sales\n $\n14,189 $\n14,082 \n1%\n \n \n \n \n \nGross margin\n $\n4,506 $\n5,063 \n(11%)\n(gross margin %)\n \n32% \n36% \n \n \n \n \n \n \nSelling, general and administrative expenses\n $\n1,898 $\n1,827 \n4%\n(as a % of net sales)\n \n13% \n13% \n \n \n \n \n \n \nResearch, development and engineering expenses\n $\n1,047 $\n995 \n5%\n(as a % of net sales)\n \n7% \n7% \n \n \n \n \n \n \nTranslated earnings contract gain, net\n $\n351 $\n354 \n(1%)\n(as a % of net sales)\n \n2% \n3% \n \n \n \n \n \n \nIncome before income taxes\n $\n1,797 $\n2,426 \n(26%)\n(as a % of net sales)\n \n13% \n17% \n \n \n \n \n \n \nProvision for income taxes\n $\n(411) $\n(491) \n16%\nEffective tax rate\n \n23% \n20% \n \n \n \n \n \n \nNet income attributable to Corning Incorporated\n $\n1,316 $\n1,906 \n(31%)\n(as a % of net sales)\n \n9% \n14% \n \n \n \n \n \n \nComprehensive income attributable to Corning Incorporated\n $\n661 $\n1,471 \n(55%)\n \n24\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00005",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Does Corning have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.",
      "doc_name": "CORNING_2022_10K",
      "company": "Corning",
      "answer": "Yes. Corning had a positive working capital amount of $831 million by FY 2022 close. This answer considers only operating current assets and current liabilities that were clearly shown in the balance sheet.",
      "reasoning": "To determine if Corning has positive working capital for FY2022, we need to look at the working capital figure provided in the evidence. According to Evidence 5, Corning's working capital as of December 31, 2022, was $2,278 million. Working capital is calculated as current assets minus current liabilities. Since this figure is positive, it indicates that Corning has more current assets than current liabilities, which is a sign of good short-term financial health. Therefore, based on the provided data, Corning does indeed have positive working capital for FY2022.",
      "generated_answer": "Yes, Corning has positive working capital of $2,278 million based on FY2022 data.",
      "evidence": [
        {
          "evidence_text": "Consolidated Balance Sheets\nCorning Incorporated and Subsidiary Companies\n \n \n \nDecember 31,\n \n(in millions, except share and per share amounts)\n \n2022\n \n2021\n \n \n \n \n \nAssets\n \n \n \n \n \n \n \nCurrent assets:\n \n \n \nCash and cash equivalents\n $\n1,671 $\n2,148 \nTrade accounts receivable, net of doubtful accounts - $40 and $42\n \n1,721 \n2,004 \nInventories (Note 5)\n \n2,904 \n2,481 \nOther current assets (Notes 10 and 14)\n \n1,157 \n1,026 \nTotal current assets\n \n7,453 \n7,659 \n \n \n \n \nProperty, plant and equipment, net of accumulated depreciation - $14,147 and $13,969 (Note 8)\n \n15,371 \n15,804 \nGoodwill, net (Note 9)\n \n2,394 \n2,421 \nOther intangible assets, net (Note 9)\n \n1,029 \n1,148 \nDeferred income taxes (Note 7)\n \n1,073 \n1,066 \nOther assets (Notes 10 and 14)\n \n2,179 \n2,056 \n \n \n \n \nTotal Assets\n $\n29,499 $\n30,154 \n \n \n \n \nLiabilities and Equity\n \n \n \n \n \n \n \nCurrent liabilities:\n \n \n \nCurrent portion of long-term debt and short-term borrowings (Note 11)\n $\n224 $\n55 \nAccounts payable\n \n1,804 \n1,612 \nOther accrued liabilities (Notes 10 and 13)\n \n3,147 \n3,139 \nTotal current liabilities\n \n5,175 \n4,806 \n \n \n \n \nLong-term debt (Note 11)\n \n6,687 \n6,989 \nPostretirement benefits other than pensions (Note 12)\n \n407 \n622 \nOther liabilities (Notes 10 and 13)\n \n4,955 \n5,192 \nTotal liabilities\n \n17,224 \n17,609",
          "doc_name": "CORNING_2022_10K",
          "evidence_page_num": 59,
          "evidence_text_full_page": "Table of Contents\n \nConsolidated Balance Sheets\nCorning Incorporated and Subsidiary Companies\n \n \n \nDecember 31,\n \n(in millions, except share and per share amounts)\n \n2022\n \n2021\n \n \n \n \n \nAssets\n \n \n \n \n \n \n \nCurrent assets:\n \n \n \nCash and cash equivalents\n $\n1,671 $\n2,148 \nTrade accounts receivable, net of doubtful accounts - $40 and $42\n \n1,721 \n2,004 \nInventories (Note 5)\n \n2,904 \n2,481 \nOther current assets (Notes 10 and 14)\n \n1,157 \n1,026 \nTotal current assets\n \n7,453 \n7,659 \n \n \n \n \nProperty, plant and equipment, net of accumulated depreciation - $14,147 and $13,969 (Note 8)\n \n15,371 \n15,804 \nGoodwill, net (Note 9)\n \n2,394 \n2,421 \nOther intangible assets, net (Note 9)\n \n1,029 \n1,148 \nDeferred income taxes (Note 7)\n \n1,073 \n1,066 \nOther assets (Notes 10 and 14)\n \n2,179 \n2,056 \n \n \n \n \nTotal Assets\n $\n29,499 $\n30,154 \n \n \n \n \nLiabilities and Equity\n \n \n \n \n \n \n \nCurrent liabilities:\n \n \n \nCurrent portion of long-term debt and short-term borrowings (Note 11)\n $\n224 $\n55 \nAccounts payable\n \n1,804 \n1,612 \nOther accrued liabilities (Notes 10 and 13)\n \n3,147 \n3,139 \nTotal current liabilities\n \n5,175 \n4,806 \n \n \n \n \nLong-term debt (Note 11)\n \n6,687 \n6,989 \nPostretirement benefits other than pensions (Note 12)\n \n407 \n622 \nOther liabilities (Notes 10 and 13)\n \n4,955 \n5,192 \nTotal liabilities\n \n17,224 \n17,609 \n \n \n \n \nCommitments and contingencies (Note 13)\n \n \n \nShareholders equity (Note 16):\n \n \n \nCommon stock Par value $0.50 per share; Shares authorized 3.8 billion; Shares issued: 1.8 billion and 1.8\nbillion\n \n910 \n907 \nAdditional paid-in capital common stock\n \n16,682 \n16,475 \nRetained earnings\n \n16,778 \n16,389 \nTreasury stock, at cost; Shares held: 977 million and 970 million\n \n(20,532) \n(20,263)\nAccumulated other comprehensive loss\n \n(1,830) \n(1,175)\nTotal Corning Incorporated shareholders equity\n \n12,008 \n12,333 \nNon-controlling interest\n \n267 \n212 \nTotal equity\n \n12,275 \n12,545 \n \n \n \n \nTotal Liabilities and Equity\n $\n29,499 $\n30,154 \n \nThe accompanying notes are an integral part of these consolidated financial statements.\n60\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00790",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning)",
      "question": "Is CVS Health a capital-intensive business based on FY2022 data?",
      "doc_name": "CVSHEALTH_2022_10K",
      "company": "CVS Health",
      "answer": "Yes, CVS Health requires an extensive asset base to operate, which is evident from its ROA of only 1.82% in 2022 and 3.39% in 2021, though it should be noted that a significant portion of this asset base is goodwill, and CVS's fixed assets/total assets ratio is on the lower side of 5.6%.",
      "reasoning": "To determine if CVS Health is a capital-intensive business based on FY2022 data, we can analyze several key pieces of evidence:\n\n1. **Capital Expenditures**: Evidence 1 states that CVS Health invested approximately $2.3 billion in net capital improvements in 2022, with 73% of total capital expenditures directed towards technology and strategic initiatives. This indicates a significant investment in infrastructure and technology, which is characteristic of capital-intensive businesses.\n\n2. **Cash Flow from Operations**: Evidence 10 shows that CVS generated $16.2 billion in net cash provided by operating activities, which is substantial. However, the cash used in investing activities was $5.0 billion, indicating a strong commitment to capital investments.\n\n3. **Long-term Debt**: Evidence 20 indicates that CVS Health's long-term debt increased significantly to $39.7 billion in 2022, primarily due to acquisitions. This high level of debt suggests that the company is financing its capital expenditures through borrowing, which is common in capital-intensive industries.\n\n4. **Working Capital Needs**: Evidence 12 highlights that CVS has significant ongoing cash requirements for capital expenditures, indicating that maintaining and expanding its operations requires substantial capital.\n\n5. **Comparison to Industry Standards**: Capital-intensive businesses typically have high capital expenditures relative to their revenues. Given CVS's substantial investments in property, plant, and equipment, along with its ongoing need for capital to support growth and maintain operations, it aligns with the characteristics of a capital-intensive business.\n\nOverall, the combination of high capital expenditures, significant long-term debt, and ongoing cash requirements for capital investments supports the conclusion that CVS Health operates as a capital-intensive business.",
      "generated_answer": "Yes, CVS Health is a capital-intensive business based on FY2022 data.",
      "evidence": [
        {
          "evidence_text": "Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts\n2022\n2021\n2020\nRevenues:\n \n \n \nProducts\n$\n226,616 $\n203,738 $\n190,688 \nPremiums\n85,330 \n76,132 \n69,364 \nServices\n9,683 \n11,042 \n7,856 \nNet investment income\n838 \n1,199 \n798 \nTotal revenues\n322,467 \n292,111 \n268,706 \nOperating costs:\nCost of products sold\n196,892 \n175,803 \n163,981 \nBenefit costs\n71,281 \n64,260 \n55,679 \nOpioid litigation charges\n5,803 \n \n \nLoss on assets held for sale\n2,533 \n \n \nStore impairments\n \n1,358 \n \nGoodwill impairment\n \n431 \n \nOperating expenses\n38,212 \n37,066 \n35,135 \nTotal operating costs\n314,721 \n278,918 \n254,795 \nOperating income\n7,746 \n13,193 \n13,911 \nInterest expense\n2,287 \n2,503 \n2,907 \nLoss on early extinguishment of debt\n \n452 \n1,440 \nOther income\n(169)\n(182)\n(206)\nIncome before income tax provision\n5,628 \n10,420 \n9,770 \nIncome tax provision\n1,463 \n2,522 \n2,569 \nIncome from continuing operations\n4,165 \n7,898 \n7,201 \nLoss from discontinued operations, net of tax\n \n \n(9)\nNet income\n4,165 \n7,898 \n7,192",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 107,
          "evidence_text_full_page": "Index to Consolidated Financial Statements\nConsolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts\n2022\n2021\n2020\nRevenues:\n \n \n \nProducts\n$\n226,616 $\n203,738 $\n190,688 \nPremiums\n85,330 \n76,132 \n69,364 \nServices\n9,683 \n11,042 \n7,856 \nNet investment income\n838 \n1,199 \n798 \nTotal revenues\n322,467 \n292,111 \n268,706 \nOperating costs:\nCost of products sold\n196,892 \n175,803 \n163,981 \nBenefit costs\n71,281 \n64,260 \n55,679 \nOpioid litigation charges\n5,803 \n \n \nLoss on assets held for sale\n2,533 \n \n \nStore impairments\n \n1,358 \n \nGoodwill impairment\n \n431 \n \nOperating expenses\n38,212 \n37,066 \n35,135 \nTotal operating costs\n314,721 \n278,918 \n254,795 \nOperating income\n7,746 \n13,193 \n13,911 \nInterest expense\n2,287 \n2,503 \n2,907 \nLoss on early extinguishment of debt\n \n452 \n1,440 \nOther income\n(169)\n(182)\n(206)\nIncome before income tax provision\n5,628 \n10,420 \n9,770 \nIncome tax provision\n1,463 \n2,522 \n2,569 \nIncome from continuing operations\n4,165 \n7,898 \n7,201 \nLoss from discontinued operations, net of tax\n \n \n(9)\nNet income\n4,165 \n7,898 \n7,192 \nNet (income) loss attributable to noncontrolling interests\n(16)\n12 \n(13)\nNet income attributable to CVS Health\n$\n4,149 $\n7,910 $\n7,179 \nBasic earnings per share:\nIncome from continuing operations attributable to CVS Health\n$\n3.16 $\n6.00 $\n5.49 \nLoss from discontinued operations attributable to CVS Health\n$\n $\n $\n(0.01)\nNet income attributable to CVS Health\n$\n3.16 $\n6.00 $\n5.48 \nWeighted average basic shares outstanding\n1,312 \n1,319 \n1,309 \nDiluted earnings per share:\nIncome from continuing operations attributable to CVS Health\n$\n3.14 $\n5.95 $\n5.47 \nLoss from discontinued operations attributable to CVS Health\n$\n $\n $\n(0.01)\nNet income attributable to CVS Health\n$\n3.14 $\n5.95 $\n5.46 \nWeighted average diluted shares outstanding\n1,323 \n1,329 \n1,314 \nDividends declared per share\n$\n2.20 $\n2.00 $\n2.00 \nSee accompanying notes to consolidated financial statements.\n106\n"
        },
        {
          "evidence_text": "Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts\n2022\n2021\nAssets:\n \nCash and cash equivalents\n$\n12,945 $\n9,408 \nInvestments\n2,778 \n3,117 \nAccounts receivable, net\n27,276 \n24,431 \nInventories\n19,090 \n17,760 \nAssets held for sale\n908 \n \nOther current assets\n2,685 \n5,292 \nTotal current assets\n65,682 \n60,008 \nLong-term investments\n21,096 \n23,025 \nProperty and equipment, net\n12,873 \n12,896 \nOperating lease right-of-use assets\n17,872 \n19,122 \nGoodwill\n78,150 \n79,121 \nIntangible assets, net\n24,754 \n29,026 \nSeparate accounts assets\n3,228 \n5,087 \nOther assets\n4,620 \n4,714 \nTotal assets\n$\n228,275 $\n232,999",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 109,
          "evidence_text_full_page": "Index to Consolidated Financial Statements\nConsolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts\n2022\n2021\nAssets:\n \nCash and cash equivalents\n$\n12,945 $\n9,408 \nInvestments\n2,778 \n3,117 \nAccounts receivable, net\n27,276 \n24,431 \nInventories\n19,090 \n17,760 \nAssets held for sale\n908 \n \nOther current assets\n2,685 \n5,292 \nTotal current assets\n65,682 \n60,008 \nLong-term investments\n21,096 \n23,025 \nProperty and equipment, net\n12,873 \n12,896 \nOperating lease right-of-use assets\n17,872 \n19,122 \nGoodwill\n78,150 \n79,121 \nIntangible assets, net\n24,754 \n29,026 \nSeparate accounts assets\n3,228 \n5,087 \nOther assets\n4,620 \n4,714 \nTotal assets\n$\n228,275 $\n232,999 \nLiabilities:\nAccounts payable\n$\n14,838 $\n12,544 \nPharmacy claims and discounts payable\n19,423 \n17,330 \nHealth care costs payable\n10,406 \n8,808 \nPolicyholders funds\n1,500 \n4,301 \nAccrued expenses\n18,745 \n17,670 \nOther insurance liabilities\n1,140 \n1,303 \nCurrent portion of operating lease liabilities\n1,678 \n1,646 \nCurrent portion of long-term debt\n1,778 \n4,205 \nLiabilities held for sale\n228 \n \nTotal current liabilities\n69,736 \n67,807 \nLong-term operating lease liabilities\n16,800 \n18,177 \nLong-term debt\n50,476 \n51,971 \nDeferred income taxes\n3,880 \n6,270 \nSeparate accounts liabilities\n3,228 \n5,087 \nOther long-term insurance liabilities\n6,108 \n6,402 \nOther long-term liabilities\n6,732 \n1,904 \nTotal liabilities\n156,960 \n157,618 \nCommitments and contingencies (Note 16)\nShareholders equity:\nPreferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding\n \n \nCommon stock, par value $0.01: 3,200 shares authorized; 1,758 shares issued and 1,300 shares outstanding at\nDecember 31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital\nsurplus\n48,193 \n47,377 \nTreasury stock, at cost: 458 and 422 shares at December 31, 2022 and 2021\n(31,858)\n(28,173)\nRetained earnings\n56,145 \n54,906 \nAccumulated other comprehensive income (loss)\n(1,465)\n965 \nTotal CVS Health shareholders equity\n71,015 \n75,075 \nNoncontrolling interests\n300 \n306 \nTotal shareholders equity\n71,315 \n75,381 \nTotal liabilities and shareholders equity\n$\n228,275 $\n232,999 \nSee accompanying notes to consolidated financial statements.\n108\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01107",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Has CVS Health reported any materially important ongoing legal battles from 2022, 2021 and 2020?",
      "doc_name": "CVSHEALTH_2022_10K",
      "company": "CVS Health",
      "answer": "Yes, CVS Health has been involved in multiple ongoing legal battles. Some notable legal dispute areas for CVS are: (1) usual and customary pricing litigation: where it's claimed that CVSâs retail pharmacies overcharged for prescription drugs; (2) PBM litigation and investigations: where it's claimed that that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products; and (3) controlled substances litigation: legal matters around opioids for which CVS has agreed to pay up to $4.3 billion to claimants in remediation and $625 million to attorneys and fees",
      "reasoning": "The evidence provided indicates that CVS Health is currently involved in several significant legal battles that could materially impact the company. In 2022, CVS Health faced ongoing litigation related to opioid claims, including a jury judgment against them for $651 million, which they are appealing. Additionally, they have been involved in multiple class action lawsuits regarding their pricing practices and alleged overcharging for prescription drugs, which are still pending. In 2021, CVS Health was also involved in ERISA-related lawsuits concerning fiduciary duties and investment practices in their 401(k) plan, which were dismissed but are under appeal. Furthermore, investigations by the DOJ regarding their prescription processing practices and potential false claims submitted to Medicare are ongoing. In 2020, CVS Health faced similar legal challenges, including class actions related to their PBM practices and pricing strategies. Overall, the evidence shows that CVS Health has multiple ongoing legal issues from 2020 to 2022 that are materially important to their financial and operational status.",
      "generated_answer": "Yes, CVS Health has reported several materially important ongoing legal battles from 2022, 2021, and 2020, including opioid litigation, ERISA-related lawsuits, and investigations by the DOJ.",
      "evidence": [
        {
          "evidence_text": "Usual and Customary Pricing Litigation\nThe Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Companys retail\npharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process.",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 172,
          "evidence_text_full_page": "to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved\nfor several years. The Company also may be named from time to time in qui tam actions initiated by private third parties that could also be separately pursued\nby a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs\nincurred in these matters can be substantial, regardless of the outcome.\nThe Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably\nestimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that\nwould make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company\ndoes not establish an accrued liability. None of the Companys accruals for outstanding legal matters are material individually or in the aggregate to the\nCompanys financial condition.\nExcept as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable\nto reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses\nand assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and\nrights to indemnification, will have a material adverse effect on the Companys financial position. Substantial unanticipated verdicts, fines and rulings,\nhowever, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the\noutcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental\ninvestigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or\nloss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be\nmaterial to the Company.\nUsual and Customary Pricing Litigation\nThe Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Companys retail\npharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions\nare brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal\ntheories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. In October 2022, one of the litigating\nshareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to\ndemonstrate demand futility. The Company is defending itself against these claims.\nPBM Litigation and Investigations\nThe Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.\nThe Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug\npricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal\ntheories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is\ndefending itself against these claims. The Company has also received subpoenas, civil investigative demands (CIDs), and other requests for documents and\ninformation from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices,\nincluding pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for\ninformation.\nUnited States ex rel. Behnke v. CVS Caremark Corporation, et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court\nunsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused\nto be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true\nprices paid by the Companys PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Companys PBM.\nThe Company is defending itself against these claims.\n171\n"
        },
        {
          "evidence_text": "The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug\npricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal\ntheories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products.",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 172,
          "evidence_text_full_page": "to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved\nfor several years. The Company also may be named from time to time in qui tam actions initiated by private third parties that could also be separately pursued\nby a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs\nincurred in these matters can be substantial, regardless of the outcome.\nThe Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably\nestimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that\nwould make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company\ndoes not establish an accrued liability. None of the Companys accruals for outstanding legal matters are material individually or in the aggregate to the\nCompanys financial condition.\nExcept as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable\nto reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses\nand assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and\nrights to indemnification, will have a material adverse effect on the Companys financial position. Substantial unanticipated verdicts, fines and rulings,\nhowever, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the\noutcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental\ninvestigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or\nloss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be\nmaterial to the Company.\nUsual and Customary Pricing Litigation\nThe Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Companys retail\npharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions\nare brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal\ntheories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. In October 2022, one of the litigating\nshareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to\ndemonstrate demand futility. The Company is defending itself against these claims.\nPBM Litigation and Investigations\nThe Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.\nThe Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug\npricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal\ntheories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is\ndefending itself against these claims. The Company has also received subpoenas, civil investigative demands (CIDs), and other requests for documents and\ninformation from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices,\nincluding pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for\ninformation.\nUnited States ex rel. Behnke v. CVS Caremark Corporation, et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court\nunsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused\nto be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true\nprices paid by the Companys PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Companys PBM.\nThe Company is defending itself against these claims.\n171\n"
        },
        {
          "evidence_text": "In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a\nleadership group of a number of state Attorneys General and the Plaintiffs Executive Committee (PEC). The agreement would resolve substantially all\nopioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the\nsettlement would be approximately $4.3 billion in opioid remediation and $625 million in attorneys fees and costs and additional remediation. The amounts\nwould be payable over 10 years, beginning in 2023.",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 173,
          "evidence_text_full_page": "Controlled Substances Litigation, Audits and Subpoenas\nIn December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as\ncounties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of\nwidespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is\npending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases\nthat name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state\ncourts.\nIn addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against\nall such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General\nand insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas,\nCIDs, and other requests for information.\nIn November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a\njudgment jointly against the three defendants in the amount of $651 million to be paid over 15 years, and also ordered certain injunctive relief. The Company is\nappealing the judgment and has not accrued a liability for this matter. In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a\nsettlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the\nsettlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484 million, which is to be\npaid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484 million liability associated with this legal\nsettlement. In August 2022, CVS Pharmacy, Inc. entered into an agreement with the State of New Mexico to settle all opioid claims against it and its parents\nand subsidiaries by the State of New Mexico and participating subdivisions. In September 2022, CVS Pharmacy, Inc. entered into an agreement with the State\nof West Virginia to settle all opioid claims against it and its parents and subsidiaries by the State of West Virginia and participating subdivisions. Also in\nSeptember 2022, CVS Pharmacy, Inc. entered into an agreement with the Cherokee Nation to settle all opioid claims against it and its parents and subsidiaries\nby the Cherokee Nation.\nIn December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a\nleadership group of a number of state Attorneys General and the Plaintiffs Executive Committee (PEC). The agreement would resolve substantially all\nopioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the\nsettlement would be approximately $4.3 billion in opioid remediation and $625 million in attorneys fees and costs and additional remediation. The amounts\nwould be payable over 10 years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The\nsettlement agreement is available at nationalopioidsettlement.com.\nUnder the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the\ngovernmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to\nthe settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a\ncorresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating\ngovernmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.\nThe Company has been informed that 45 states, the District of Columbia, and all eligible United States territories have elected to join the settlement. Three\nstates were the subject of earlier settlements. The Company has elected to proceed with the settlement process based on that level of participation. The\nsettlement process will progress to the period during which subdivisions may elect to join.\nIn December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The\nagreement would resolve substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the\nsettlement would be $113 million in opioid remediation and $18 million in attorneys fees and costs. The amounts would be payable over 10 years, beginning\nin 2023. The agreement is contingent upon sufficient participation by tribes.\n172\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01244",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Has CVS Health paid dividends to common shareholders in Q2 of FY2022?",
      "doc_name": "CVSHEALTH_2022_10K",
      "company": "CVS Health",
      "answer": "Yes, CVS paid a $ 0.55 dividend per share every quarter in FY2022",
      "reasoning": "To determine if CVS Health paid dividends to common shareholders in Q2 of FY2022, we can refer to the evidence provided. Evidence 3 states that during 2022, the quarterly cash dividend was $0.55 per share. Additionally, Evidence 4 confirms that CVS Health has consistently paid cash dividends every quarter since becoming a public company. Since Q2 of FY2022 falls within the year 2022, and the company declared a dividend of $0.55 per share for that year, it is clear that CVS Health did indeed pay dividends to common shareholders in Q2 of FY2022.",
      "generated_answer": "Yes, CVS Health paid dividends to common shareholders in Q2 of FY2022.",
      "evidence": [
        {
          "evidence_text": "Dividends\nDuring 2022, 2021 and 2020, the quarterly cash dividend was $0.55, $0.50 and $0.50 per share, respectively.",
          "doc_name": "CVSHEALTH_2022_10K",
          "evidence_page_num": 67,
          "evidence_text_full_page": "Table of Contents\nPART II\nItem 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.\nMarket Information\nCVS Health Corporations common stock is listed on the New York Stock Exchange under the symbol CVS.\nDividends\nDuring 2022, 2021 and 2020, the quarterly cash dividend was $0.55, $0.50 and $0.50 per share, respectively. In December 2022, the Board authorized a 10%\nincrease in the quarterly cash dividend to $0.605 per share effective in 2023. CVS Health Corporation has paid cash dividends every quarter since becoming a\npublic company. Future dividends will depend on the Companys earnings, capital requirements, financial condition and other factors considered relevant by\nthe Board.\nSee Note 12 Shareholders Equity included in Item 8 of this 10-K for information regarding CVS Health Corporations dividends.\nHolders of Common Stock\nAs of February 1, 2023, there were 24,142 registered holders of the registrants common stock according to the records maintained by the registrants transfer\nagent.\nIssuer Purchases of Equity Securities\nThe following share repurchase programs have been authorized by the Board:\nIn billions\nAuthorization Date\nAuthorized\nRemaining as of\nDecember 31, 2022\nNovember 17, 2022 (2022 Repurchase Program)\n$\n10.0 \n$\n10.0 \nDecember 9, 2021 (2021 Repurchase Program)\n10.0 \n6.5 \nEach of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of\nopen market repurchases, privately negotiated transactions, accelerated share repurchase (ASR) transactions, and/or other derivative transactions. Both the\n2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time.\nDuring the year ended December 31, 2022, the Company repurchased an aggregate of 34.1 million shares of common stock for approximately $3.5 billion\npursuant to the 2021 Repurchase Program, including share repurchases under the $1.5 billion fixed dollar ASR transaction described below. During the years\nended December 31, 2021 and 2020, the Company did not repurchase any shares of common stock.\nPursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0 billion fixed dollar ASR with Citibank, N.A. (Citibank).\nUpon payment of the $2.0 billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporations common stock\nequal to 80% of the $2.0 billion notional amount of the ASR or approximately 17.4 million shares at a price of $92.19 per share, which were placed into\ntreasury stock in January 2023. At the conclusion of the ASR, the Company may receive additional shares representing the remaining 20% of the $2.0 billion\nnotional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Companys stock\nover an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Citibank\nwhich, at the Companys option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that\ncould be delivered to the Company is 43.4 million.\nPursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5 billion fixed dollar ASR with Barclays Bank PLC. Upon\npayment of the $1.5 billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporations common stock equal to\n80% of the $1.5 billion notional amount of the ASR or approximately 11.6 million shares at a price of $103.34 per share, which were placed into treasury stock\nin January 2022. The\n66\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00956",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning)",
      "question": "Are JnJ's FY2022 financials that of a high growth company?",
      "doc_name": "JOHNSON_JOHNSON_2022_10K",
      "company": "Johnson & Johnson",
      "answer": "No, JnJ's FY2022 financials are not of a high growth company as sales grew by 1.3% in FY2022.",
      "reasoning": "To determine if Johnson & Johnson's (J&J) FY2022 financials reflect those of a high growth company, we need to analyze the reported sales growth and earnings performance. \n\n1. **Sales Growth**: J&J reported a full-year sales growth of only 1.3% to $94.9 billion, which is relatively low compared to typical high-growth companies that often exhibit double-digit growth rates. The operational growth, excluding the impact of COVID-19 vaccine sales, was 6.1%, which is better but still not indicative of high growth. \n\n2. **Earnings Performance**: The earnings per share (EPS) decreased by 13.8% to $6.73, indicating a decline in profitability. Although the adjusted EPS increased by 3.6% to $10.15, this is not sufficient to classify the company as high growth, especially when the reported EPS shows a significant decline. \n\n3. **Market Guidance**: For 2023, J&J has guided for adjusted operational sales growth of 4.0% and adjusted operational EPS of $10.50, reflecting growth of 3.5%. While this shows some improvement, it still does not align with the characteristics of a high growth company. \n\n4. **Overall Context**: The company is facing macroeconomic challenges, including unfavorable foreign exchange rates and reduced sales from COVID-19 vaccines, which have impacted its growth trajectory. \n\nIn summary, the combination of low sales growth, declining reported earnings, and modest guidance for future growth does not support the classification of J&J as a high growth company in FY2022.",
      "generated_answer": "No, J&J's FY2022 financials do not reflect those of a high growth company.",
      "evidence": [
        {
          "evidence_text": "Results of Operations\nAnalysis of Consolidated Sales\nFor discussion on results of operations and financial condition pertaining to the fiscal years 2021 and 2020 see the Companys Annual Report on Form 10-\nK for the fiscal year ended January 2, 2022, Item 7. Management's Discussion and Analysis of Results of Operations and Financial Condition.\nIn 2022, worldwide sales increased 1.3% to $94.9 billion as compared to an increase of 13.6% in 2021. These sales changes consisted of the following:\nSales increase/(decrease) due to:\n2022\n2021\nVolume\n6.9 %\n12.9 %\nPrice\n(0.8)\n(0.7)\nCurrency\n(4.8)\n1.4 \nTotal\n1.3 %\n13.6 %",
          "doc_name": "JOHNSON_JOHNSON_2022_10K",
          "evidence_page_num": 27,
          "evidence_text_full_page": "Results of Operations\nAnalysis of Consolidated Sales\nFor discussion on results of operations and financial condition pertaining to the fiscal years 2021 and 2020 see the Companys Annual Report on Form 10-\nK for the fiscal year ended January 2, 2022, Item 7. Management's Discussion and Analysis of Results of Operations and Financial Condition.\nIn 2022, worldwide sales increased 1.3% to $94.9 billion as compared to an increase of 13.6% in 2021. These sales changes consisted of the following:\nSales increase/(decrease) due to:\n2022\n2021\nVolume\n6.9 %\n12.9 %\nPrice\n(0.8)\n(0.7)\nCurrency\n(4.8)\n1.4 \nTotal\n1.3 %\n13.6 %\nThe net impact of acquisitions and divestitures on the worldwide sales growth was a negative impact of 0.1% in 2022 and a negative impact of 0.6% in\n2021.\nSales by U.S. companies were $48.6 billion in 2022 and $47.2 billion in 2021. This represents increases of 3.0% in 2022 and 9.3% in 2021. Sales by\ninternational companies were $46.4 billion in 2022 and $46.6 billion in 2021. This represents a decrease of 0.6% in 2022 and an increase of 18.2% in 2021.\nThe five-year compound annual growth rates for worldwide, U.S. and international sales were 4.4%, 4.0% and 4.9%, respectively. The ten-year\ncompound annual growth rates for worldwide, U.S. and international sales were 3.5%, 5.0% and 2.2%, respectively.\nIn 2022, sales by companies in Europe experienced a decline of 0.6% as compared to the prior year, which included operational growth of 11.0% and a\nnegative currency impact of 11.6%. Sales by companies in the Western Hemisphere, excluding the U.S., achieved growth of 6.5% as compared to the prior\nyear, which included operational growth of 10.2%, and a negative currency impact of 3.7%. Sales by companies in the Asia-Pacific, Africa region\nexperienced a decline of 2.8% as compared to the prior year, including operational growth of 6.2% and a negative currency impact of 9.0%.\nIn 2022, the Company utilized three wholesalers distributing products for all three segments that represented approximately 16.5%, 13.0% and 12.0%\nof the total consolidated revenues. In 2021, the Company had three wholesalers distributing products for all three segments that represented approximately\n14.0%, 11.0% and 11.0% of the total consolidated revenues.\nNote: values may have been rounded\n22\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00669",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Numerical reasoning OR Logical reasoning",
      "question": "What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.",
      "doc_name": "JOHNSON_JOHNSON_2022_10K",
      "company": "Johnson & Johnson",
      "answer": "For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment.",
      "reasoning": "To analyze the change in gross margin for Johnson & Johnson (J&J) in FY2022, we need to consider the components that affect gross margin, which is calculated as (Sales - Cost of Goods Sold) / Sales. From the evidence, we see that J&J's reported sales for FY2022 were $94.943 billion, while the cost of products sold was $31.089 billion, resulting in a gross profit of $63.854 billion. The gross margin percentage for FY2022 can be calculated as follows: Gross Margin = Gross Profit / Sales = $63.854 billion / $94.943 billion = 67.2%. \n\nComparing this to FY2021, where the gross margin was 67.9%, we see a decrease in gross margin. The evidence indicates that the decrease in gross margin was primarily driven by several factors: \n1. **Increased Cost of Products Sold**: The cost of products sold increased as a percentage of sales due to one-time COVID-19 vaccine manufacturing exit costs, currency impacts, and commodity inflation in the MedTech and Consumer Health segments. \n2. **Litigation and Other Expenses**: There were significant litigation-related expenses and other costs that impacted overall profitability. \n3. **Sales Decline**: The sales decline in certain segments, particularly due to reduced COVID-19 vaccine sales, also contributed to the lower gross margin. \n\nGiven these factors, gross margin is a useful metric for J&J as it reflects the efficiency of production and pricing strategies, especially in a company with diverse segments like pharmaceuticals and consumer health. However, it should be analyzed alongside other metrics such as net earnings and operating income to get a complete picture of financial health, especially in light of significant one-time costs and litigation expenses that can distort gross margin figures.",
      "generated_answer": "The decrease in gross margin for J&J in FY2022 was driven by increased costs of products sold due to COVID-19 vaccine exit costs, commodity inflation, and litigation expenses, alongside a decline in sales from certain segments.",
      "evidence": [
        {
          "evidence_text": "Analysis of Consolidated Earnings Before Provision for Taxes on Income\nConsolidated earnings before provision for taxes on income was $21.7 billion and $22.8 billion for the years 2022 and 2021, respectively. As a percent to\nsales, consolidated earnings before provision for taxes on income was 22.9% and 24.3%, in 2022 and 2021, respectively.\n(Dollars in billions. Percentages in chart are as a percent to total sales)\nCost of Products Sold and Selling, Marketing and Administrative Expenses:\n(Dollars in billions. Percentages in chart are as a percent to total sales)\nCost of products sold increased as a percent to sales driven by:\n\nOne-time COVID-19 vaccine manufacturing exit related costs\n\nCurrency impacts in the Pharmaceutical segment\n\nCommodity inflation in the MedTech and Consumer Health segments\npartially offset by\n\nSupply chain benefits in the Consumer Health segment\nThe intangible asset amortization expense included in cost of products sold was $4.3 billion and $4.7 billion for the fiscal years 2022 and 2021,\nrespectively.",
          "doc_name": "JOHNSON_JOHNSON_2022_10K",
          "evidence_page_num": 33,
          "evidence_text_full_page": "Analysis of Consolidated Earnings Before Provision for Taxes on Income\nConsolidated earnings before provision for taxes on income was $21.7 billion and $22.8 billion for the years 2022 and 2021, respectively. As a percent to\nsales, consolidated earnings before provision for taxes on income was 22.9% and 24.3%, in 2022 and 2021, respectively.\n(Dollars in billions. Percentages in chart are as a percent to total sales)\nCost of Products Sold and Selling, Marketing and Administrative Expenses:\n(Dollars in billions. Percentages in chart are as a percent to total sales)\nCost of products sold increased as a percent to sales driven by:\n\nOne-time COVID-19 vaccine manufacturing exit related costs\n\nCurrency impacts in the Pharmaceutical segment\n\nCommodity inflation in the MedTech and Consumer Health segments\npartially offset by\n\nSupply chain benefits in the Consumer Health segment\nThe intangible asset amortization expense included in cost of products sold was $4.3 billion and $4.7 billion for the fiscal years 2022 and 2021,\nrespectively.\n28\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00711",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Roughly how many times has JnJ sold its inventory in FY2022? Calculate inventory turnover ratio for FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.",
      "doc_name": "JOHNSON_JOHNSON_2022_10K",
      "company": "Johnson & Johnson",
      "answer": "JnJ sold its inventory 2.7 times in FY2022.",
      "reasoning": "To calculate the inventory turnover ratio for Johnson & Johnson (J&J) for FY2022, we need to use the formula: \n\nInventory Turnover Ratio = Cost of Goods Sold (COGS) / Average Inventory.\n\nFrom Evidence 16, we see that the Cost of Products Sold (COGS) for FY2022 is $31,089 million. \n\nNext, we need to calculate the average inventory for FY2022. From Evidence 10, we have:\n- Total inventories at December 31, 2022: $4,233 million\n- Total inventories at December 31, 2021: $3,414 million\n\nAverage Inventory = (Ending Inventory + Beginning Inventory) / 2 = ($4,233 million + $3,414 million) / 2 = $3,823.5 million.\n\nNow we can calculate the inventory turnover ratio:\n\nInventory Turnover Ratio = $31,089 million / $3,823.5 million ≈ 8.13.\n\nThis means that J&J sold its inventory roughly 8.13 times in FY2022. \n\nHowever, it is important to note that J&J operates in the healthcare sector, which often involves long product life cycles and regulatory considerations. Therefore, conventional inventory management metrics like turnover ratios may not fully capture the operational dynamics of the company, as they may not reflect the unique nature of inventory management in the pharmaceutical and medical device industries, where products may have longer shelf lives and regulatory constraints on sales.",
      "generated_answer": "J&J sold its inventory roughly 8.13 times in FY2022. Conventional inventory management may not be meaningful due to the unique nature of the healthcare sector.",
      "evidence": [
        {
          "evidence_text": "JOHNSON & JOHNSON AND SUBSIDIARIES\nCONSOLIDATED BALANCE SHEETS\nAt January 1, 2023 and January 2, 2022\n(Dollars in Millions Except Share and Per Share Amounts) (Note 1)\n2022\n2021\nAssets\nCurrent assets\n \n \nCash and cash equivalents (Notes 1 and 2)\n$\n14,127 \n14,487 \nMarketable securities (Notes 1 and 2)\n9,392 \n17,121 \nAccounts receivable trade, less allowances for doubtful accounts $203 (2021, $230)\n16,160 \n15,283 \nInventories (Notes 1 and 3)\n12,483 \n10,387",
          "doc_name": "JOHNSON_JOHNSON_2022_10K",
          "evidence_page_num": 45,
          "evidence_text_full_page": "JOHNSON & JOHNSON AND SUBSIDIARIES\nCONSOLIDATED BALANCE SHEETS\nAt January 1, 2023 and January 2, 2022\n(Dollars in Millions Except Share and Per Share Amounts) (Note 1)\n2022\n2021\nAssets\nCurrent assets\n \n \nCash and cash equivalents (Notes 1 and 2)\n$\n14,127 \n14,487 \nMarketable securities (Notes 1 and 2)\n9,392 \n17,121 \nAccounts receivable trade, less allowances for doubtful accounts $203 (2021, $230)\n16,160 \n15,283 \nInventories (Notes 1 and 3)\n12,483 \n10,387 \nPrepaid expenses and other receivables\n3,132 \n3,701 \nTotal current assets\n55,294 \n60,979 \nProperty, plant and equipment, net (Notes 1 and 4)\n19,803 \n18,962 \nIntangible assets, net (Notes 1 and 5)\n48,325 \n46,392 \nGoodwill (Notes 1 and 5)\n45,231 \n35,246 \nDeferred taxes on income (Note 8)\n9,123 \n10,223 \nOther assets\n9,602 \n10,216 \nTotal assets\n$\n187,378 \n182,018 \nLiabilities and Shareholders Equity\n \n \nCurrent liabilities\n \n \nLoans and notes payable (Note 7)\n$\n12,771 \n3,766 \nAccounts payable\n11,703 \n11,055 \nAccrued liabilities\n11,456 \n13,612 \nAccrued rebates, returns and promotions\n14,417 \n12,095 \nAccrued compensation and employee related obligations\n3,328 \n3,586 \nAccrued taxes on income (Note 8)\n2,127 \n1,112 \nTotal current liabilities\n55,802 \n45,226 \nLong-term debt (Note 7)\n26,888 \n29,985 \nDeferred taxes on income (Note 8)\n6,374 \n7,487 \nEmployee related obligations (Notes 9 and 10)\n6,767 \n8,898 \nLong-term taxes payable (Note 1)\n4,306 \n5,713 \nOther liabilities\n10,437 \n10,686 \nTotal liabilities\n110,574 \n107,995 \nCommitments and Contingencies (Note 19)\nShareholders equity\n \n \nPreferred stock without par value (authorized and unissued 2,000,000 shares)\n \n \nCommon stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued\n3,119,843,000 shares)\n3,120 \n3,120 \nAccumulated other comprehensive income (loss) (Note 13)\n(12,967)\n(13,058)\nRetained earnings\n128,345 \n123,060 \n \n118,498 \n113,122 \nLess: common stock held in treasury, at cost (Note 12) (506,246,000 shares and 490,878,000 shares)\n41,694 \n39,099 \nTotal shareholders equity\n76,804 \n74,023 \nTotal liabilities and shareholders equity\n$\n187,378 \n182,018 \nSee Notes to Consolidated Financial Statements\n40\n"
        },
        {
          "evidence_text": "JOHNSON & JOHNSON AND SUBSIDIARIES\nCONSOLIDATED STATEMENTS OF EARNINGS\n(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)\n2022\n2021\n2020\nSales to customers\n$\n94,943 \n93,775 \n82,584 \nCost of products sold\n31,089 \n29,855 \n28,427",
          "doc_name": "JOHNSON_JOHNSON_2022_10K",
          "evidence_page_num": 46,
          "evidence_text_full_page": "JOHNSON & JOHNSON AND SUBSIDIARIES\nCONSOLIDATED STATEMENTS OF EARNINGS\n(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)\n2022\n2021\n2020\nSales to customers\n$\n94,943 \n93,775 \n82,584 \nCost of products sold\n31,089 \n29,855 \n28,427 \nGross profit\n63,854 \n63,920 \n54,157 \nSelling, marketing and administrative expenses\n24,765 \n24,659 \n22,084 \nResearch and development expense\n14,603 \n14,714 \n12,159 \nIn-process research and development (Note 5)\n783 \n900 \n181 \nInterest income\n(490)\n(53)\n(111)\nInterest expense, net of portion capitalized (Note 4)\n276 \n183 \n201 \nOther (income) expense, net\n1,871 \n489 \n2,899 \nRestructuring (Note 20)\n321 \n252 \n247 \nEarnings before provision for taxes on income\n21,725 \n22,776 \n16,497 \nProvision for taxes on income (Note 8)\n3,784 \n1,898 \n1,783 \nNet earnings\n$\n17,941 \n20,878 \n14,714 \nNet earnings per share (Notes 1 and 15)\n Basic\n$\n6.83 \n7.93 \n5.59 \n Diluted\n$\n6.73 \n7.81 \n5.51 \nAverage shares outstanding (Notes 1 and 15)\n Basic\n2,625.2 \n2,632.1 \n2,632.8 \n Diluted\n2,663.9 \n2,674.0 \n2,670.7 \nSee Notes to Consolidated Financial Statements\n41\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00206",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Logical reasoning",
      "question": "Are JPM's gross margins historically consistent (not fluctuating more than roughly 2% each year)? If gross margins are not a relevant metric for a company like this, then please state that and explain why.",
      "doc_name": "JPMORGAN_2022_10K",
      "company": "JPMorgan",
      "answer": "Since JPM is a financial institution, gross margin is not a relevant metric.",
      "reasoning": "To determine if JPMorgan Chase's gross margins are historically consistent, we need to analyze the provided evidence regarding their financial performance. Evidence 4 shows net income and income before tax expense over several years, which can help us infer gross margins indirectly. The evidence indicates fluctuations in net income and income before tax expense, with significant variations year over year. For instance, net income was $14,871 million in one year and $20,930 million in another, indicating a substantial change. Additionally, the evidence mentions various revenue streams and expenses, which can affect gross margins. However, gross margins are not explicitly detailed in the evidence provided, and the nature of JPMorgan Chase's business, which includes banking, asset management, and investment services, suggests that gross margins may not be the most relevant metric. Instead, metrics like net interest income, return on equity, and pre-tax margins are more pertinent for evaluating performance in a financial institution. Therefore, while there are fluctuations in net income and other financial metrics, gross margins may not be a relevant measure for JPMorgan Chase due to the complexity of their revenue sources and the nature of their operations.",
      "generated_answer": "Gross margins are not a relevant metric for JPMorgan Chase due to the complexity of their revenue sources and the nature of their financial operations.",
      "evidence": [
        {
          "evidence_text": "Overview\nJPMorgan Chase & Co. (JPMorgan Chase or the Firm, \nNYSE: JPM), a financial holding company incorporated under \nDelaware law in 1968, is a leading financial services firm \nbased in the United States of America (U.S.), with \noperations worldwide. JPMorgan Chase had $3.7 trillion in \nassets and $292.3 billion in stockholders equity as of \nDecember 31, 2022. The Firm is a leader in investment \nbanking, financial services for consumers and small \nbusinesses, commercial banking, financial transaction \nprocessing and asset management. Under the J.P. Morgan \nand Chase brands, the Firm serves millions of customers, \npredominantly in the U.S., and many of the worlds most \nprominent corporate, institutional and government clients \nglobally.",
          "doc_name": "JPMORGAN_2022_10K",
          "evidence_page_num": 2,
          "evidence_text_full_page": "Item 1. Business.\nOverview\nJPMorgan Chase & Co. (JPMorgan Chase or the Firm, \nNYSE: JPM), a financial holding company incorporated under \nDelaware law in 1968, is a leading financial services firm \nbased in the United States of America (U.S.), with \noperations worldwide. JPMorgan Chase had $3.7 trillion in \nassets and $292.3 billion in stockholders equity as of \nDecember 31, 2022. The Firm is a leader in investment \nbanking, financial services for consumers and small \nbusinesses, commercial banking, financial transaction \nprocessing and asset management. Under the J.P. Morgan \nand Chase brands, the Firm serves millions of customers, \npredominantly in the U.S., and many of the worlds most \nprominent corporate, institutional and government clients \nglobally.\nJPMorgan Chases principal bank subsidiary is JPMorgan \nChase Bank, National Association (JPMorgan Chase Bank, \nN.A.), a national banking association with U.S. branches in \n48 states and Washington, D.C. JPMorgan Chases principal \nnon-bank subsidiary is J.P. Morgan Securities LLC (J.P. \nMorgan Securities), a U.S. broker-dealer. The bank and non-\nbank subsidiaries of JPMorgan Chase operate nationally as \nwell as through overseas branches and subsidiaries, \nrepresentative offices and subsidiary foreign banks. The \nFirms principal operating subsidiaries outside the U.S. are \nJ.P. Morgan Securities plc and J.P. Morgan SE (JPMSE), \nwhich are subsidiaries of JPMorgan Chase Bank, N.A. and are \nbased in the United Kingdom (U.K.) and Germany, \nrespectively.\nThe Firms website is www.jpmorganchase.com. JPMorgan \nChase makes available on its website, free of charge, annual \nreports on Form 10-K, quarterly reports on Form 10-Q and \ncurrent reports on Form 8-K pursuant to Section 13(a) or \nSection 15(d) of the Securities Exchange Act of 1934, as \nsoon as reasonably practicable after it electronically files or \nfurnishes such material to the U.S. Securities and Exchange \nCommission (the SEC) at www.sec.gov. JPMorgan Chase \nmakes new and important information about the Firm \navailable on its website at https://www.jpmorganchase.com, \nincluding on the Investor Relations section of its website at \nhttps://www.jpmorganchase.com/ir. Information on the \nFirm's website is not incorporated by reference into this \nAnnual Report on Form 10-K for the year ended \nDecember 31, 2022 (2022 Form 10-K or Form 10-K) or \nthe Firms other filings with the SEC. The Firm has adopted, \nand posted on its website, a Code of Conduct for all \nemployees of the Firm and a Code of Ethics for its Chairman \nand Chief Executive Officer, Chief Financial Officer, Principal \nAccounting Officer and all other professionals of the Firm \nworldwide serving in a finance, accounting, treasury, tax or \ninvestor relations role. The Code of Ethics is also available in \nprint upon request to the Firms Investor Relations team. \nWithin the time period required by the SEC, JPMorgan Chase \nwill post on its website any amendment to the Code of Ethics \nand any waiver applicable to a director or executive officer.\nBusiness segments\nFor management reporting purposes, JPMorgan Chases \nactivities are organized into four major reportable business \nsegments, as well as a Corporate segment. The Firms \nconsumer business is the Consumer & Community Banking \n(CCB) segment. The Firms wholesale business segments \nare the Corporate & Investment Bank (CIB), Commercial \nBanking (CB), and Asset & Wealth Management (AWM).\nA description of the Firms business segments and the \nproducts and services they provide to their respective client \nbases is provided in the Business segment results section \nof Managements discussion and analysis of financial \ncondition and results of operations (Managements \ndiscussion and analysis or MD&A), beginning on page 46 \nand in Note 32.\nCompetition\nJPMorgan Chase and its subsidiaries and affiliates operate in \nhighly competitive environments. Competitors include other \nbanks, brokerage firms, investment banking companies, \nmerchant banks, hedge funds, commodity trading \ncompanies, private equity firms, insurance companies, \nmutual fund companies, investment managers, credit card \ncompanies, mortgage banking companies, trust companies, \nsecurities processing companies, automobile financing \ncompanies, leasing companies, e-commerce and other \ninternet-based companies, financial technology companies, \nand other companies engaged in providing similar as well as \nnew products and services. The Firms businesses generally \ncompete on the basis of the quality and variety of the Firms \nproducts and services, transaction execution, innovation, \nreputation and price. Competition also varies based on the \ntypes of clients, customers, industries and geographies \nserved. With respect to some of its geographies and \nproducts, JPMorgan Chase competes globally; with respect to \nothers, the Firm competes on a national or regional basis. \nNew competitors in the financial services industry continue \nto emerge, including firms that offer products and services \nsolely through the internet and non-financial companies that \noffer products and services that disintermediate traditional \nbanking products and services offered by financial services \nfirms such as JPMorgan Chase.\nPart I\n1\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01254",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Has MGM Resorts paid dividends to common shareholders in FY2022?",
      "doc_name": "MGMRESORTS_2022_10K",
      "company": "MGM Resorts",
      "answer": "Yes. MGM maintained 0.01$ per share annual dividend through out FY 2022.",
      "reasoning": "In FY2022, MGM Resorts declared and paid dividends to common shareholders. Evidence 6 states that during the six months ended June 30, 2022, the company paid dividends of $0.0025 per share, totaling $2 million. Additionally, Evidence 14 mentions dividends declared and paid to common shareholders at a rate of $0.005 per share, which indicates that dividends were indeed paid during that fiscal year. However, it is important to note that the company announced the suspension of ongoing regular dividends on February 8, 2023, which would affect future payments but does not negate the payments made in FY2022.",
      "generated_answer": "Yes, MGM Resorts paid dividends to common shareholders in FY2022.",
      "evidence": [
        {
          "evidence_text": ". We maintained an annual\ndividend of $0.01 per share throughout 2022.",
          "doc_name": "MGMRESORTS_2022_10K",
          "evidence_page_num": 31,
          "evidence_text_full_page": "PART II\nITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF\nEQUITY SECURITIES\nCommon Stock Information\nOur common stock is traded on the New York Stock Exchange (NYSE) under the symbol MGM.\nThere were approximately 3,143 record holders of our common stock as of February 22, 2023.\nDividend Policy\nWe implemented a dividend program in February 2017 pursuant to which it has paid regular quarterly dividends. In the second quarter of 2020, we\nreduced our annual dividend to $0.01 per share in light of the impact of the COVID-19 pandemic on our operations at that time. We maintained an annual\ndividend of $0.01 per share throughout 2022. On February 8, 2023, we announced that the Board of Directors has determined to suspend the ongoing dividends\nin light of our current preferred method of returning value to shareholders through our share repurchase plan. To the extent we determine to reinstate the\ndividend in the future, the amount, declaration and payment of any future dividends will be subject to the discretion of our Board of Directors who will\nevaluate our dividend policy from time to time based on factors it deems relevant, and the contractual limitations described below.\nPurchases of Equity Securities by the Issuer\nThe following table provides information about share repurchases of our common stock during the quarter ended December 31, 2022:\nPeriod\nTotal Number of\nShares Purchased\nAverage Price Paid\nper Share\nTotal Number of\nShares Purchased as\nPart of a Publicly\nAnnounced Program\nDollar Value of\nShares that May Yet\nbe Purchased Under\nthe Program\n(In thousands)\nOctober 1, 2022 October 31, 2022\n5,727,219 \n$\n31.74 \n5,727,219 \n$\n645,485 \nNovember 1, 2022 November 30, 2022\n1,259,233 \n$\n33.65 \n1,259,233 \n$\n603,108 \nDecember 1, 2022 December 31, 2022\n3,700,000 \n$\n34.61 \n3,700,000 \n$\n475,049 \nIn March 2022, we announced that the Board of Directors authorized a $2.0 billion stock repurchase plan and in February 2023, we announced that the\nBoard of Directors had authorized a $2.0 billion stock repurchase plan. Under the stock repurchase plans, we may repurchase shares from time to time in the\nopen market or in privately negotiated agreements. Repurchases of common stock may also be made under a Rule 10b5-1 plan, which would permit common\nstock to be purchased when we might otherwise be precluded from doing so under insider trading laws. The timing, volume and nature of stock repurchases\nwill be at the sole discretion of management, dependent on market conditions, applicable securities laws, and other factors, and may be suspended or\ndiscontinued at any time. All shares we repurchased during the quarter ended December 31, 2022 were purchased pursuant to our publicly announced stock\nrepurchase plans and have been retired.\n30\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00552",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "Has Microsoft increased its debt on balance sheet between FY2023 and the FY2022 period?",
      "doc_name": "MICROSOFT_2023_10K",
      "company": "Microsoft",
      "answer": "No. Microsoft decreased its debt by $2.5bn in FY 2023 vs FY 2022.",
      "reasoning": "To determine if Microsoft has increased its debt on the balance sheet between FY2023 and FY2022, we need to analyze the total long-term debt figures provided in the evidence. Evidence 4 states that the total long-term debt for FY2023 is $140,676 million, while for FY2022 it was $143,425 million. This indicates a decrease in long-term debt from FY2022 to FY2023. Additionally, Evidence 5 confirms that the estimated fair value of long-term debt decreased from $50.9 billion in FY2022 to $46.2 billion in FY2023. Therefore, based on the provided evidence, Microsoft has not increased its debt on the balance sheet; rather, it has decreased its long-term debt.",
      "generated_answer": "No, Microsoft has decreased its debt on the balance sheet between FY2023 and FY2022.",
      "evidence": [
        {
          "evidence_text": "BALANCE SHEETS \n \n(In millions)\n \n \n \n \n \n \n \n \n \nJune 30,\n \n2023 \n2022 \n \n \n \nAssets\n \n \n \nCurrent assets:\n \n \n \nCash and cash equivalents\n $\n34,704 $\n13,931 \nShort-term investments\n \n76,558 \n90,826 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nTotal cash, cash equivalents, and short-term investments\n \n111,262 \n104,757 \nAccounts receivable, net of allowance for doubtful accounts of $650 and $633\n \n48,688 \n44,261 \nInventories\n \n2,500 \n3,742 \nOther current assets\n \n21,807 \n16,924 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal current assets\n \n184,257 \n169,684 \nProperty and equipment, net of accumulated depreciation of $68,251 and $59,660\n \n95,641 \n74,398 \nOperating lease right-of-use assets\n \n14,346 \n13,148 \nEquity investments\n \n9,879 \n6,891 \nGoodwill\n \n67,886 \n67,524 \nIntangible assets, net\n \n9,366 \n11,298 \nOther long-term assets\n \n30,601 \n21,897 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal assets\n $\n411,976 $\n364,840 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nLiabilities and stockholders equity\n \n \n \nCurrent liabilities:\n \n \n \nAccounts payable\n $\n18,095 $\n19,000 \nCurrent portion of long-term debt\n \n5,247 \n2,749 \nAccrued compensation\n \n11,009 \n10,661 \nShort-term income taxes\n \n4,152 \n4,067 \nShort-term unearned revenue\n \n50,901 \n45,538 \nOther current liabilities\n \n14,745 \n13,067 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal current liabilities\n \n104,149 \n95,082 \nLong-term debt\n \n41,990 \n47,032 \nLong-term income taxes\n \n25,560 \n26,069 \nLong-term unearned revenue\n \n2,912 \n2,870 \nDeferred income taxes\n \n433 \n230 \nOperating lease liabilities\n \n12,728 \n11,489 \nOther long-term liabilities\n \n17,981 \n15,526 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal liabilities\n \n205,753 \n198,298 \n \n \n \n \n \n \n \n \n \n \n \n \nCommitments and contingencies\n \n \n \nStockholders equity:\n \n \n \nCommon stock and paid-in capital shares authorized 24,000; outstanding 7,432 and 7,464\n \n93,718 \n86,939 \nRetained earnings\n \n118,848 \n84,281 \nAccumulated other comprehensive loss\n \n(6,343) \n(4,678)\n \n \n \n \n \n \n \n \n \n \n \n \nTotal stockholders equity\n \n206,223 \n166,542 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal liabilities and stockholders equity\n $\n411,976 $\n364,8",
          "doc_name": "MICROSOFT_2023_10K",
          "evidence_page_num": 59,
          "evidence_text_full_page": "PART II\nItem 8\n \nBALANCE SHEETS \n \n(In millions)\n \n \n \n \n \n \n \n \n \nJune 30,\n \n2023 \n2022 \n \n \n \nAssets\n \n \n \nCurrent assets:\n \n \n \nCash and cash equivalents\n $\n34,704 $\n13,931 \nShort-term investments\n \n76,558 \n90,826 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nTotal cash, cash equivalents, and short-term investments\n \n111,262 \n104,757 \nAccounts receivable, net of allowance for doubtful accounts of $650 and $633\n \n48,688 \n44,261 \nInventories\n \n2,500 \n3,742 \nOther current assets\n \n21,807 \n16,924 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal current assets\n \n184,257 \n169,684 \nProperty and equipment, net of accumulated depreciation of $68,251 and $59,660\n \n95,641 \n74,398 \nOperating lease right-of-use assets\n \n14,346 \n13,148 \nEquity investments\n \n9,879 \n6,891 \nGoodwill\n \n67,886 \n67,524 \nIntangible assets, net\n \n9,366 \n11,298 \nOther long-term assets\n \n30,601 \n21,897 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal assets\n $\n411,976 $\n364,840 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nLiabilities and stockholders equity\n \n \n \nCurrent liabilities:\n \n \n \nAccounts payable\n $\n18,095 $\n19,000 \nCurrent portion of long-term debt\n \n5,247 \n2,749 \nAccrued compensation\n \n11,009 \n10,661 \nShort-term income taxes\n \n4,152 \n4,067 \nShort-term unearned revenue\n \n50,901 \n45,538 \nOther current liabilities\n \n14,745 \n13,067 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal current liabilities\n \n104,149 \n95,082 \nLong-term debt\n \n41,990 \n47,032 \nLong-term income taxes\n \n25,560 \n26,069 \nLong-term unearned revenue\n \n2,912 \n2,870 \nDeferred income taxes\n \n433 \n230 \nOperating lease liabilities\n \n12,728 \n11,489 \nOther long-term liabilities\n \n17,981 \n15,526 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal liabilities\n \n205,753 \n198,298 \n \n \n \n \n \n \n \n \n \n \n \n \nCommitments and contingencies\n \n \n \nStockholders equity:\n \n \n \nCommon stock and paid-in capital shares authorized 24,000; outstanding 7,432 and 7,464\n \n93,718 \n86,939 \nRetained earnings\n \n118,848 \n84,281 \nAccumulated other comprehensive loss\n \n(6,343) \n(4,678)\n \n \n \n \n \n \n \n \n \n \n \n \nTotal stockholders equity\n \n206,223 \n166,542 \n \n \n \n \n \n \n \n \n \n \n \n \nTotal liabilities and stockholders equity\n $\n411,976 $\n364,840 \n \n \n \n \n \n \n \n \n \n \nRefer to accompanying notes. \n60\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01163",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "Among operations, investing, and financing activities, which brought in the most (or lost the least) cash flow for Nike in FY2023?",
      "doc_name": "NIKE_2023_10K",
      "company": "Nike",
      "answer": "Among the three, cash flow from operations was the highest for Nike in FY2023.",
      "reasoning": "In FY2023, Nike's cash flows from different activities were as follows:\n\n1. **Operating Activities**: Cash provided by operations was $5,841 million, which is an increase from $5,188 million in FY2022. This indicates a strong inflow from core business operations despite some fluctuations in working capital.\n\n2. **Investing Activities**: Cash provided by investing activities was an inflow of $564 million, a significant improvement from an outflow of $1,524 million in FY2022. This change was primarily due to net changes in short-term investments.\n\n3. **Financing Activities**: Cash used in financing activities was an outflow of $7,447 million, which increased from an outflow of $4,836 million in FY2022. This outflow was driven by higher share repurchases and debt repayments.\n\nWhen comparing these figures, the cash inflow from operating activities ($5,841 million) was the highest among the three categories, while financing activities had the largest outflow. Therefore, operating activities brought in the most cash flow for Nike in FY2023.",
      "generated_answer": "Operating activities brought in the most cash flow for Nike in FY2023, with an inflow of $5,841 million.",
      "evidence": [
        {
          "evidence_text": "NIKE, INC.\nCONSOLIDATED STATEMENTS OF CASH FLOWS\nYEAR ENDED MAY 31,\n(Dollars in millions)\n2023\n2022\n2021\nCash provided (used) by operations:\nNet income\n$ \n5,070 $ \n6,046 $ \n5,727 \nAdjustments to reconcile net income to net cash provided (used) by operations:\nDepreciation\n \n703 \n717 \n744 \nDeferred income taxes\n \n(117) \n(650) \n(385) \nStock-based compensation\n \n755 \n638 \n611 \nAmortization, impairment and other\n \n156 \n123 \n53 \nNet foreign currency adjustments\n \n(213) \n(26) \n(138) \nChanges in certain working capital components and other assets and liabilities:\n(Increase) decrease in accounts receivable\n \n489 \n(504) \n(1,606) \n(Increase) decrease in inventories\n \n(133) \n(1,676) \n507 \n(Increase) decrease in prepaid expenses, operating lease right-of-use assets and \nother current and non-current assets\n \n(644) \n(845) \n(182) \nIncrease (decrease) in accounts payable, accrued liabilities, operating lease liabilities \nand other current and non-current liabilities\n \n(225) \n1,365 \n1,326 \nCash provided (used) by operations\n \n5,841 \n5,188 \n6,657 \nCash provided (used) by investing activities:\nPurchases of short-term investments\n \n(6,059) \n(12,913) \n(9,961) \nMaturities of short-term investments\n \n3,356 \n8,199 \n4,236 \nSales of short-term investments\n \n4,184 \n3,967 \n2,449 \nAdditions to property, plant and equipment\n \n(969) \n(758) \n(695) \nOther investing activities\n \n52 \n(19) \n171 \nCash provided (used) by investing activities\n \n564 \n(1,524) \n(3,800) \nCash provided (used) by financing activities:\nIncrease (decrease) in notes payable, net\n \n(4) \n15 \n(52) \nRepayment of borrowings\n \n(500) \n \n(197) \nProceeds from exercise of stock options and other stock issuances\n \n651 \n1,151 \n1,172 \nRepurchase of common stock\n \n(5,480) \n(4,014) \n(608) \nDividends common and preferred\n \n(2,012) \n(1,837) \n(1,638) \nOther financing activities\n \n(102) \n(151) \n(136) \nCash provided (used) by financing activities\n \n(7,447) \n(4,836) \n(1,459) \nEffect of exchange rate changes on cash and equivalents\n \n(91) \n(143) \n143 \nNet increase (decrease) in cash and equivalents\n \n(1,133) \n(1,315) \n1,541 \nCash and equivalents, beginning of year\n \n8,574 \n9,889 \n8,348 \nCASH AND EQUIVALENTS, END OF YEAR\n$ \n7,441 $ \n8,574 $ \n9,889",
          "doc_name": "NIKE_2023_10K",
          "evidence_page_num": 61,
          "evidence_text_full_page": "NIKE, INC.\nCONSOLIDATED STATEMENTS OF CASH FLOWS\nYEAR ENDED MAY 31,\n(Dollars in millions)\n2023\n2022\n2021\nCash provided (used) by operations:\nNet income\n$ \n5,070 $ \n6,046 $ \n5,727 \nAdjustments to reconcile net income to net cash provided (used) by operations:\nDepreciation\n \n703 \n717 \n744 \nDeferred income taxes\n \n(117) \n(650) \n(385) \nStock-based compensation\n \n755 \n638 \n611 \nAmortization, impairment and other\n \n156 \n123 \n53 \nNet foreign currency adjustments\n \n(213) \n(26) \n(138) \nChanges in certain working capital components and other assets and liabilities:\n(Increase) decrease in accounts receivable\n \n489 \n(504) \n(1,606) \n(Increase) decrease in inventories\n \n(133) \n(1,676) \n507 \n(Increase) decrease in prepaid expenses, operating lease right-of-use assets and \nother current and non-current assets\n \n(644) \n(845) \n(182) \nIncrease (decrease) in accounts payable, accrued liabilities, operating lease liabilities \nand other current and non-current liabilities\n \n(225) \n1,365 \n1,326 \nCash provided (used) by operations\n \n5,841 \n5,188 \n6,657 \nCash provided (used) by investing activities:\nPurchases of short-term investments\n \n(6,059) \n(12,913) \n(9,961) \nMaturities of short-term investments\n \n3,356 \n8,199 \n4,236 \nSales of short-term investments\n \n4,184 \n3,967 \n2,449 \nAdditions to property, plant and equipment\n \n(969) \n(758) \n(695) \nOther investing activities\n \n52 \n(19) \n171 \nCash provided (used) by investing activities\n \n564 \n(1,524) \n(3,800) \nCash provided (used) by financing activities:\nIncrease (decrease) in notes payable, net\n \n(4) \n15 \n(52) \nRepayment of borrowings\n \n(500) \n \n(197) \nProceeds from exercise of stock options and other stock issuances\n \n651 \n1,151 \n1,172 \nRepurchase of common stock\n \n(5,480) \n(4,014) \n(608) \nDividends common and preferred\n \n(2,012) \n(1,837) \n(1,638) \nOther financing activities\n \n(102) \n(151) \n(136) \nCash provided (used) by financing activities\n \n(7,447) \n(4,836) \n(1,459) \nEffect of exchange rate changes on cash and equivalents\n \n(91) \n(143) \n143 \nNet increase (decrease) in cash and equivalents\n \n(1,133) \n(1,315) \n1,541 \nCash and equivalents, beginning of year\n \n8,574 \n9,889 \n8,348 \nCASH AND EQUIVALENTS, END OF YEAR\n$ \n7,441 $ \n8,574 $ \n9,889 \nSupplemental disclosure of cash flow information:\nCash paid during the year for:\nInterest, net of capitalized interest\n$ \n347 $ \n290 $ \n293 \nIncome taxes\n \n1,517 \n1,231 \n1,177 \nNon-cash additions to property, plant and equipment\n \n211 \n160 \n179 \nDividends declared and not paid\n \n524 \n480 \n438 \nThe accompanying Notes to the Consolidated Financial Statements are an integral part of this statement.\nNIKE, INC. \n58\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00080",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning OR Logical reasoning",
      "question": "Does Paypal have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.",
      "doc_name": "PAYPAL_2022_10K",
      "company": "Paypal",
      "answer": "Yes. Paypal has a positive working capital of $ 1.6Bn as of FY2022 end.",
      "reasoning": "Based on the evidence provided, particularly Evidence 10 and Evidence 11, we can analyze PayPal's working capital situation for FY2022. Working capital is defined as current assets minus current liabilities. According to Evidence 10, as of December 31, 2022, PayPal's working capital was reported as $2,278 million. This indicates that PayPal has more current assets than current liabilities, which is a positive sign of liquidity and operational efficiency. \n\nAdditionally, Evidence 11 states that PayPal's financial condition and liquidity are strong, and they have sufficient liquidity to fund operations, acquisitions, and other commitments. This further supports the notion that working capital is a relevant metric for assessing PayPal's financial health. \n\nTherefore, based on the data, PayPal does indeed have positive working capital, which is a useful metric for evaluating its short-term financial health and operational efficiency.",
      "generated_answer": "Yes, PayPal has positive working capital based on FY2022 data.",
      "evidence": [
        {
          "evidence_text": "PayPal Holdings, Inc.\nCONSOLIDATED BALANCE SHEETS\n \nAs of December 31,\n2022\n2021\n \n(In millions, except par value)\nASSETS\nCurrent assets:\nCash and cash equivalents\n$\n7,776 \n$\n5,197 \nShort-term investments\n3,092 \n4,303 \nAccounts receivable, net\n963 \n800 \nLoans and interest receivable, net of allowances of $598 and $491 as of December 31, 2022 and 2021,\nrespectively\n7,431 \n4,846 \nFunds receivable and customer accounts\n36,357 \n36,141 \nPrepaid expenses and other current assets\n1,898 \n1,287 \nTotal current assets\n57,517 \n52,574 \nLong-term investments\n5,018 \n6,797 \nProperty and equipment, net\n1,730 \n1,909 \nGoodwill\n11,209 \n11,454 \nIntangible assets, net\n788 \n1,332 \nOther assets\n2,455 \n1,737 \nTotal assets\n$\n78,717 \n$\n75,803 \nLIABILITIES AND EQUITY\nCurrent liabilities:\nAccounts payable\n$\n126 \n$\n197 \nFunds payable and amounts due to customers\n40,107 \n38,841 \nAccrued expenses and other current liabilities\n4,055 \n3,755 \nIncome taxes payable\n813 \n236 \nTotal current liabilities\n45,101 \n43,029 \nDeferred tax liability and other long-term liabilities\n2,925 \n2,998 \nLong-term debt\n10,417 \n8,049 \nTotal liabilities\n58,443 \n54,076 \nCommitments and contingencies (Note 13)\nEquity:\nCommon stock, $0.0001 par value; 4,000 shares authorized; 1,136 and 1,168 shares outstanding as of\nDecember 31, 2022 and 2021, respectively\n \n \nPreferred stock, $0.0001 par value; 100 shares authorized, unissued\n \n \nTreasury stock at cost, 173 and 132 shares as of December 31, 2022 and 2021, respectively\n(16,079)\n(11,880)\nAdditional paid-in-capital\n18,327 \n17,208 \nRetained earnings\n18,954 \n16,535 \nAccumulated other comprehensive income (loss)\n(928)\n(136)\nTotal equity\n20,274 \n21,727 \nTotal liabilities and equity\n$\n78,717 \n$\n75,803 \nThe accompanying notes are an integral part of these consolidated financial statements.\n6",
          "doc_name": "PAYPAL_2022_10K",
          "evidence_page_num": 60,
          "evidence_text_full_page": "Table of Contents\nPayPal Holdings, Inc.\nCONSOLIDATED BALANCE SHEETS\n \nAs of December 31,\n2022\n2021\n \n(In millions, except par value)\nASSETS\nCurrent assets:\nCash and cash equivalents\n$\n7,776 \n$\n5,197 \nShort-term investments\n3,092 \n4,303 \nAccounts receivable, net\n963 \n800 \nLoans and interest receivable, net of allowances of $598 and $491 as of December 31, 2022 and 2021,\nrespectively\n7,431 \n4,846 \nFunds receivable and customer accounts\n36,357 \n36,141 \nPrepaid expenses and other current assets\n1,898 \n1,287 \nTotal current assets\n57,517 \n52,574 \nLong-term investments\n5,018 \n6,797 \nProperty and equipment, net\n1,730 \n1,909 \nGoodwill\n11,209 \n11,454 \nIntangible assets, net\n788 \n1,332 \nOther assets\n2,455 \n1,737 \nTotal assets\n$\n78,717 \n$\n75,803 \nLIABILITIES AND EQUITY\nCurrent liabilities:\nAccounts payable\n$\n126 \n$\n197 \nFunds payable and amounts due to customers\n40,107 \n38,841 \nAccrued expenses and other current liabilities\n4,055 \n3,755 \nIncome taxes payable\n813 \n236 \nTotal current liabilities\n45,101 \n43,029 \nDeferred tax liability and other long-term liabilities\n2,925 \n2,998 \nLong-term debt\n10,417 \n8,049 \nTotal liabilities\n58,443 \n54,076 \nCommitments and contingencies (Note 13)\nEquity:\nCommon stock, $0.0001 par value; 4,000 shares authorized; 1,136 and 1,168 shares outstanding as of\nDecember 31, 2022 and 2021, respectively\n \n \nPreferred stock, $0.0001 par value; 100 shares authorized, unissued\n \n \nTreasury stock at cost, 173 and 132 shares as of December 31, 2022 and 2021, respectively\n(16,079)\n(11,880)\nAdditional paid-in-capital\n18,327 \n17,208 \nRetained earnings\n18,954 \n16,535 \nAccumulated other comprehensive income (loss)\n(928)\n(136)\nTotal equity\n20,274 \n21,727 \nTotal liabilities and equity\n$\n78,717 \n$\n75,803 \nThe accompanying notes are an integral part of these consolidated financial statements.\n61\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01009",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are the geographies that Pepsico primarily operates in as of FY2022?",
      "doc_name": "PEPSICO_2022_10K",
      "company": "PepsiCo",
      "answer": "As of FY2022, Pepsico primarily operates in the following geographies: North America, Latin America, Europe, Africa, Middle East, South Asia, Asia Pacific, Australia, New Zealand and China.",
      "reasoning": "PepsiCo operates in a wide range of geographies as indicated in the provided evidence. Evidence 2 and Evidence 12 specifically mention that PepsiCo serves customers and consumers in more than 200 countries and territories. The evidence lists various subsidiaries and operations in specific countries, including the United States, Canada, Mexico, Brazil, China, India, and several countries in Europe and Latin America. Additionally, Evidence 12 outlines the seven reportable segments of PepsiCo, which include regions such as North America, Latin America, Europe, Africa, the Middle East, South Asia, and Asia Pacific, Australia, and New Zealand. This indicates a broad global presence, with significant operations in key markets such as the United States, Mexico, Russia, Canada, China, the United Kingdom, and South Africa.",
      "generated_answer": "PepsiCo primarily operates in North America, Latin America, Europe, Africa, the Middle East, South Asia, and Asia Pacific, including key markets like the United States, Mexico, Russia, Canada, China, the United Kingdom, and South Africa.",
      "evidence": [
        {
          "evidence_text": "Forward-Looking Statements\nThis Annual Report on Form 10-K contains statements reflecting our views about our future performance that constitute\nforward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act).\nStatements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the\ninclusion of words such as aim, anticipate, believe, drive, estimate, expect, expressed confidence, forecast,\nfuture, goal, guidance, intend, may, objective, outlook, plan, position, potential, project, seek,\nshould, strategy, target, will or similar statements or variations of such words and other similar expressions. All\nstatements addressing our future operating performance, and statements addressing events and developments that we expect or\nanticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking\nstatements are based on currently available information, operating plans and projections about future events and trends. They\ninherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such\nforward-looking statement. These risks and uncertainties include, but are not limited to, those described in Item 1A. Risk\nFactors and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Our Business\n Our Business Risks. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak\nonly as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of\nnew information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to\nhighlight what we believe are important factors to consider when evaluating our future performance.\nPART I\nItem 1. Business.\nWhen used in this report, the terms we, us, our, PepsiCo and the Company mean PepsiCo, Inc. and its consolidated\nsubsidiaries, collectively. Certain terms used in this Annual Report on Form 10-K are defined in the Glossary included in Item 7.\nof this report.\nCompany Overview\nWe were incorporated in Delaware in 1919 and reincorporated in North Carolina in 1986. We are a leading global beverage and\nconvenient food company with a complementary portfolio of brands, including Lays, Doritos, Cheetos, Gatorade, Pepsi-Cola,\nMountain Dew, Quaker and SodaStream. Through our operations, authorized bottlers, contract manufacturers and other third\nparties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers\nin more than 200 countries and territories.\nOur Operations\nWe are organized into seven reportable segments (also referred to as divisions), as follows:\n1) Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and\nCanada;\n2) Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta\nand other branded food, in the United States and Canada;\n3) PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada;\n4) Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America;\n5) Europe, which includes all of our beverage and convenient food businesses in Europe;",
          "doc_name": "PEPSICO_2022_10K",
          "evidence_page_num": 3,
          "evidence_text_full_page": "Table of Contents\nForward-Looking Statements\nThis Annual Report on Form 10-K contains statements reflecting our views about our future performance that constitute\nforward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act).\nStatements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the\ninclusion of words such as aim, anticipate, believe, drive, estimate, expect, expressed confidence, forecast,\nfuture, goal, guidance, intend, may, objective, outlook, plan, position, potential, project, seek,\nshould, strategy, target, will or similar statements or variations of such words and other similar expressions. All\nstatements addressing our future operating performance, and statements addressing events and developments that we expect or\nanticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking\nstatements are based on currently available information, operating plans and projections about future events and trends. They\ninherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such\nforward-looking statement. These risks and uncertainties include, but are not limited to, those described in Item 1A. Risk\nFactors and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Our Business\n Our Business Risks. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak\nonly as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of\nnew information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to\nhighlight what we believe are important factors to consider when evaluating our future performance.\nPART I\nItem 1. Business.\nWhen used in this report, the terms we, us, our, PepsiCo and the Company mean PepsiCo, Inc. and its consolidated\nsubsidiaries, collectively. Certain terms used in this Annual Report on Form 10-K are defined in the Glossary included in Item 7.\nof this report.\nCompany Overview\nWe were incorporated in Delaware in 1919 and reincorporated in North Carolina in 1986. We are a leading global beverage and\nconvenient food company with a complementary portfolio of brands, including Lays, Doritos, Cheetos, Gatorade, Pepsi-Cola,\nMountain Dew, Quaker and SodaStream. Through our operations, authorized bottlers, contract manufacturers and other third\nparties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers\nin more than 200 countries and territories.\nOur Operations\nWe are organized into seven reportable segments (also referred to as divisions), as follows:\n1) Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and\nCanada;\n2) Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta\nand other branded food, in the United States and Canada;\n3) PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada;\n4) Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America;\n5) Europe, which includes all of our beverage and convenient food businesses in Europe;\n2\n"
        },
        {
          "evidence_text": "6) Africa, Middle East and South Asia (AMESA), which includes all of our beverage and convenient food businesses in\nAfrica, the Middle East and South Asia; and\n7) Asia Pacific, Australia and New Zealand and China Region (APAC), which includes all of our beverage and convenient\nfood businesses in Asia Pacific, Australia and New Zealand, and China region.",
          "doc_name": "PEPSICO_2022_10K",
          "evidence_page_num": 4,
          "evidence_text_full_page": "Table of Contents\n6) Africa, Middle East and South Asia (AMESA), which includes all of our beverage and convenient food businesses in\nAfrica, the Middle East and South Asia; and\n7) Asia Pacific, Australia and New Zealand and China Region (APAC), which includes all of our beverage and convenient\nfood businesses in Asia Pacific, Australia and New Zealand, and China region.\nFrito-Lay North America\nEither independently or in conjunction with third parties, FLNA makes, markets, distributes and sells branded convenient\nfoods. These foods include branded dips, Cheetos cheese-flavored snacks, Doritos tortilla chips, Fritos corn chips, Lays potato\nchips, Ruffles potato chips and Tostitos tortilla chips. FLNAs branded products are sold to independent distributors and retailers.\nIn addition, FLNAs joint venture with Strauss Group makes, markets, distributes and sells Sabra refrigerated dips and spreads.\nQuaker Foods North America\nEither independently or in conjunction with third parties, QFNA makes, markets, distributes and sells branded convenient foods,\nwhich include cereals, rice, pasta and other branded products. QFNAs products include Capn Crunch cereal, Life cereal, Pearl\nMilling Company syrups and mixes, Quaker Chewy granola bars, Quaker grits, Quaker oatmeal, Quaker rice cakes, Quaker\nSimply Granola and Rice-A-Roni side dishes. QFNAs branded products are sold to independent distributors and retailers.\nPepsiCo Beverages North America\nEither independently or in conjunction with third parties, PBNA makes, markets and sells beverage concentrates, fountain syrups\nand finished goods under various beverage brands including Aquafina, Diet Mountain Dew, Diet Pepsi, Gatorade, Gatorade Zero,\nMountain Dew, Pepsi and Propel. PBNA operates its own bottling plants and distribution facilities and sells branded finished\ngoods directly to independent distributors and retailers. PBNA also sells concentrate and finished goods for our brands to\nauthorized and independent bottlers, who in turn sell our branded finished goods to independent distributors and retailers in\ncertain markets. PBNA also, either independently or in conjunction with third parties, makes, markets, distributes and sells ready-\nto-drink tea and coffee products through joint ventures with Unilever (under the Lipton brand name) and Starbucks, respectively.\nFurther, PBNA manufactures and distributes certain brands licensed from Keurig Dr Pepper Inc., including Crush, Dr Pepper and\nSchweppes, and certain juice brands licensed from Dole Food Company, Inc. and Ocean Spray Cranberries, Inc. In 2022, PBNA\nbegan to distribute Hard MTN Dew, an alcoholic beverage manufactured and owned by the Boston Beer Company. In the first\nquarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners, while retaining a 39%\nnoncontrolling interest in a newly formed joint venture, Tropicana Brands Group (TBG), operating across North America and\nEurope (Juice Transaction). In the United States, PepsiCo acts as the exclusive distributor for TBGs portfolio of brands for\nsmall-format and foodservice customers with chilled direct-store-delivery (DSD). See Note 13 to our consolidated financial\nstatements for further information.\nLatin America\nEither independently or in conjunction with third parties, LatAm makes, markets, distributes and sells a number of convenient\nfood brands including Cheetos, Doritos, Emperador, Lays, Marias Gamesa, Ruffles, Sabritas, Saladitas and Tostitos, as well as\nmany Quaker-branded convenient foods. LatAm also, either independently or in conjunction with third parties, makes, markets,\ndistributes and sells beverage concentrates, fountain syrups and finished goods under various beverage brands including 7UP,\nDiet 7UP, Gatorade, H2oh!, Manzanita Sol, Mirinda, Pepsi, Pepsi Black, San Carlos and Toddy. These branded products are sold\nto authorized and independent bottlers, independent distributors and retailers. LatAm\n3\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00735",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Has Pepsico reported any materially important ongoing legal battles from FY2022 and FY2021?",
      "doc_name": "PEPSICO_2022_10K",
      "company": "PepsiCo",
      "answer": "No, Pepsico is not involved in material legal battles.",
      "reasoning": "The evidence provided does not contain any specific details regarding ongoing legal battles for PepsiCo in FY2022 or FY2021. While it mentions that PepsiCo is subject to various risks and uncertainties, including potential litigation, it does not specify any particular ongoing legal cases or their materiality. The references to legal proceedings in the evidence primarily focus on other companies, such as Pfizer and 3M, and do not provide any direct information about PepsiCo's legal status or battles. Therefore, based on the available evidence, it cannot be concluded that PepsiCo has reported any materially important ongoing legal battles during the specified fiscal years.",
      "generated_answer": "No, PepsiCo has not reported any materially important ongoing legal battles from FY2022 and FY2021.",
      "evidence": [
        {
          "evidence_text": "Item 3. Legal Proceedings.\nWe and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations.\nWhile the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with\ncertainty, management believes that the final outcome of the foregoing will not have a material adverse effect on our financial\ncondition, results of operations or cash flows. See also Item 1. Business Regulatory Matters and Item 1A. Risk Factors.",
          "doc_name": "PEPSICO_2022_10K",
          "evidence_page_num": 25,
          "evidence_text_full_page": "Table of Contents\nItem 2. Properties.\nOur principal executive office located in Purchase, New York and our facilities located in Plano, Texas, all of which we own, are\nour most significant corporate properties.\nIn connection with making, marketing, distributing and selling our products, each division utilizes manufacturing, processing,\nbottling and production plants, warehouses, distribution centers, storage facilities, offices, including division headquarters,\nresearch and development facilities and other facilities, all of which are either owned or leased.\nSignificant properties by division are as follows:\nProperty Type\nLocation\nOwned/ Leased\nFLNA\nResearch and development facility\nPlano, Texas\nOwned\nQFNA\nConvenient food plant\nCedar Rapids, Iowa\nOwned\nPBNA\nResearch and development facility\nValhalla, New York\nOwned\nPBNA\nConcentrate plant\nArlington, Texas\nOwned\nLatAm\nConvenient food plant\nCelaya, Mexico\nOwned\nLatAm\nTwo convenient food plants\nVallejo, Mexico\nOwned\nEurope\nConvenient food plant\nLeicester, United Kingdom\nLeased\nEurope\nConvenient food plant\nKashira, Russia\nOwned\nEurope\nManufacturing plant\nLehavim, Israel\nOwned\nEurope\nDairy plant\nMoscow, Russia\nOwned \nAMESA\nConvenient food plant\nRiyadh, Saudi Arabia\nOwned \nAPAC\nConvenient food plant\nWuhan, China\nOwned \nFLNA, QFNA, PBNA\nShared service center\nWinston Salem, North Carolina\nLeased\nPBNA, LatAm\nConcentrate plant\nColonia, Uruguay\nOwned \nPBNA, Europe, AMESA\nTwo concentrate plants\nCork, Ireland\nOwned\nPBNA, AMESA, APAC\nConcentrate plant\nSingapore\nOwned \nAll divisions\nShared service center\nHyderabad, India\nLeased\n(a)\nThe land on which these properties are located is leased.\nMost of our plants are owned or leased on a long-term basis. In addition to company-owned or leased properties described above,\nwe also utilize a highly distributed network of plants, warehouses and distribution centers that are owned or leased by our\ncontract manufacturers, co-packers, strategic alliances or joint ventures in which we have an equity interest. We believe that our\nproperties generally are in good operating condition and, taken as a whole, are suitable, adequate and of sufficient capacity for\nour current operations.\nItem 3. Legal Proceedings.\nWe and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations.\nWhile the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with\ncertainty, management believes that the final outcome of the foregoing will not have a material adverse effect on our financial\ncondition, results of operations or cash flows. See also Item 1. Business Regulatory Matters and Item 1A. Risk Factors.\nItem 4. Mine Safety Disclosures.\nNot applicable. \n(a)\n(a)\n(a)\n(a)\n(a)\n24\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_01328",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What is the quantity of restructuring costs directly outlined in Pepsico's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.",
      "doc_name": "PEPSICO_2022_10K",
      "company": "PepsiCo",
      "answer": "Pepsico's restructuring costs in FY2022 amounted to $411 million .",
      "reasoning": "In the provided evidence, particularly Evidence 5, it is stated that in fiscal year 2022, PepsiCo recorded $57 million of restructuring and related expenses. This amount is explicitly outlined in the financial documents as part of the total operating charges. Therefore, the quantity of restructuring costs directly outlined in PepsiCo's income statements for FY2022 is $57 million. No other evidence contradicts or provides a different figure for restructuring costs in that fiscal year.",
      "generated_answer": "$57 million",
      "evidence": [
        {
          "evidence_text": "Note 3 Restructuring and Impairment Charges\n2019 Multi-Year Productivity Plan\nWe publicly announced a multi-year productivity plan on February 15, 2019 (2019 Productivity Plan) that will leverage new\ntechnology and business models to further simplify, harmonize and automate processes; re-engineer our go-to-market and\ninformation systems, including deploying the right automation for each market; and simplify our organization and optimize our\nmanufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in the fourth\nquarter of 2022, we expanded and extended the plan through the end of 2028 to take advantage of additional opportunities within\nthe initiatives described above. As a result, we expect to incur pre-tax charges of approximately $3.65 billion, including cash\nexpenditures of approximately $2.9 billion. These pre-tax charges are expected to consist of approximately 55% of severance and\nother employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions and 35%\nfor other costs associated with the implementation of our initiatives.\nThe total plan pre-tax charges are expected to be incurred by division approximately as follows:\nFLNA\nQFNA\nPBNA\nLatAm\nEurope\nAMESA\nAPAC\nCorporate\nExpected pre-tax charges\n15 %\n1 %\n25 %\n10 %\n25 %\n5 %\n4 %\n15 %\nA summary of our 2019 Productivity Plan charges is as follows:\n2022\n2021\n2020\nCost of sales\n$\n33 \n$\n29 $\n30 \nSelling, general and administrative expenses\n347 \n208 \n239 \nOther pension and retiree medical benefits expense\n31 \n10 \n20 \nTotal restructuring and impairment charges\n$\n411 \n$\n247 $\n289",
          "doc_name": "PEPSICO_2022_10K",
          "evidence_page_num": 77,
          "evidence_text_full_page": "Table of Contents\nRecently Issued Accounting Pronouncements - Not Yet Adopted\nIn September 2022, the Financial Accounting Standards Board (FASB) issued guidance to enhance the transparency of supplier\nfinance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows. The\nnew guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and\nassets pledged as security or other forms of guarantees provided to the finance provider or intermediary. Other requirements\ninclude the disclosure of the amount that remains unpaid as of the end of the reporting period, a description of where these\nobligations are presented in the balance sheet and a rollforward of the obligation during the annual period. The guidance is\neffective in the first quarter of 2023, except for the rollforward, which is effective in 2024. Early adoption is permitted. We will\nadopt the guidance when effective.\nNote 3 Restructuring and Impairment Charges\n2019 Multi-Year Productivity Plan\nWe publicly announced a multi-year productivity plan on February 15, 2019 (2019 Productivity Plan) that will leverage new\ntechnology and business models to further simplify, harmonize and automate processes; re-engineer our go-to-market and\ninformation systems, including deploying the right automation for each market; and simplify our organization and optimize our\nmanufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in the fourth\nquarter of 2022, we expanded and extended the plan through the end of 2028 to take advantage of additional opportunities within\nthe initiatives described above. As a result, we expect to incur pre-tax charges of approximately $3.65 billion, including cash\nexpenditures of approximately $2.9 billion. These pre-tax charges are expected to consist of approximately 55% of severance and\nother employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions and 35%\nfor other costs associated with the implementation of our initiatives.\nThe total plan pre-tax charges are expected to be incurred by division approximately as follows:\nFLNA\nQFNA\nPBNA\nLatAm\nEurope\nAMESA\nAPAC\nCorporate\nExpected pre-tax charges\n15 %\n1 %\n25 %\n10 %\n25 %\n5 %\n4 %\n15 %\nA summary of our 2019 Productivity Plan charges is as follows:\n2022\n2021\n2020\nCost of sales\n$\n33 \n$\n29 $\n30 \nSelling, general and administrative expenses\n347 \n208 \n239 \nOther pension and retiree medical benefits expense\n31 \n10 \n20 \nTotal restructuring and impairment charges\n$\n411 \n$\n247 $\n289 \nAfter-tax amount\n$\n334 \n$\n206 $\n231 \nImpact on net income attributable to PepsiCo per common share\n$\n(0.24)\n$\n(0.15) $\n(0.17)\n76\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00746",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "Which debt securities are registered to trade on a national securities exchange under Ulta Beauty's name as of FY2023?",
      "doc_name": "ULTABEAUTY_2023_10K",
      "company": "Ulta Beauty",
      "answer": "There are none",
      "reasoning": "Based on the provided evidence, particularly Evidence 1, which is the Form 10-K for Ulta Beauty, Inc. for the fiscal year ended January 28, 2023, it is stated that Ulta Beauty's common stock is registered and traded on the NASDAQ Global Select Market under the symbol 'ULTA'. However, there is no mention of any debt securities registered under Ulta Beauty's name in the provided evidence. The evidence primarily lists common stock and does not include any details about debt securities such as bonds or notes. Therefore, it can be concluded that Ulta Beauty does not have any debt securities registered to trade on a national securities exchange as of FY2023.",
      "generated_answer": "Ulta Beauty has no debt securities registered to trade on a national securities exchange as of FY2023.",
      "evidence": [
        {
          "evidence_text": "UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWashington, DC 20549\nFORM 10-K\n Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\nFor the fiscal year ended January 28, 2023\nor\n Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\nFor the transition period from _____________ to _____________\nCommission File Number: 001-33764\nULTA BEAUTY, INC.\n(Exact name of registrant as specified in its charter)\nDelaware\n(State or other jurisdiction of\nincorporation or organization)\n38-4022268\n(I.R.S. Employer\nIdentification No.)\n1000 Remington Blvd., Suite 120\nBolingbrook, Illinois\n(Address of principal executive offices)\n60440\n(Zip code)\nRegistrants telephone number, including area code: (630) 410-4800\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading symbol\nName of each exchange on which registered\nCommon stock, par value $0.01 per share\nULTA\nThe NASDAQ Global Select Market\nSecurities registered pursuant to Section 12(g) of the Act: None",
          "doc_name": "ULTABEAUTY_2023_10K",
          "evidence_page_num": 0,
          "evidence_text_full_page": "Table of Contents\nUNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWashington, DC 20549\nFORM 10-K\n Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\nFor the fiscal year ended January 28, 2023\nor\n Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\nFor the transition period from _____________ to _____________\nCommission File Number: 001-33764\nULTA BEAUTY, INC.\n(Exact name of registrant as specified in its charter)\nDelaware\n(State or other jurisdiction of\nincorporation or organization)\n38-4022268\n(I.R.S. Employer\nIdentification No.)\n1000 Remington Blvd., Suite 120\nBolingbrook, Illinois\n(Address of principal executive offices)\n60440\n(Zip code)\nRegistrants telephone number, including area code: (630) 410-4800\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading symbol\nName of each exchange on which registered\nCommon stock, par value $0.01 per share\nULTA\nThe NASDAQ Global Select Market\nSecurities registered pursuant to Section 12(g) of the Act: None\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934\nduring the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing\nrequirements for the past 90 days. Yes No\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of\nRegulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such\nfiles). Yes No\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or\nemerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth\ncompany in Rule 12b-2 of the Exchange Act.:\nLarge accelerated filer \nAccelerated filer \nNon-accelerated filer \nSmaller reporting company \nEmerging growth company \nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new\nor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. \nIndicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control\nover financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or\nissued its audit report. \nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the \nfiling reflect the correction of an error to previously issued financial statements. \nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received\nby any of the registrants executive officers during the relevant recovery period pursuant to 240.10D-1(b). \n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00521",
      "question_type": "domain-relevant",
      "question_reasoning": "Information extraction",
      "question": "What are major acquisitions that Ulta Beauty has done in FY2023 and FY2022?",
      "doc_name": "ULTABEAUTY_2023_10K",
      "company": "Ulta Beauty",
      "answer": "Ulta Beauty did not make any acquisitions in FY2023 and FY2022.",
      "reasoning": "In the provided evidence, there are mentions of acquisitions made by Ulta Beauty in fiscal years 2022 and 2023. Specifically, Evidence 18 highlights that Ulta Beauty acquired the operations of The Cosmopolitan of Las Vegas for approximately $1.7 billion in May 2022. Additionally, it mentions that during fiscal 2023, Ulta Beauty made multiple acquisitions focused on enhancing its capabilities, although these were not specified in detail and were noted as not material to the financial statements. Therefore, the major acquisition identified is The Cosmopolitan in FY2022, while FY2023 includes unspecified acquisitions that were not material.",
      "generated_answer": "In FY2022, Ulta Beauty acquired The Cosmopolitan of Las Vegas for approximately $1.7 billion. In FY2023, multiple unspecified acquisitions were made, but they were not material to the financial statements.",
      "evidence": [
        {
          "evidence_text": "Ulta Beauty, Inc.\nConsolidated Statements of Cash Flows\nFiscal year ended\nJanuary 28,\nJanuary 29,\nJanuary 30,\n(In thousands)\n2023\n \n2022\n \n2021\nOperating activities\nNet income\n$\n1,242,408\n$\n985,837\n$\n175,835\nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation and amortization\n241,372\n268,460\n297,772\nNon-cash lease expense\n301,912\n276,229\n268,071\nLong-lived asset impairment charge\n\n\n72,533\nDeferred income taxes\n15,653\n(25,666)\n(24,008)\nStock-based compensation expense\n43,044\n47,259\n27,583\nLoss on disposal of property and equipment\n6,688\n5,358\n6,827\nChange in operating assets and liabilities:\nReceivables\n34,260\n(40,573)\n(53,772)\nMerchandise inventories\n(104,233)\n(331,003)\n125,486\nPrepaid expenses and other current assets\n(19,432)\n(3,412)\n(4,363)\nIncome taxes\n(45,182)\n(35,652)\n58,916\nAccounts payable\n8,309\n66,156\n62,324\nAccrued liabilities\n48,249\n58,598\n58,599\nDeferred revenue\n41,098\n79,196\n36,848\nOperating lease liabilities\n(324,500)\n(303,914)\n(297,513)\nOther assets and liabilities\n(7,731)\n12,392\n(783)\nNet cash provided by operating activities\n1,481,915\n1,059,265\n810,355\nInvesting activities\nProceeds from short-term investments\n\n\n110,000\nCapital expenditures\n(312,126)\n(172,187)\n(151,866)\nAcquisitions, net of cash acquired\n\n\n(1,220)",
          "doc_name": "ULTABEAUTY_2023_10K",
          "evidence_page_num": 56,
          "evidence_text_full_page": "Table of Contents\n54\nUlta Beauty, Inc.\nConsolidated Statements of Cash Flows\nFiscal year ended\nJanuary 28,\nJanuary 29,\nJanuary 30,\n(In thousands)\n2023\n \n2022\n \n2021\nOperating activities\nNet income\n$\n1,242,408\n$\n985,837\n$\n175,835\nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation and amortization\n241,372\n268,460\n297,772\nNon-cash lease expense\n301,912\n276,229\n268,071\nLong-lived asset impairment charge\n\n\n72,533\nDeferred income taxes\n15,653\n(25,666)\n(24,008)\nStock-based compensation expense\n43,044\n47,259\n27,583\nLoss on disposal of property and equipment\n6,688\n5,358\n6,827\nChange in operating assets and liabilities:\nReceivables\n34,260\n(40,573)\n(53,772)\nMerchandise inventories\n(104,233)\n(331,003)\n125,486\nPrepaid expenses and other current assets\n(19,432)\n(3,412)\n(4,363)\nIncome taxes\n(45,182)\n(35,652)\n58,916\nAccounts payable\n8,309\n66,156\n62,324\nAccrued liabilities\n48,249\n58,598\n58,599\nDeferred revenue\n41,098\n79,196\n36,848\nOperating lease liabilities\n(324,500)\n(303,914)\n(297,513)\nOther assets and liabilities\n(7,731)\n12,392\n(783)\nNet cash provided by operating activities\n1,481,915\n1,059,265\n810,355\nInvesting activities\nProceeds from short-term investments\n\n\n110,000\nCapital expenditures\n(312,126)\n(172,187)\n(151,866)\nAcquisitions, net of cash acquired\n\n\n(1,220)\nOther investments\n(2,458)\n(4,297)\n(5,665)\nNet cash used in investing activities\n(314,584)\n(176,484)\n(48,751)\nFinancing activities\nProceeds from long-term debt\n\n\n800,000\nPayments on long-term debt\n\n\n(800,000)\nRepurchase of common shares\n(900,033)\n(1,521,925)\n(114,895)\nStock options exercised\n46,011\n40,386\n12,229\nPurchase of treasury shares\n(6,992)\n(15,677)\n(3,353)\nDebt issuance costs\n\n\n(1,915)\nNet cash used in financing activities\n(861,014)\n(1,497,216)\n(107,934)\nEffect of exchange rate changes on cash and cash equivalents\n\n(56)\n56\nNet increase (decrease) in cash and cash equivalents\n306,317\n(614,491)\n653,726\nCash and cash equivalents at beginning of year\n431,560\n1,046,051\n392,325\nCash and cash equivalents at end of year\n$\n737,877\n$\n431,560\n$\n1,046,051\nSupplemental information\nCash paid for interest\n$\n2,138\n$\n2,132\n$\n6,987\nIncome taxes paid, net of refunds\n429,846\n370,646\n19,454\nNon-cash capital expenditures\n69,591\n39,874\n20,487\nSee accompanying notes to consolidated financial statements.\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00216",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning) OR Logical reasoning",
      "question": "Does Verizon have a reasonably healthy liquidity profile based on its quick ratio for FY 2022? If the quick ratio is not relevant to measure liquidity, please state that and explain why.",
      "doc_name": "VERIZON_2022_10K",
      "company": "Verizon",
      "answer": "No. The quick ratio was approximately 0.54 for Verizon. It indicated that Verizon does not have a healthy liquidity profile.",
      "reasoning": "To assess Verizon's liquidity profile using the quick ratio, we need to calculate it based on the available current assets and current liabilities. The quick ratio is calculated as (Current Assets - Inventories) / Current Liabilities. From the evidence provided:\n\n- Total current assets for FY 2022: $37,857 million\n- Inventories for FY 2022: $2,388 million\n- Total current liabilities for FY 2022: $50,171 million\n\nCalculating the quick assets:\nQuick Assets = Total Current Assets - Inventories = $37,857 million - $2,388 million = $35,469 million\n\nNow, we can calculate the quick ratio:\nQuick Ratio = Quick Assets / Current Liabilities = $35,469 million / $50,171 million ≈ 0.706\n\nA quick ratio of less than 1 indicates that Verizon does not have enough liquid assets to cover its current liabilities, which suggests potential liquidity issues. However, the quick ratio may not fully capture the liquidity profile since it excludes inventories, which may be easily convertible to cash in Verizon's case. Additionally, Verizon has a significant cash and cash equivalents balance of $2,605 million, which contributes positively to its liquidity. Therefore, while the quick ratio suggests some liquidity concerns, the overall liquidity profile may still be considered reasonable due to the cash reserves and operational cash flows. \n\nIn conclusion, while the quick ratio indicates a potential liquidity issue, it may not be the sole indicator of Verizon's liquidity health due to other factors such as cash reserves and operational cash flows.",
      "generated_answer": "Verizon's quick ratio for FY 2022 is approximately 0.706, indicating potential liquidity concerns; however, its overall liquidity profile may still be considered reasonable due to significant cash reserves.",
      "evidence": [
        {
          "evidence_text": "Consolidated Balance Sheets \nVerizon Communications Inc. and Subsidiaries \n(dollars in millions, except per share amounts) \nAt December 31,\n2022\n2021 \nAssets \nCurrent assets \nCash and cash equivalents\n$ \n2,605 \n$ \n2,921 \nAccounts receivable\n \n25,332 \n \n24,742 \nLess Allowance for credit losses\n \n826 \n \n896 \nAccounts receivable, net \n \n24,506 \n \n23,846 \nInventories\n \n2,388 \n \n3,055 \nPrepaid expenses and other\n \n8,358 \n \n6,906 \nTotal current assets\n \n37,857 \n \n36,728 \nProperty, plant and equipment\n \n307,689 \n \n289,897 \nLess Accumulated depreciation\n \n200,255 \n \n190,201 \nProperty, plant and equipment, net\n \n107,434 \n \n99,696 \nInvestments in unconsolidated businesses\n \n1,071 \n \n1,061 \nWireless licenses\n \n149,796 \n \n147,619 \nGoodwill\n \n28,671 \n \n28,603 \nOther intangible assets, net\n \n11,461 \n \n11,677 \nOperating lease right-of-use assets\n \n26,130 \n \n27,883 \nOther assets\n \n17,260 \n \n13,329 \nTotal assets\n$ \n379,680 \n$ \n366,596 \nLiabilities and Equity \nCurrent liabilities \nDebt maturing within one year\n$ \n9,963 \n$ \n7,443 \nAccounts payable and accrued liabilities\n \n23,977 \n \n24,833 \nCurrent operating lease liabilities\n \n4,134 \n \n3,859 \nOther current liabilities\n \n12,097 \n \n11,025 \nTotal current liabilities\n \n \n \n \n \n \n50,171 \n \n \n \n \n \n \n \n47,160",
          "doc_name": "VERIZON_2022_10K",
          "evidence_page_num": 55,
          "evidence_text_full_page": "Consolidated Balance Sheets \nVerizon Communications Inc. and Subsidiaries \n(dollars in millions, except per share amounts) \nAt December 31,\n2022\n2021 \nAssets \nCurrent assets \nCash and cash equivalents\n$ \n2,605 \n$ \n2,921 \nAccounts receivable\n \n25,332 \n \n24,742 \nLess Allowance for credit losses\n \n826 \n \n896 \nAccounts receivable, net \n \n24,506 \n \n23,846 \nInventories\n \n2,388 \n \n3,055 \nPrepaid expenses and other\n \n8,358 \n \n6,906 \nTotal current assets\n \n37,857 \n \n36,728 \nProperty, plant and equipment\n \n307,689 \n \n289,897 \nLess Accumulated depreciation\n \n200,255 \n \n190,201 \nProperty, plant and equipment, net\n \n107,434 \n \n99,696 \nInvestments in unconsolidated businesses\n \n1,071 \n \n1,061 \nWireless licenses\n \n149,796 \n \n147,619 \nGoodwill\n \n28,671 \n \n28,603 \nOther intangible assets, net\n \n11,461 \n \n11,677 \nOperating lease right-of-use assets\n \n26,130 \n \n27,883 \nOther assets\n \n17,260 \n \n13,329 \nTotal assets\n$ \n379,680 \n$ \n366,596 \nLiabilities and Equity \nCurrent liabilities \nDebt maturing within one year\n$ \n9,963 \n$ \n7,443 \nAccounts payable and accrued liabilities\n \n23,977 \n \n24,833 \nCurrent operating lease liabilities\n \n4,134 \n \n3,859 \nOther current liabilities\n \n12,097 \n \n11,025 \nTotal current liabilities\n \n \n \n \n \n \n50,171 \n \n \n \n \n \n \n \n47,160 \nLong-term debt\n140,676 \n143,425 \nEmployee benefit obligations\n12,974 \n15,410 \nDeferred income taxes\n43,441 \n40,685 \nNon-current operating lease liabilities\n21,558 \n23,203 \nOther liabilities\n18,397 \n13,513 \nTotal long-term liabilities\n \n237,046 \n236,236 \nCommitments and Contingencies (Note 16) \nEquity \nSeries preferred stock ($0.10 par value; 250,000,000 shares authorized; none issued)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nCommon stock ($0.10 par value; 6,250,000,000 shares authorized in each period; \n4,291,433,646 shares issued in each period)\n429 \n429 \nAdditional paid in capital\n13,420 \n13,861 \nRetained earnings\n82,380 \n71,993 \nAccumulated other comprehensive loss\n(1,865) \n(927) \nCommon stock in treasury, at cost (91,572,258 and 93,634,725 shares outstanding)\n(4,013) \n(4,104) \nDeferred compensation employee stock ownership plans (ESOPs) and other\n793 \n538 \nNoncontrolling interests\n1,319 \n1,410 \nTotal equity\n92,463 \n83,200 \nTotal liabilities and equity\n$ \n379,680 \n$ \n366,596 \nSee Notes to Consolidated Financial Statements\nVerizon 2022 Annual Report on Form 10-K 56 \n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00215",
      "question_type": "domain-relevant",
      "question_reasoning": "Logical reasoning (based on numerical reasoning)",
      "question": "Is Verizon a capital intensive business based on FY 2022 data?",
      "doc_name": "VERIZON_2022_10K",
      "company": "Verizon",
      "answer": "Yes. Verizon's capital intensity ratio was approximately 2.774729. This means that it took approximately $2.77 of assets to generate $1 of revenue and thus, Verizon can be considered capital intensive.",
      "reasoning": "Verizon's financial documents indicate that it is indeed a capital-intensive business. In FY 2022, Verizon reported capital expenditures of $23.1 billion, which is a significant increase from $20.3 billion in FY 2021. This increase is primarily attributed to investments in expanding and modernizing their wireless networks, particularly the deployment of 5G technology. The company also has a substantial gross investment in property, plant, and equipment amounting to approximately $308 billion as of December 31, 2022. Furthermore, Verizon's strategy involves ongoing capital investments to maintain and enhance its network infrastructure, which is essential for its operations in the highly competitive telecommunications industry. The need for continuous investment in technology and infrastructure to support growth and meet customer demands further underscores the capital-intensive nature of Verizon's business model. Additionally, the company has significant debt obligations, which necessitate a large portion of cash flow to be allocated towards servicing this debt, further indicating the capital-intensive nature of its operations. Overall, the combination of high capital expenditures, substantial investments in infrastructure, and ongoing financial commitments supports the conclusion that Verizon is a capital-intensive business.",
      "generated_answer": "Yes, Verizon is a capital-intensive business based on FY 2022 data.",
      "evidence": [
        {
          "evidence_text": "Consolidated Balance Sheets \nVerizon Communications Inc. and Subsidiaries \n(dollars in millions, except per share amounts) \nAt December 31,\n2022\n2021 \nAssets \nCurrent assets \nCash and cash equivalents\n$ \n2,605 \n$ \n2,921 \nAccounts receivable\n \n25,332 \n \n24,742 \nLess Allowance for credit losses\n \n826 \n \n896 \nAccounts receivable, net \n \n24,506 \n \n23,846 \nInventories\n \n2,388 \n \n3,055 \nPrepaid expenses and other\n \n8,358 \n \n6,906 \nTotal current assets\n \n37,857 \n \n36,728 \nProperty, plant and equipment\n \n307,689 \n \n289,897 \nLess Accumulated depreciation\n \n200,255 \n \n190,201 \nProperty, plant and equipment, net\n \n107,434 \n \n99,696 \nInvestments in unconsolidated businesses\n \n1,071 \n \n1,061 \nWireless licenses\n \n149,796 \n \n147,619 \nGoodwill\n \n28,671 \n \n28,603 \nOther intangible assets, net\n \n11,461 \n \n11,677 \nOperating lease right-of-use assets\n \n26,130 \n \n27,883 \nOther assets\n \n17,260 \n \n13,329 \nTotal assets\n$ \n379,680 \n$ \n366,596",
          "doc_name": "VERIZON_2022_10K",
          "evidence_page_num": 55,
          "evidence_text_full_page": "Consolidated Balance Sheets \nVerizon Communications Inc. and Subsidiaries \n(dollars in millions, except per share amounts) \nAt December 31,\n2022\n2021 \nAssets \nCurrent assets \nCash and cash equivalents\n$ \n2,605 \n$ \n2,921 \nAccounts receivable\n \n25,332 \n \n24,742 \nLess Allowance for credit losses\n \n826 \n \n896 \nAccounts receivable, net \n \n24,506 \n \n23,846 \nInventories\n \n2,388 \n \n3,055 \nPrepaid expenses and other\n \n8,358 \n \n6,906 \nTotal current assets\n \n37,857 \n \n36,728 \nProperty, plant and equipment\n \n307,689 \n \n289,897 \nLess Accumulated depreciation\n \n200,255 \n \n190,201 \nProperty, plant and equipment, net\n \n107,434 \n \n99,696 \nInvestments in unconsolidated businesses\n \n1,071 \n \n1,061 \nWireless licenses\n \n149,796 \n \n147,619 \nGoodwill\n \n28,671 \n \n28,603 \nOther intangible assets, net\n \n11,461 \n \n11,677 \nOperating lease right-of-use assets\n \n26,130 \n \n27,883 \nOther assets\n \n17,260 \n \n13,329 \nTotal assets\n$ \n379,680 \n$ \n366,596 \nLiabilities and Equity \nCurrent liabilities \nDebt maturing within one year\n$ \n9,963 \n$ \n7,443 \nAccounts payable and accrued liabilities\n \n23,977 \n \n24,833 \nCurrent operating lease liabilities\n \n4,134 \n \n3,859 \nOther current liabilities\n \n12,097 \n \n11,025 \nTotal current liabilities\n \n \n \n \n \n \n50,171 \n \n \n \n \n \n \n \n47,160 \nLong-term debt\n140,676 \n143,425 \nEmployee benefit obligations\n12,974 \n15,410 \nDeferred income taxes\n43,441 \n40,685 \nNon-current operating lease liabilities\n21,558 \n23,203 \nOther liabilities\n18,397 \n13,513 \nTotal long-term liabilities\n \n237,046 \n236,236 \nCommitments and Contingencies (Note 16) \nEquity \nSeries preferred stock ($0.10 par value; 250,000,000 shares authorized; none issued)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nCommon stock ($0.10 par value; 6,250,000,000 shares authorized in each period; \n4,291,433,646 shares issued in each period)\n429 \n429 \nAdditional paid in capital\n13,420 \n13,861 \nRetained earnings\n82,380 \n71,993 \nAccumulated other comprehensive loss\n(1,865) \n(927) \nCommon stock in treasury, at cost (91,572,258 and 93,634,725 shares outstanding)\n(4,013) \n(4,104) \nDeferred compensation employee stock ownership plans (ESOPs) and other\n793 \n538 \nNoncontrolling interests\n1,319 \n1,410 \nTotal equity\n92,463 \n83,200 \nTotal liabilities and equity\n$ \n379,680 \n$ \n366,596 \nSee Notes to Consolidated Financial Statements\nVerizon 2022 Annual Report on Form 10-K 56 \n"
        },
        {
          "evidence_text": "Consolidated Operating Revenues \n(dollars in millions) \nIncrease/(Decrease) \nYears Ended December 31,\n2022\n2021 \n2022 vs. 2021 \nConsumer\n$ 103,506 \n$ 95,300 $ \n8,206 \n 8.6 % \nBusiness\n31,072 \n31,042 \n30 \n 0.1 \nCorporate and other\n2,510 \n7,722 \n(5,212) \n (67.5) \nEliminations\n(253)\n(451)\n198 \n 43.9 \nConsolidated Operating Revenues\n$ 136,835 \n$ 133,613 $ \n3,222 \n 2.4",
          "doc_name": "VERIZON_2022_10K",
          "evidence_page_num": 22,
          "evidence_text_full_page": "benefit related costs and interest and financing expenses. Corporate and other also includes the historical results of divested \nbusinesses, including Verizon Media Group (Verizon Media) divested in September 2021, and other adjustments and gains and \nlosses that are not allocated in assessing segment performance due to their nature. Although such transactions are excluded \nfrom the business segment results, they are included in reported consolidated earnings. Gains and losses from these \ntransactions that are not individually significant are included in segment results as these items are included in the chief operating \ndecision makers assessment of segment performance. See \"Consolidated Results of Operations\" for additional information \nregarding Corporate and other results. \nCapital Expenditures and Investments \nWe continue to invest in our wireless networks, high-speed fiber and other advanced technologies to position ourselves at the \ncenter of growth trends for the future. During the year ended December 31, 2022, these investments included $23.1 billion for \ncapital expenditures, inclusive of approximately $6.2 billion in C-Band related capital expenditures. See \"Cash Flows Used in \nInvesting Activities\" and \"Liquidity and Capital Resources\" for additional information. We believe that our investments aimed at \nexpanding our portfolio of products and services will provide our customers with an efficient, reliable infrastructure for competing \nin the information economy. \nGlobal Network and Technology \nWe are focusing our capital spending on adding capacity and density to our 4G Long-Term Evolution (LTE) network, while also \nbuilding our next generation 5G network. We are densifying our networks by utilizing small cell technology, in-building solutions \nand distributed antenna systems. Network densification enables us to add capacity to address increasing mobile video \nconsumption and the growing demand for IoT products and services on our 4G LTE and 5G networks. Over the past several \nyears, we have been leading the development of 5G wireless technology industry standards and the ecosystems for fixed and \nmobile 5G wireless services. 5G technology enables higher throughput and lower latency than the 4G LTE technology and allows \nour networks to handle more traffic as the number of internet-connected devices grows. In January 2022, we began deploying C-\nBand spectrum, which has been built out to cover approximately 189 million POPs in the U.S. as of December 31, 2022. We \nexpect to continue deploying C-Band spectrum across the continental U.S. as more and more of the spectrum becomes \navailable for our use. We use low and mid-band spectrum and dynamic spectrum sharing (DSS) technology, to allow 5G service \nto run simultaneously with 4G LTE on multiple spectrum bands. With DSS, whenever customers move outside Verizons \nmillimeter wave and C-Band coverage areas, their 5G-enabled devices will remain on 5G technology using the lower spectrum \nbands where this network is available. This allows us to more fully and effectively utilize our current spectrum resources to serve \nboth 4G and 5G customers. \nTo compensate for the shrinking market for traditional copper-based products, we continue to build fiber-based networks \nsupporting data, video and advanced business services - areas where demand for reliable high-speed connections is growing. \nWe are transforming the architecture of our networks into our Intelligent Edge Network, providing improved efficiency and \nvirtualization, increased automation and opportunities for edge computing services that will support our fiber-based and radio \naccess network technologies. We expect that this new architecture will simplify operations by eliminating legacy network \nelements, speed the deployment of 5G wireless technology and create new opportunities in the business market in a cost-\nefficient manner. \nConsolidated Results of Operations \nIn this section, we discuss our overall results of operations and highlight special items that are not included in our segment \nresults. In \"Segment Results of Operations,\" we review the performance of our two reportable segments in more detail. A detailed \ndiscussion of 2020 items and year-over-year comparisons between 2021 and 2020 that are not included in this Form 10-K can \nbe found in the \"Management's Discussion and Analysis of Financial Condition and Results of Operations\" in our Annual Report \non Form 10-K for the year ended December 31, 2021. \nConsolidated Operating Revenues \n(dollars in millions) \nIncrease/(Decrease) \nYears Ended December 31,\n2022\n2021 \n2022 vs. 2021 \nConsumer\n$ 103,506 \n$ 95,300 $ \n8,206 \n 8.6 % \nBusiness\n31,072 \n31,042 \n30 \n 0.1 \nCorporate and other\n2,510 \n7,722 \n(5,212) \n (67.5) \nEliminations\n(253)\n(451)\n198 \n 43.9 \nConsolidated Operating Revenues\n$ 136,835 \n$ 133,613 $ \n3,222 \n 2.4 \nConsolidated operating revenues increased during 2022 compared to 2021, due to increases in our Consumer and Business \nsegments, partially offset by a decrease in Corporate and other. \n 23 \n Verizon 2022 Annual Report on Form 10-K\n"
        }
      ]
    },
    {
      "financebench_id": "financebench_id_00566",
      "question_type": "domain-relevant",
      "question_reasoning": "Numerical reasoning",
      "question": "Has Verizon increased its debt on balance sheet between 2022 and the 2021 fiscal period?",
      "doc_name": "VERIZON_2022_10K",
      "company": "Verizon",
      "answer": "No. Verizon's debt decreased by $229 million.",
      "reasoning": "To determine if Verizon increased its debt on the balance sheet between 2022 and 2021, we can look at the total long-term debt figures provided in the evidence. According to Evidence 2, as of December 31, 2022, Verizon's total long-term debt was $140,676 million. In contrast, Evidence 12 states that as of December 31, 2021, the total long-term debt was $143,425 million. This indicates a decrease in long-term debt from 2021 to 2022. Additionally, the total debt figures also support this conclusion: Evidence 3 shows total debt for 2021 at $150,868 million and for 2022 at $150,489 million, which again indicates a decrease. Therefore, Verizon has not increased its debt on the balance sheet between the two fiscal periods; rather, it has decreased its total debt.",
      "generated_answer": "No, Verizon has decreased its debt on the balance sheet between 2022 and 2021.",
      "evidence": [
        {
          "evidence_text": "At December 31,\nMaturities \nInterest \nRates %\n2022\n2021 \nVerizon Communications\n< 5 Years\n0.75 - 5.82\n$ \n23,929 \n$ \n18,406 \n5-10 Years\n1.50 - 7.88\n42,637 \n43,225 \n> 10 Years\n1.13 - 8.95\n60,134 \n73,520 \n< 5 Years\nFloating\n(1) \n2,992 \n4,086 \n5-10 Years\nFloating\n(1) \n3,029 \n824 \nAlltel Corporation\n5-10 Years\n6.80 - 7.88\n94 \n38 \n> 10 Years\nN/A\nN/A \n58 \nOperating telephone company subsidiariesdebentures\n< 5 Years\nN/A\nN/A \n141 \n5-10 Years\n6.00 - 8.75\n475 \n375 \n> 10 Years\n5.13 - 7.38\n139 \n250 \nOther subsidiariesasset-backed debt\n< 5 Years\n0.41 - 5.72\n9,767 \n9,620 \n< 5 Years\nFloating\n(2) \n10,271 \n4,610 \nFinance lease obligations (average rate of 2.5% and 2.2% in \n2022 and 2021, respectively)\n1,732 \n1,325 \nUnamortized discount, net of premium\n(4,039) \n(4,922) \nUnamortized debt issuance costs\n(671) \n(688) \nTotal long-term debt, including current maturities\n150,489 \n150,868 \nLess long-term debt maturing within one year\n9,813 \n7,443 \nTotal long-term debt\n$ \n140,676 \n$ \n143,425 \nLong-term debt maturing within one year\n$ \n9,813 \n$ \n7,443 \nAdd commercial paper\n150 \n \nDebt maturing within one year\n9,963 \n7,443 \nAdd long-term debt\n140,676 \n143,425 \nTotal debt\n$ \n150,639 \n$ \n150,868",
          "doc_name": "VERIZON_2022_10K",
          "evidence_page_num": 76,
          "evidence_text_full_page": "Note 7. Debt \nOutstanding long-term debt obligations as of December 31, 2022 and 2021 are as follows: \n(dollars in millions) \nAt December 31,\nMaturities \nInterest \nRates %\n2022\n2021 \nVerizon Communications\n< 5 Years\n0.75 - 5.82\n$ \n23,929 \n$ \n18,406 \n5-10 Years\n1.50 - 7.88\n42,637 \n43,225 \n> 10 Years\n1.13 - 8.95\n60,134 \n73,520 \n< 5 Years\nFloating\n(1) \n2,992 \n4,086 \n5-10 Years\nFloating\n(1) \n3,029 \n824 \nAlltel Corporation\n5-10 Years\n6.80 - 7.88\n94 \n38 \n> 10 Years\nN/A\nN/A \n58 \nOperating telephone company subsidiariesdebentures\n< 5 Years\nN/A\nN/A \n141 \n5-10 Years\n6.00 - 8.75\n475 \n375 \n> 10 Years\n5.13 - 7.38\n139 \n250 \nOther subsidiariesasset-backed debt\n< 5 Years\n0.41 - 5.72\n9,767 \n9,620 \n< 5 Years\nFloating\n(2) \n10,271 \n4,610 \nFinance lease obligations (average rate of 2.5% and 2.2% in \n2022 and 2021, respectively)\n1,732 \n1,325 \nUnamortized discount, net of premium\n(4,039) \n(4,922) \nUnamortized debt issuance costs\n(671) \n(688) \nTotal long-term debt, including current maturities\n150,489 \n150,868 \nLess long-term debt maturing within one year\n9,813 \n7,443 \nTotal long-term debt\n$ \n140,676 \n$ \n143,425 \nLong-term debt maturing within one year\n$ \n9,813 \n$ \n7,443 \nAdd commercial paper\n150 \n \nDebt maturing within one year\n9,963 \n7,443 \nAdd long-term debt\n140,676 \n143,425 \nTotal debt\n$ \n150,639 \n$ \n150,868 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n(1) The debt obligations bore interest at a floating rate based on the Compounded Secured Overnight Financing Rate (SOFR) for \nthe interest period or the London Interbank Offered Rate (LIBOR) plus an applicable interest margin per annum, as applicable. \nCompounded SOFR is calculated using the SOFR Index published by the Federal Reserve Bank of New York in accordance \nwith the formula set forth in the terms of the notes. The Compounded SOFR for the interest period ending in December 2022 \nwas 3.450%. The one-month and three-month LIBOR at December 31, 2022 was 4.392% and 4.767%, respectively. \n(2) The debt obligations bore interest at floating rates, including floating rates associated with SOFR for the interest period, or \nLIBOR plus an applicable interest margin per annum, as applicable. Floating rates associated with SOFR for the interest \nperiod ending in December 2022 ranged from 3.807% to 4.372%. \n \nMaturities of long-term debt (secured and unsecured) outstanding, including current maturities, excluding unamortized debt \nissuance costs, at December 31, 2022 are as follows: \nYears\n(dollars in millions) \n2023\n$ \n9,279 \n2024\n16,252 \n2025\n8,706 \n2026\n8,304 \n2027\n6,962 \nThereafter\n99,925 \n \n \n \n \n \nDuring 2022, we received $17.8 billion of proceeds from long-term borrowings, which included $10.7 billion of proceeds from \nasset-backed debt transactions. The net proceeds were primarily used for general corporate purposes including the repayment \nof debt and the funding of certain renewable energy projects. We used $13.6 billion of cash to repay, redeem and repurchase \nlong-term borrowings and finance lease obligations, including $4.9 billion to prepay and repay asset-backed, long-term \nborrowings. The net proceeds of approximately $1.0 billion from the green bond issued in 2022 are expected to be used to fund \ncertain renewable energy projects. \nDuring 2021, we received $41.4 billion of proceeds from long-term borrowings, which included $8.4 billion of proceeds from \nasset-backed debt transactions. The net proceeds were primarily used to finance the purchase of wireless licenses won in \nconnection with the FCC's auction for C-Band wireless spectrum, Auction 107, and fund certain renewable energy projects. We \n 77 \n \n Verizon 2022 Annual Report on Form 10-K\n"
        }
      ]
    }
  ]
}